BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388:2654-2664. [PMID: 27156933 DOI: 10.1016/s0140-6736(16)30354-3] [Cited by in Crossref: 1078] [Cited by in F6Publishing: 1035] [Article Influence: 154.0] [Reference Citation Analysis]
Number Citing Articles
1 Pang T, Tang Q, Wei J, Li J, Ma L, Qin Q, Ma J, He H, Chen Y. Construction of a novel immune-related prognostic-predicting model of gastric cancer. Gene 2023;852:147032. [PMID: 36403868 DOI: 10.1016/j.gene.2022.147032] [Reference Citation Analysis]
2 Xu B, Li W, Lu C, Wang Y, Li C, Sun D. A near-infrared photoelectrochemical immunosensor for CA72-4 sensing based on SnS nanorods integrated with gold nanoparticles. Talanta 2023;253:123910. [PMID: 36152609 DOI: 10.1016/j.talanta.2022.123910] [Reference Citation Analysis]
3 Liu G, Xia Y, Wang H, Jin X, Chen S, Chen W, Zhang C, He Y. Downregulation of CYRI-B promotes migration, invasion and EMT by activating the Rac1-STAT3 pathway in gastric cancer. Exp Cell Res 2023;423:113453. [PMID: 36584745 DOI: 10.1016/j.yexcr.2022.113453] [Reference Citation Analysis]
4 Pohekar M, Shinde R. Critical Analysis of the Klass-02 Randomized Clinical Trial. JAMA Surg 2023. [PMID: 36696130 DOI: 10.1001/jamasurg.2022.6913] [Reference Citation Analysis]
5 Paridar Y, Hosseinpour H, Mard-soltani M, Mehr SP, Shakerian N, Dezfuli DA, Khalili S, Abyaz MR. Evaluation of the clinical significance of BTG1 gene expression and pepsinogen in serum and cancerous tissue and gastric atrophy.. [DOI: 10.21203/rs.3.rs-2447479/v1] [Reference Citation Analysis]
6 Vo D, Ghosh P, Sahoo D. Artificial intelligence-guided discovery of gastric cancer continuum. Gastric Cancer 2023;:1-12. [PMID: 36692601 DOI: 10.1007/s10120-022-01360-3] [Reference Citation Analysis]
7 Li D, Xia L, Huang P, Wang Z, Guo Q, Huang C, Leng W, Qin S. Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2/FGFR1/PI3K/AKT axis. Cell Death Discov 2023;9:17. [PMID: 36681667 DOI: 10.1038/s41420-023-01336-x] [Reference Citation Analysis]
8 Chen Z, Zheng Y, Fan P, Li M, Liu W, Yuan H, Liu X, Zhang Z, Wu Z, Wang Y, Ji R, Guo Q, Ye Y, Zhang J, Li X, An F, Lu L, Li Y, Wang X, Zhang J, Guan Q, Li Q, Liu M, Ren Q, Hu X, Lu H, Zhang H, Zhao Y, Gou X, Shu X, Wang J, Hu Z, Xue S, Liu J, Zhou Y. Risk factors in the development of gastric adenocarcinoma in the general population: A cross-sectional study of the Wuwei Cohort. Front Microbiol 2023;13. [DOI: 10.3389/fmicb.2022.1024155] [Reference Citation Analysis]
9 Okuno K, Watanabe S, Roy S, Kanda M, Tokunaga M, Kodera Y, Kinugasa Y, Goel A. A liquid biopsy signature for predicting early recurrence in patients with gastric cancer. Br J Cancer 2023. [PMID: 36631634 DOI: 10.1038/s41416-022-02138-1] [Reference Citation Analysis]
10 Ansari S, Nikpour P. LNCAROD promotes the proliferation and migration of gastric cancer: a bioinformatics analysis and experimental validation. Funct Integr Genomics 2023;23:34. [PMID: 36625949 DOI: 10.1007/s10142-022-00954-5] [Reference Citation Analysis]
11 Cui Y, Yu Y, Zheng S, Ying J, Du Y, Wang Y, Wang X, Shen Z, Liu F, Lv M, Sun Y, Liu T. Does resection after neoadjuvant chemotherapy of Docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? A multicenter, prospective cohort study (Neo-REGATTA).. [DOI: 10.21203/rs.3.rs-2411695/v1] [Reference Citation Analysis]
12 Deng M, Zhang L, Zheng W, Chen J, Du N, Li M, Chen W, Huang Y, Zeng N, Song Y, Chen Y. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression. J Exp Clin Cancer Res 2023;42:9. [PMID: 36609449 DOI: 10.1186/s13046-022-02586-w] [Reference Citation Analysis]
13 Ji T, Gao X, Li D, Huai S, Chi Y, An X, Ji W, Yang S, Li J. Identification and validation of signature for prognosis and immune microenvironment in gastric cancer based on m6A demethylase ALKBH5. Front Oncol 2022;12:1079402. [PMID: 36686788 DOI: 10.3389/fonc.2022.1079402] [Reference Citation Analysis]
14 Zhang G, Song J, Feng Z, Zhao W, Huang P, Liu L, Zhang Y, Su X, Wu Y, Cao Y, Li Z, Jie Z. Artificial intelligence applicated in gastric cancer: A bibliometric and visual analysis via CiteSpace. Front Oncol 2022;12:1075974. [PMID: 36686778 DOI: 10.3389/fonc.2022.1075974] [Reference Citation Analysis]
15 Abele M, Grabner L, Blessing T, Block A, Agaimy A, Kratz C, Simon T, Calaminus G, Heine S, Corbacioglu S, Christiansen H, Schneider DT, Brecht IB. Epidemiology and Characteristics of Gastric Carcinoma in Childhood-An Analysis of Data from Population-Based and Clinical Cancer Registries. Cancers (Basel) 2023;15. [PMID: 36612313 DOI: 10.3390/cancers15010317] [Reference Citation Analysis]
16 Halfdanarson TR, Sonbol MB, Starr JS, Hallemeier CL. Esophageal and gastric cancer. Cardio-Oncology Practice Manual : a Companion to Braunwald 's Heart Disease 2023. [DOI: 10.1016/b978-0-323-68135-3.00050-7] [Reference Citation Analysis]
17 Lee CYC, Olivier A, Honing J, Lydon AM, Richardson S, O'Donovan M, Tischkowitz M, Fitzgerald RC, di Pietro M. Endoscopic surveillance with systematic random biopsy for the early diagnosis of hereditary diffuse gastric cancer: a prospective 16-year longitudinal cohort study. Lancet Oncol 2023;24:107-16. [PMID: 36509094 DOI: 10.1016/S1470-2045(22)00700-8] [Reference Citation Analysis]
18 Mi C, Zhao Y, Ren L, Zhang D. HIF1α/CCL7/KIAA1199 axis mediates hypoxia-induced gastric cancer aggravation and glycolysis alteration. J Clin Biochem Nutr 2023. [DOI: 10.3164/jcbn.22-48] [Reference Citation Analysis]
19 Cui Y, Yu Y, Yu S, Li W, Wang Y, Li Q, Liu T. Phase I study of adjuvant chemotherapy with nab-paclitaxel and S-1 for stage III Lauren's diffuse-type gastric cancer after D2 resection (NORDICA study). Cancer Med 2022. [PMID: 35751496 DOI: 10.1002/cam4.4966] [Reference Citation Analysis]
20 Abdel-tawab MS, Fouad H, Yahiya A, Tammam AA, Fahmy AM, Shaaban S, Abdel-salam SM, Elazeem NAA. Evaluation of CEP55, SERPINE1 and SMPD3 genes and proteins as diagnostic and prognostic biomarkers in gastric carcinoma in Egyptian patients. Beni-Suef Univ J Basic Appl Sci 2022;11:153. [DOI: 10.1186/s43088-022-00334-9] [Reference Citation Analysis]
21 Chen S, Xu J, Yin S, Wang H, Liu G, Jin X, Zhang J, Wang H, Wang H, Li H, Liang J, He Y, Zhang C. Identification of a Two-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival in Diffuse-Type Gastric Cancer. Curr Oncol 2022;30:171-83. [PMID: 36661663 DOI: 10.3390/curroncol30010014] [Reference Citation Analysis]
22 Sun CC, Li L, Tao HQ, Jiang ZC, Wang L, Wang HJ. The role of NLRP3 inflammasome in digestive system malignancy. Front Cell Dev Biol 2022;10:1051612. [PMID: 36619871 DOI: 10.3389/fcell.2022.1051612] [Reference Citation Analysis]
23 Liu S, Wong HY, Xie L, Kim Y, Shu D, Zheng B, Liu N, Xing C, Chen X, Dong Q. Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer: a Bayesian network meta-analysis. Sci Rep 2022;12:22024. [PMID: 36539429 DOI: 10.1038/s41598-022-24426-9] [Reference Citation Analysis]
24 Lu Y, Meng Q, Bai L, Wang R, Sun Y, Li J, Fan J, Tian T. LINC00858 stabilizes RAN expression and promotes metastasis of gastric cancer. Biol Direct 2022;17:41. [PMID: 36528654 DOI: 10.1186/s13062-022-00355-5] [Reference Citation Analysis]
25 Han Chen, Xin Yu, Ruoyun Yang, Shuo Li, Guoxin Zhang, Xinmin Si, Xiaoying Zhou. The Long-Term Outcomes of Surgery Versus Endoscopic Treatment in Patients With Siewert Type II T1M0N0 Adenocarcinoma of the Esophagogastric Junction. Cancer Control 2022;29:10732748221143389. [PMID: 36523149 DOI: 10.1177/10732748221143389] [Reference Citation Analysis]
26 Lu X, Fu Y, Gu L, Zhang Y, Liao AY, Wang T, Jia B, Zhou D, Liao L. Integrated proteome and phosphoproteome analysis of gastric adenocarcinoma reveals molecular signatures capable of stratifying patient outcome. Mol Oncol 2022. [PMID: 36520032 DOI: 10.1002/1878-0261.13361] [Reference Citation Analysis]
27 Tian C, Zhao J, Liu D, Sun J, Ji C, Jiang Q, Li H, Wang X, Sun Y. Identification of metabolism-related genes for predicting peritoneal metastasis in patients with gastric cancer. BMC Genom Data 2022;23:84. [PMID: 36503378 DOI: 10.1186/s12863-022-01096-0] [Reference Citation Analysis]
28 Guo Y, Zhang L, Ma Q. A novel association between Bmi-1 protein expression and the SUVmax obtained by (18)F-FDG PET/CT in patients with gastric adenocarcinoma. Open Life Sci 2022;17:1617-28. [PMID: 36561502 DOI: 10.1515/biol-2022-0087] [Reference Citation Analysis]
29 Lee J, Kim MH, Kim H. Anti-Oxidant and Anti-Inflammatory Effects of Astaxanthin on Gastrointestinal Diseases. Int J Mol Sci 2022;23. [PMID: 36555112 DOI: 10.3390/ijms232415471] [Reference Citation Analysis]
30 Xi S, Jing L, Lili W, Tingting L, Jun L, Ming W, Zhiqiang W, Peng J. Magnetic controlled capsule endoscope (MCCE)'s diagnostic performance for H. pylori infection status based on the Kyoto classification of gastritis. BMC Gastroenterol 2022;22:502. [PMID: 36474169 DOI: 10.1186/s12876-022-02589-z] [Reference Citation Analysis]
31 Li D, Shen L, Zhang X, Chen Z, Huang P, Huang C, Qin S. LncRNA ELF3-AS1 inhibits gastric cancer by forming a negative feedback loop with SNAI2 and regulates ELF3 mRNA stability via interacting with ILF2/ILF3 complex. J Exp Clin Cancer Res 2022;41:332. [PMID: 36457025 DOI: 10.1186/s13046-022-02541-9] [Reference Citation Analysis]
32 Wang Y, Li T, Yang L, Zhang X, Wang X, Su X, Ji C, Wang Z. Cancer-associated fibroblast-released extracellular vesicles carrying miR-199a-5p induces the progression of​ gastric cancer through regulation of FKBP5-mediated AKT1/mTORC1 signaling pathway. Cell Cycle 2022;21:2590-601. [PMID: 36005478 DOI: 10.1080/15384101.2022.2105092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Dong J, Yang J, Yu W, Li H, Cai M, Xu JL, Xu HD, Shi YF, Guan X, Cheng XD, Qin JJ. Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3). J Enzyme Inhib Med Chem 2022;37:2004-16. [PMID: 35844184 DOI: 10.1080/14756366.2022.2100366] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Pan J, Gu X, Luo J, Qian X, Gao Q, Li T, Ye L, Li C. Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1073688] [Reference Citation Analysis]
35 Huang G, Cai G, Hu D, Li J, Xu Q, Chen Z, Xu B. Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition. Cell Oncol (Dordr) 2022. [PMID: 36214997 DOI: 10.1007/s13402-022-00722-4] [Reference Citation Analysis]
36 Hao D, Li Q, Feng QX, Qi L, Liu XS, Arefan D, Zhang YD, Wu S. SurvivalCNN: A deep learning-based method for gastric cancer survival prediction using radiological imaging data and clinicopathological variables. Artif Intell Med 2022;134:102424. [PMID: 36462894 DOI: 10.1016/j.artmed.2022.102424] [Reference Citation Analysis]
37 Hu K, Zheng Q, Wang Y, Zhao M, Sun Z. Clinical and prognostic features of E-cadherin in adenocarcinoma of the esophagogastric junction patients. European Journal of Cancer Prevention 2022;Publish Ahead of Print. [DOI: 10.1097/cej.0000000000000776] [Reference Citation Analysis]
38 Pal D, Sahu P, Sethi G, Wallace CE, Bishayee A. Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases. Pharmaceutics 2022;14. [PMID: 36559116 DOI: 10.3390/pharmaceutics14122624] [Reference Citation Analysis]
39 Yu D, Ou Z, Zhang W, He H, Li Y, He W, Zhang M, Gao Y, Wu F, Chen Q. Global and national trends in years of life lost and years lived with disability caused by three common gastrointestinal cancers from 1990 to 2019. BMC Gastroenterol 2022;22:493. [DOI: 10.1186/s12876-022-02567-5] [Reference Citation Analysis]
40 Wang H, Yin X, Lou SH, Fang TY, Han BL, Gao JL, Wang YF, Zhang DX, Wang XB, Lu ZF, Wu JP, Zhang JQ, Wang YM, Zhang Y, Xue YW. Metastatic lymph nodes and prognosis assessed by the number of retrieved lymph nodes in gastric cancer. World J Gastrointest Surg 2022; 14(11): 1230-1249 [DOI: 10.4240/wjgs.v14.i11.1230] [Reference Citation Analysis]
41 Ma Y, Xu H, Zhou Z, Tian Y, Du K, Zhang H, Jiang X, Lu J, Niu Y, Tu L, Liu H, Zhu H, Chen P, Liu Y. CFNC, a neocryptolepine derivative, inhibited the growth of gastric cancer AGS cells by inhibiting PI3K/AKT signaling pathway. Eur J Pharmacol 2022;938:175408. [PMID: 36442620 DOI: 10.1016/j.ejphar.2022.175408] [Reference Citation Analysis]
42 Ma Y, Xin Y, Su D, Zhou Y, Li H, Zou H, Yu X, Yang Q, Cui J, Wang C, Zhang Y. Comparative efficacy and toxicity of immune checkpoint inhibitors in combination with or without chemotherapy treatment for advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.958783] [Reference Citation Analysis]
43 Lan WH, Lin TY, Yeh JA, Feng CL, Hsu JT, Lin HJ, Kuo CJ, Lai CH. Mechanism Underlying Metformin Action and Its Potential to Reduce Gastric Cancer Risk. Int J Mol Sci 2022;23. [PMID: 36430639 DOI: 10.3390/ijms232214163] [Reference Citation Analysis]
44 Jiang D, Ma P. Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1057455] [Reference Citation Analysis]
45 Gu Y, Zhang P, Wang J, Lin C, Liu H, Li H, He H, Li R, Zhang H, Zhang W. Somatic ARID1A mutation stratifies patients with gastric cancer to PD-1 blockade and adjuvant chemotherapy. Cancer Immunol Immunother 2022. [DOI: 10.1007/s00262-022-03326-x] [Reference Citation Analysis]
46 Rosa F, Schena CA, Laterza V, Quero G, Fiorillo C, Strippoli A, Pozzo C, Papa V, Alfieri S. The Role of Surgery in the Management of Gastric Cancer: State of the Art. Cancers (Basel) 2022;14. [PMID: 36428634 DOI: 10.3390/cancers14225542] [Reference Citation Analysis]
47 Zeng J, Li M, Dai K, Zuo B, Guo J, Zang L. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer. Pathol Oncol Res 2022;28. [DOI: 10.3389/pore.2022.1610643] [Reference Citation Analysis]
48 Di Carlo S, Siragusa L, Fassari A, Fiori E, La Rovere F, Izzo P, Usai V, Cavallaro G, Franceschilli M, Dhimolea S, Sibio S. Laparoscopic versus Open Total Gastrectomy for Locally Advanced Gastric Cancer: Short and Long-Term Results. Curr Oncol 2022;29:8442-55. [PMID: 36354725 DOI: 10.3390/curroncol29110665] [Reference Citation Analysis]
49 Kim E, Kim H, Yeo MK, Kim CH, Kim JY, Park S, Kim HS, Chae YS. Identification of a Novel Long Non-coding RNA, lnc-ATMIN-4:2, and its Clinicopathological and Prognostic Significance in Advanced Gastric Cancer. Cancer Genomics Proteomics 2022;19:761-72. [PMID: 36316044 DOI: 10.21873/cgp.20358] [Reference Citation Analysis]
50 Yu H, Zhang F, Wen Y, Zheng Z, Chen G, Pan Y, Wu P, Ye Q, Han J, Chen X, Liu C, Shen T. Mechanism of interventional effect and targets of Zhuyu pill in regulating and suppressing colitis and cholestasis. Front Pharmacol 2022;13:1038188. [PMID: 36408242 DOI: 10.3389/fphar.2022.1038188] [Reference Citation Analysis]
51 Ma H, Li N, Mo Z. Elevated Notch-1 expression promotes the lymph node metastasis of gastric cancer and the Notch-1-PTEN-ERK1/2 signalling axis promotes the progression of gastric cancer. Cytokine 2022;159:156013. [PMID: 36067712 DOI: 10.1016/j.cyto.2022.156013] [Reference Citation Analysis]
52 Yan X, Wang J, Bai Y. Potentials of circSOBP in the diagnosis and prognosis of gastric cancer. Scand J Gastroenterol 2022;57:1344-8. [PMID: 35993263 DOI: 10.1080/00365521.2022.2088246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Zhao X, Liu X, Li W, Qiu L, Huang M, Wang C, Chen Z, Zhang W, Feng W, Guo W, Zhu X. Randomized phase II study of TX followed by XELOX versus the reverse sequence for chemo-naive patients with metastatic gastric cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.911160] [Reference Citation Analysis]
54 Ding S, Zheng X, Wang S, Wu M, Wu Y, Sun C, Yang L, Xue L, Wang B, Wang C, Xie Y. Long-term nutritional status after total gastrectomy was comparable to proximal gastrectomy but with much less reflux esophagitis and anastomotic stenosis. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.973902] [Reference Citation Analysis]
55 Gu L, Huang T, Qiu S, Hong J, Fu R, Ni C, Dai S, Chen P, He N. Efficacy of PD-1/PD-L1 inhibitors in patients with advanced gastroesophageal cancer: An updated meta-analysis based on randomized controlled trials. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1009254] [Reference Citation Analysis]
56 Yao Y, Zhu X, Liu W, Jiang J, Jiang H. Meta-analysis of the prognostic value of circulating tumor cells in gastrointestinal cancer. Medicine (Baltimore) 2022;101:e31099. [PMID: 36281182 DOI: 10.1097/MD.0000000000031099] [Reference Citation Analysis]
57 Jin J, Zhang Q, Dong B, Ma T, Mei X, Wang X, Song S, Peng J, Wu A, Dong L, Kong D. Automatic detection of early gastric cancer in endoscopy based on Mask region-based convolutional neural networks (Mask R-CNN)(with video). Front Oncol 2022;12:927868. [DOI: 10.3389/fonc.2022.927868] [Reference Citation Analysis]
58 Ikoma T, Matsumoto T, Kurioka Y, Takatani M, Nagai H, Matsumoto Y, Satake H, Yasui H. Improvement of Body Weight and Nutritional Status in Gastric Cancer Patients Enhances the Benefit of Nivolumab Therapy. JCM 2022;11:6100. [DOI: 10.3390/jcm11206100] [Reference Citation Analysis]
59 Vo D, Ghosh P, Sahoo D. Artificial Intelligence Guided Discovery of Gastric Cancer Continuum.. [DOI: 10.1101/2022.10.05.510975] [Reference Citation Analysis]
60 Shen J, Lian X, Guan Q, He L, Zhang F, Shen J. Neoadjuvant Chemo-Radiation Using IGRT in Patients with Locally Advanced Gastric Cancer. Curr Oncol 2022;29:7450-60. [PMID: 36290863 DOI: 10.3390/curroncol29100586] [Reference Citation Analysis]
61 Nickel F, Studier-fischer A, Hausmann D, Klotz R, Vogel-adigozalov SL, Tenckhoff S, Klose C, Feisst M, Zimmermann S, Babic B, Berlt F, Bruns C, Gockel I, Graf S, Grimminger P, Gutschow CA, Hoeppner J, Ludwig K, Mirow L, Mönig S, Reim D, Seyfried F, Stange D, Billeter A, Nienhüser H, Probst P, Schmidt T, Müller-stich BP. Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765). BMJ Open 2022;12:e064286. [DOI: 10.1136/bmjopen-2022-064286] [Reference Citation Analysis]
62 Luo R. CircRNA circ-MYBL2 absorbs precursor miR-92b in the nucleus to suppress its role in enhancing gastric cancer cell proliferation. Am J Med Sci 2022;364:454-60. [PMID: 35644224 DOI: 10.1016/j.amjms.2022.05.022] [Reference Citation Analysis]
63 Wang Q, Cao T, Zhang X, Hui J, Wang C, Zhang W, Wang P, Zhou Y, Han S, Wang F. ATXN2-Mediated PI3K/AKT Activation Confers Gastric Cancer Chemoresistance and Attenuates CD8+ T Cell Cytotoxicity. Journal of Immunology Research 2022;2022:1-16. [DOI: 10.1155/2022/6863240] [Reference Citation Analysis]
64 Parihar A, Malviya S, Khan R. Identification of Biomarkers Associated with Cancer Using Integrated Bioinformatic Analysis. Biomedical Engineering 2022. [DOI: 10.5772/intechopen.101432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Ji T, Gao X, Li D, Huai S, Chi Y, An X, Ji W, Yang S, Li J. Identification of Prognosis Signature and Analysis of the Immune Microenvironment in Gastric Cancer Based on ALKBH5.. [DOI: 10.21203/rs.3.rs-2084871/v1] [Reference Citation Analysis]
66 Wen Y, Wang Y, Huang Y, Liu Z, Hui C. Correlation of PLVAP protein expression with microbial composition, clinicopathological features and prognosis of patients with stomach adenocarcinoma.. [DOI: 10.21203/rs.3.rs-2082894/v1] [Reference Citation Analysis]
67 Liu SX, Zhou Y, Zhao L, Zhou LS, Sun J, Liu GJ, Du YS, Zhou YN. Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggerred development of gastric cancer. Free Radic Biol Med 2022:S0891-5849(22)00600-1. [PMID: 36152915 DOI: 10.1016/j.freeradbiomed.2022.09.018] [Reference Citation Analysis]
68 Zeng J, Ran K, Li X, Tao L, Wang Q, Ren J, Hu R, Zhu Y, Liu Z, Yu L. A novel small molecule RK-019 inhibits FGFR2-amplification gastric cancer cell proliferation and induces apoptosis in vitro and in vivo. Front Pharmacol 2022;13:998199. [DOI: 10.3389/fphar.2022.998199] [Reference Citation Analysis]
69 Kuznetsov D, Dezhurov S, Krylsky D, Novikov V, Neschisliaev V, Kuznetsova A. Use of folic acid nanosensors with excellent photostability for hybrid imaging. J Zhejiang Univ Sci B 2022;23:784-90. [PMID: 36111575 DOI: 10.1631/jzus.B2200107] [Reference Citation Analysis]
70 Corso C, Aponte DM, Preciado J, Medina-parra J, Sabbagh Sanvicente LC. Prevalencia y localización gástrica del Helicobacter pylori en pacientes con atrofia y metaplasia intestinal en una institución de alta complejidad en Colombia. Rev colomb Gastroenterol 2022;37:289-295. [DOI: 10.22516/25007440.858] [Reference Citation Analysis]
71 Ma D, Zhang Y, Shao X, Wu C, Wu J. PET/CT for Predicting Occult Lymph Node Metastasis in Gastric Cancer. Current Oncology 2022;29:6523-6539. [DOI: 10.3390/curroncol29090513] [Reference Citation Analysis]
72 Yang P, Yang H, Zhou H, Li Q, Wei S, Wang Q, Yan Y, Liu Y, Pan H, Li S. Weipiling decoction alleviates N-methyl-N-nitro-N′-nitrosoguanidine-induced gastric precancerous lesions via NF-κB signalling pathway inhibition. Chin Med 2022;17. [DOI: 10.1186/s13020-022-00663-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Chen C, Du Y, Liu Y, Shi Y, Niu Y, Jin G, Shen J, Lyu J, Lin L. Characteristics of gastric cancer gut microbiome according to tumor stage and age segmentation. Appl Microbiol Biotechnol 2022. [PMID: 36083304 DOI: 10.1007/s00253-022-12156-x] [Reference Citation Analysis]
74 Hu K, Zhang Y, Rong J, Deng W, Xiao B. Overexpression of lncRNA TCLlnc1 in gastric cancer predicts postoperative distant recurrence and poor survival. Anticancer Drugs 2022. [PMID: 36066396 DOI: 10.1097/CAD.0000000000001396] [Reference Citation Analysis]
75 Wang L, Chen Y, Tan J, Ge Y, Xu Z, Wels M, Pan Z. Efficacy and prognostic value of delta radiomics on dual-energy computed tomography for gastric cancer with neoadjuvant chemotherapy: a preliminary study. Acta Radiol 2022;:2841851221123971. [PMID: 36062762 DOI: 10.1177/02841851221123971] [Reference Citation Analysis]
76 Wu Z, Huo X, Yang T, Liu K, Wu T, Feng Z, Wang M, Li F, Jia J, Zhang X, Gao W, Yu L. CRISPR/Cas9-3NLS/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression. Front Oncol 2022;12:978533. [DOI: 10.3389/fonc.2022.978533] [Reference Citation Analysis]
77 Wang P, Tang C, Li J, Jin R, Chen Y, Zeng C. Prediction model of lymph node metastasis for early gastric cancer: a better choice than computed tomography.. [DOI: 10.21203/rs.3.rs-1984319/v1] [Reference Citation Analysis]
78 Liu C, Tao Y, Lin H, Lou X, Wu S, Chen L. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling. Front Mol Biosci 2022;9:962435. [DOI: 10.3389/fmolb.2022.962435] [Reference Citation Analysis]
79 Xue C, Xu YH. Trastuzumab combined chemotherapy for the treatment of HER2-positive advanced gastric cancer: A systematic review and meta-analysis of randomized controlled trial. Medicine (Baltimore) 2022;101:e29992. [PMID: 36042610 DOI: 10.1097/MD.0000000000029992] [Reference Citation Analysis]
80 Liu Z, Li T, Wang Z, Liu J, Huang S, Min BH, An JY, Kim KM, Kim S, Chen Y, Liu H, Kim Y, Wong DT, Huang TJ, Xie Y. Gold Nanopyramid Arrays for Non-Invasive Surface-Enhanced Raman Spectroscopy-Based Gastric Cancer Detection via sEVs. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c01986] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Pozzi V, Campagna R, Sartini D, Emanuelli M. Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms. Biomolecules 2022;12:1173. [DOI: 10.3390/biom12091173] [Reference Citation Analysis]
82 Yu K, Gu Y, Zhang P, Fang H, Cao Y, Wang J, Lin C, Liu H, Zhang H, He H, Li R, Qin J, Li H, Xu J. Intratumoral PD-1+CD8+ T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer. Br J Cancer 2022. [PMID: 36002752 DOI: 10.1038/s41416-022-01939-8] [Reference Citation Analysis]
83 Qiu L, Kang H, Yang J, Zheng Y, Chen A, Chen C, Wang X, Fang Q, Zhu W, Sha O, Wang Y. Accurate prediction of stomach adenocarcinomas of poorest and best prognosis with a combination of gene expression and clinical signatures. GENOME INSTAB DIS 2022. [DOI: 10.1007/s42764-022-00077-y] [Reference Citation Analysis]
84 Alromi A, Sandri GBL, Bonavina L, Park S. Editorial: Surgical interventions in gastric cancer. Front Oncol 2022;12:992965. [DOI: 10.3389/fonc.2022.992965] [Reference Citation Analysis]
85 Drubay V, Nuytens F, Renaud F, Adenis A, Eveno C, Piessen G. Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management. World J Gastrointest Oncol 2022; 14(8): 1406-1428 [DOI: 10.4251/wjgo.v14.i8.1406] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Khalafiyan A, Emadi-baygi M, Wolfien M, Salehzadeh-yazdi A, Nikpour P. Construction of a three-component regulatory network of transcribed ultraconserved regions for the identification of prognostic biomarkers in gastric cancer.. [DOI: 10.1101/2022.08.12.503817] [Reference Citation Analysis]
87 Lin H. Inhibition of ZNF703 alleviates the progression of gastric cancer through inhibition of HDAC activity.. [DOI: 10.21203/rs.3.rs-1945136/v1] [Reference Citation Analysis]
88 Ledenko M, Antwi SO, Arima S, Driscoll J, Furuse J, Klümpen H, Larsen FO, Lau DK, Maderer A, Markussen A, Moehler M, Nooijen LE, Shaib WL, Tebbutt NC, André T, Ueno M, Woodford R, Yoo C, Zalupski MM, Patel T. Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials. Front Oncol 2022;12:963753. [DOI: 10.3389/fonc.2022.963753] [Reference Citation Analysis]
89 Jiang S, Ding X, Wu Q, Cheng T, Xu M, Huang J. Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer. Front Immunol 2022;13:980986. [DOI: 10.3389/fimmu.2022.980986] [Reference Citation Analysis]
90 Anwar S, Shahwan M, Hasan GM, Islam A, Hassan MI. Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy. Cell Signal 2022;99:110434. [PMID: 35961526 DOI: 10.1016/j.cellsig.2022.110434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Mehrdad SA, Mirzavi F, Seyedi SMR, Asoodeh A. The effect of angiotensin receptor blockers and angiotensin-converting enzyme inhibitors on progression of gastric cancer: systematic review and meta-analysis. Anticancer Drugs 2022. [PMID: 35946519 DOI: 10.1097/CAD.0000000000001345] [Reference Citation Analysis]
92 Ma L, Chen G, Wang D, Zhang K, Zhao F, Tang J, Zhao J, Røe OD, He S, Liao D, Gu Y, Tao M, Shu Y, Li W, Chen X. A nomogram to predict survival probability of gastric cancer patients undergoing radical surgery and adjuvant chemotherapy. Front Oncol 2022;12:893998. [DOI: 10.3389/fonc.2022.893998] [Reference Citation Analysis]
93 Yao Q, Zhang X, Chen D. The emerging potentials of lncRNA DRAIC in human cancers. Front Oncol 2022;12:867670. [DOI: 10.3389/fonc.2022.867670] [Reference Citation Analysis]
94 Chang Z, Duan Q, Yu C, Li D, Jiang H, Ge F, Xu G. Proteomics and Biochemical Analyses of Secreted Proteins Revealed a Novel Mechanism by Which ADAM12S Regulates the Migration of Gastric Cancer Cells. J Proteome Res 2022. [PMID: 35926154 DOI: 10.1021/acs.jproteome.2c00221] [Reference Citation Analysis]
95 Bi J, Jiang Y, Ye S, Wu M, Yi Y, Wang H, Wang L. Investigation of the inhibition effect of 1,2,3,4,6-pentagalloyl-β-D-glucose on gastric cancer cells based on a network pharmacology approach and experimental validation. Front Oncol 2022;12:934958. [DOI: 10.3389/fonc.2022.934958] [Reference Citation Analysis]
96 Khader A, Braschi-Amirfarzan M, McIntosh LJ, Gosangi B, Wortman JR, Wald C, Thomas R. Importance of tumor subtypes in cancer imaging. Eur J Radiol Open 2022;9:100433. [PMID: 35909389 DOI: 10.1016/j.ejro.2022.100433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Hani U, Osmani RAM, Yasmin S, Gowda BHJ, Ather H, Ansari MY, Siddiqua A, Ghazwani M, Fatease AA, Alamri AH, Rahamathulla M, Begum MY, Wahab S. Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy. Pharmaceutics 2022;14:1576. [DOI: 10.3390/pharmaceutics14081576] [Reference Citation Analysis]
98 Sun J, Li X, Chen P, Gao Y. From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer. J Inflamm Res 2022;15:4061-85. [PMID: 35873388 DOI: 10.2147/JIR.S368138] [Reference Citation Analysis]
99 Huang J, Song J, Li X, Liu S, Huang W, Shen Z, Cheng Y, Kou S, Gao Z, Tian Y, Hu J. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer. BMC Med Genomics 2022;15:164. [PMID: 35879790 DOI: 10.1186/s12920-022-01318-5] [Reference Citation Analysis]
100 Chen Z, Yuan L, Li X, Yu J, Xu Z. BMP2 inhibits cell proliferation by downregulating EZH2 in gastric cancer. Cell Cycle 2022;:1-11. [PMID: 35856444 DOI: 10.1080/15384101.2022.2092819] [Reference Citation Analysis]
101 Öztürk A. MİDEDE H. PYLORİ ERADİKASYON ORANLARI ORAL H. PYLORİNİN DİŞETİ (PERİODONTAL) TEDAVİSİ İLE ELİMİNASYONU İLE ARTIRILABİLİR Mİ? LİTERATUR TARAMASI. Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi 2022. [DOI: 10.17567/ataunidfd.956984] [Reference Citation Analysis]
102 Lu Y, Yu J, Dong Q, Du Y, Liang Z. DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis. Int J Gen Med 2022;15:6127-43. [PMID: 35846794 DOI: 10.2147/IJGM.S357096] [Reference Citation Analysis]
103 Aiba H, Suzuki N, Sagawa H, Hashimoto H, Kimura H, Inoue J, Usami T, Goto Y, Mizuno Y, Okubo T, Ito S, Takiguchi S, Murakami H. Protocol for a randomized study of the efficacy of ibandronic acid plus eldecalcitol in patients with gastric cancer after gastrectomy: A comparative study of different routes of administration of ibandronic acid. F1000Res 2022;11:796. [DOI: 10.12688/f1000research.122741.1] [Reference Citation Analysis]
104 Dong Z, Ni B, Yang L, Guan Y, Zhu C, Zhao E, Zhao G, Xia X, Zhang Z. Efficacy and Safety of Camrelizumab in Combination with Docetaxel + S-1 Sequenced by Camrelizumab + S-1 for Stage III (PD-1+/MSI-H/EBV+/dMMR) Gastric Cancer: Study Protocol for a Single-Center, Prospective, Open-Label, Single-Arm Trial. Front Surg 2022;9:917352. [PMID: 35836597 DOI: 10.3389/fsurg.2022.917352] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
105 Dong Y, Song N, Wang J, Shi L, Zhang Z, Du J. Driver Gene Alterations in Malignant Progression of Gastric Cancer. Front Oncol 2022;12:920207. [DOI: 10.3389/fonc.2022.920207] [Reference Citation Analysis]
106 Ignatavicius P, Dauksa A, Zilinskas J, Kazokaite M, Riauka R, Barauskas G. DNA Methylation of HOXA11 Gene as Prognostic Molecular Marker in Human Gastric Adenocarcinoma. Diagnostics 2022;12:1686. [DOI: 10.3390/diagnostics12071686] [Reference Citation Analysis]
107 Zhang Y, Feng Z, Xu Y, Jiang S, Zhang Q, Zhang Z, Wang K, Li X, Xu L, Yuan M, Chen Z, Cui J, Wu H, Gao Y, Wei W, Wang B, Zuo Y, Ren S. Novel roles of LSECtin in gastric cancer cell adhesion, migration, invasion, and lymphatic metastasis. Cell Death Dis 2022;13:593. [PMID: 35821222 DOI: 10.1038/s41419-022-05026-x] [Reference Citation Analysis]
108 Song S, Liu X, Ji Q, Sun D, Xiu L, Xu J, Yue X. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine 2022;20:355-364. [DOI: 10.1016/j.joim.2022.02.006] [Reference Citation Analysis]
109 Li C, Shao S, Sun Y, Shen F, Wang M, Wang H, Wang C, Hussein AF. Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer. Computational and Mathematical Methods in Medicine 2022;2022:1-5. [DOI: 10.1155/2022/8036763] [Reference Citation Analysis]
110 Li F, Wen H, Bukhari I, Liu B, Guo C, Ren F, Tang Y, Mi Y, Zheng P. Relationship Between CNVs and Immune Cells Infiltration in Gastric Tumor Microenvironment. Front Genet 2022;13:869967. [PMID: 35754804 DOI: 10.3389/fgene.2022.869967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Möhring C, Timotheou A, Mańczak A, Sadeghlar F, Zhou T, Mahn R, Bartels A, Monin M, Toma M, Feldmann G, Brossart P, Köksal M, Sarria GR, Giordano FA, Lingohr P, Jafari A, Kalff JC, Strassburg CP, Gonzalez-Carmona MA. Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter? J Cancer Res Clin Oncol 2022. [PMID: 35763109 DOI: 10.1007/s00432-022-04109-8] [Reference Citation Analysis]
112 Guo W, Cao P, Wang X, Hu M, Feng Y. Medicinal Plants for the Treatment of Gastrointestinal Cancers From the Metabolomics Perspective. Front Pharmacol 2022;13:909755. [DOI: 10.3389/fphar.2022.909755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
113 Jiao YJ, Lu TT, Liu DM, Xiang X, Wang LL, Ma SX, Wang YF, Chen YQ, Yang KH, Cai H. Comparison between laparoscopic uncut Roux-en-Y and Billroth II with Braun anastomosis after distal gastrectomy: A meta-analysis. World J Gastrointest Surg 2022; 14(6): 594-610 [DOI: 10.4240/wjgs.v14.i6.594] [Reference Citation Analysis]
114 Hu CG, Hu BE, Zhu JF, Zhu ZM, Huang C. Prognostic significance of the preoperative hemoglobin to albumin ratio for the short-term survival of gastric cancer patients . World J Gastrointest Surg 2022; 14(6): 580-593 [DOI: 10.4240/wjgs.v14.i6.580] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Chen Q, Wang Y, Liu Y, Xi B. ESRRG, ATP4A, and ATP4B as Diagnostic Biomarkers for Gastric Cancer: A Bioinformatic Analysis Based on Machine Learning. Front Physiol 2022;13:905523. [DOI: 10.3389/fphys.2022.905523] [Reference Citation Analysis]
116 Zhang X, Xu H, Zhang Y, Sun C, Li Z, Hu C, Zhao D, Guo C. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer. Front Oncol 2022;12:878546. [PMID: 35712475 DOI: 10.3389/fonc.2022.878546] [Reference Citation Analysis]
117 Boonyanugomol W, Rukseree K, Prapatpong P, Reamtong O, Baik SC, Jung M, Shin MK, Kang HL, Lee WK. Endoplasmic Reticulum Stress and Impairment of Ribosome Biogenesis Mediate the Apoptosis Induced by Ocimum x africanum Essential Oil in a Human Gastric Cancer Cell Line. Medicina (Kaunas) 2022;58:799. [PMID: 35744062 DOI: 10.3390/medicina58060799] [Reference Citation Analysis]
118 Wu B, Wang YX, Wang JJ, Xiang DF, Zhang MS, Yan ZX, Wang WY, Miao JY, Lan X, Liu JJ, Li ZY, Li C, Fan JY, Liu JY, Jiang L, Xu SL, Cui YH, Qian F. PLXDC2 enhances invadopodium formation to promote invasion and metastasis of gastric cancer cells via interacting with PTP1B. Clin Exp Metastasis 2022. [PMID: 35661947 DOI: 10.1007/s10585-022-10168-5] [Reference Citation Analysis]
119 Chen Y, Xu P, Qiu W, Zhu H, Qian C, Shen H, Zhang J. Gastric Cancer-Circulating Tumor Cells Isolation by Folic Acid Immunolipid Magnetic Beads and Clinical Application. sci adv mater 2022;14:1024-1031. [DOI: 10.1166/sam.2022.4282] [Reference Citation Analysis]
120 El Hafa F, Wang T, Ndifor VM, Jin G. Association between Helicobacter pylori antibodies determined by multiplex serology and gastric cancer risk: A meta-analysis. Helicobacter 2022;27:e12881. [PMID: 35212073 DOI: 10.1111/hel.12881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
121 Ge R, Liu K, Zhang W, Yang K, Chen X, Zhao L, Zhou Z, Hu J, Pan J. The Safety and Feasibility of Laparoscopic Gastrectomy after Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/9511066] [Reference Citation Analysis]
122 Wang L, Miao C, He Y, Li H, Zhang S, Li K, Liu H, Li W, Zhao J, Xu Y, Tang H, Zhao Q, Stefan-van Staden R. The Influence of Heavy Metals on Gastric Tumorigenesis. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/6425133] [Reference Citation Analysis]
123 Gao J, Huo S, Zhang Y, Zhao Z, Pan H, Liu X. Construction of ovarian metastasis-related immune signature predicting prognosis of gastric cancer patients. Cancer Med 2023;12:913-29. [PMID: 35621244 DOI: 10.1002/cam4.4857] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Bhardwaj P, Kumar S, Kumar Y. Deep Learning Techniques in Gastric Cancer Prediction and Diagnosis. 2022 International Conference on Machine Learning, Big Data, Cloud and Parallel Computing (COM-IT-CON) 2022. [DOI: 10.1109/com-it-con54601.2022.9850700] [Reference Citation Analysis]
125 Huang ZH, Du YP, Wen JT, Lu BF, Zhao Y. snoRNAs: functions and mechanisms in biological processes, and roles in tumor pathophysiology. Cell Death Discov 2022;8:259. [PMID: 35552378 DOI: 10.1038/s41420-022-01056-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
126 Ma Z, Liu G, Hao S, Zhao T, Chang W, Wang J, Ren H, Zhao X, Chen G. PITPNA-AS1/miR-98-5p to Mediate the Cisplatin Resistance of Gastric Cancer. Journal of Oncology 2022;2022:1-14. [DOI: 10.1155/2022/7981711] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Aziz SJ, Jalal JA, Hamadameen KS. Stromal CD10 expression in gastric adenocarcinoma. J Med Life 2022;15:679-84. [PMID: 35815076 DOI: 10.25122/jml-2021-0244] [Reference Citation Analysis]
128 Cai Y, Wu S, Jia Y, Pan X, Li C, Cui D. Potential Key Markers for Predicting the Prognosis of Gastric Adenocarcinoma Based on the Expression of Ferroptosis-Related lncRNA. Journal of Immunology Research 2022;2022:1-17. [DOI: 10.1155/2022/1249290] [Reference Citation Analysis]
129 Panarese A. Usefulness of artificial intelligence in early gastric cancer. Artif Intell Cancer 2022; 3(2): 17-26 [DOI: 10.35713/aic.v3.i2.17] [Reference Citation Analysis]
130 Dalhammar K, Kristensson J, Falkenback D, Rasmussen BH, Malmström M. Symptoms, problems and quality of life in patients newly diagnosed with oesophageal and gastric cancer - a comparative study of treatment strategy. BMC Cancer 2022;22:434. [PMID: 35448961 DOI: 10.1186/s12885-022-09536-x] [Reference Citation Analysis]
131 Shi H, Wang H, Pan J, Liu Z, Li Z. Comparing prognostic value of preoperative platelet indexes in patients with resectable gastric cancer. Sci Rep 2022;12:6480. [PMID: 35444195 DOI: 10.1038/s41598-022-10511-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
132 Kang X, Lu B, Xiao P, Hua Z, Shen R, Wu J, Wu J, Wu Z, Cheng C, Zhang J, Abdulhay E. Microbial Characteristics of Common Tongue Coatings in Patients with Precancerous Lesions of the Upper Gastrointestinal Tract. Journal of Healthcare Engineering 2022;2022:1-14. [DOI: 10.1155/2022/7598427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Liu H, Chen Y, Zhou L, Jiang X, Zhou X. MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis. Bioengineered 2022;13:9613-27. [PMID: 35412956 DOI: 10.1080/21655979.2022.2056813] [Reference Citation Analysis]
134 Chen C, Bao H, Lin W, Chen X, Huang Y, Wang H, Yang Y, Liu J, Lv X, Teng L. ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer. J Cancer 2022;13:1985-2000. [PMID: 35399734 DOI: 10.7150/jca.69544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Liu C, Sun W, Yang K, Xia B. Knockdown of TRIM65 suppressed the proliferation and invasiveness of gastric cancer cells by restricting the ubiquitin degradation of PPM1A. Exp Cell Res 2022;:113154. [PMID: 35421368 DOI: 10.1016/j.yexcr.2022.113154] [Reference Citation Analysis]
136 Savino L, Di Marcantonio MC, Moscatello C, Cotellese R, Centurione L, Muraro R, Aceto GM, Mincione G. Effects of H2O2 Treatment Combined With PI3K Inhibitor and MEK Inhibitor in AGS Cells: Oxidative Stress Outcomes in a Model of Gastric Cancer. Front Oncol 2022;12:860760. [PMID: 35372019 DOI: 10.3389/fonc.2022.860760] [Reference Citation Analysis]
137 Tang F, Hu C, Long Z, Liu Y, Li G. Molecular Characteristics and Prognostic Role of MFAP2 in Stomach Adenocarcinoma. J Healthc Eng 2022;2022:1417238. [PMID: 35356627 DOI: 10.1155/2022/1417238] [Reference Citation Analysis]
138 Kao Y, Chen C, Wei JC. Helicobacter pylori infection and risk of gastric cancer. The Lancet Public Health 2022;7:e302. [DOI: 10.1016/s2468-2667(22)00041-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Asplund J, Mattsson F, Plecka-Östlund M, Markar SR, Lagergren J. Annual surgeon and hospital volume of gastrectomy and gastric adenocarcinoma survival in a population-based cohort study. Acta Oncol 2022;61:425-32. [PMID: 35023804 DOI: 10.1080/0284186X.2022.2025612] [Reference Citation Analysis]
140 Li J, Zhu Y, Dong Z, He X, Xu M, Liu J, Zhang M, Tao X, Du H, Chen D, Huang L, Shang R, Zhang L, Luo R, Zhou W, Deng Y, Huang X, Li Y, Chen B, Gong R, Zhang C, Li X, Wu L, Yu H. Development and validation of a feature extraction-based logical anthropomorphic diagnostic system for early gastric cancer: A case-control study. eClinicalMedicine 2022;46:101366. [DOI: 10.1016/j.eclinm.2022.101366] [Reference Citation Analysis]
141 Zhang Y, Bai J, Cheng R, Zhang D, Qiu Z, Liu T, Che N, Dong X, Zhao N, Lin X, Liang X, Li F, Li Y, Sun B, Zhao X. TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of TEAD4. J Gastroenterol Hepatol 2022;37:714-26. [PMID: 35062042 DOI: 10.1111/jgh.15779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
142 Zeng L, Huang X, Tian Y, Huang J, Liu H, Wen J, Liu K, Shao Y, Luo J, Tang H, Liao Q, Lei Z, Cui W, Xia Q, Guan T, Li J, Cui S. Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy. Front Oncol 2022;12:796263. [PMID: 35350562 DOI: 10.3389/fonc.2022.796263] [Reference Citation Analysis]
143 Liu M, Li H, Zhang H, Zhou H, Jiao T, Feng M, Na F, Sun M, Zhao M, Xue L, Xu L. RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling. Cell Death Dis 2022;13:287. [PMID: 35361764 DOI: 10.1038/s41419-022-04747-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Lee HJ, Seo JW, Kim SH, Lee CY, Kim SY, Kim YM. Apoptotic Effects of Butanol Fraction of Lysimachia foenum-graecum by Regulating Akt/mTOR Signaling Pathways in AGS Gastric Cancer Cells. JKFN 2022;51:221-228. [DOI: 10.3746/jkfn.2022.51.3.221] [Reference Citation Analysis]
145 Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol 2022; 28(12): 1187-1203 [DOI: 10.3748/wjg.v28.i12.1187] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
146 Li GZ, Doherty GM, Wang J. Surgical Management of Gastric Cancer: A Review. JAMA Surg 2022. [PMID: 35319717 DOI: 10.1001/jamasurg.2022.0182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
147 Xie R, Yuan M, Jiang Y. The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer. Front Cell Dev Biol 2022;10:790947. [PMID: 35309935 DOI: 10.3389/fcell.2022.790947] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
148 Kwon S, Kim J, Kim T, Jeong W, Park EC. Association between gastric cancer and the risk of depression among South Korean adults. BMC Psychiatry 2022;22:207. [PMID: 35313847 DOI: 10.1186/s12888-022-03847-w] [Reference Citation Analysis]
149 Goto K, Morimoto M, Osaki M, Tanio A, Izutsu R, Fujiwara Y, Okada F. The impact of AMIGO2 on prognosis and hepatic metastasis in gastric cancer patients. BMC Cancer 2022;22:280. [PMID: 35296279 DOI: 10.1186/s12885-022-09339-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Wu Z, Liu P, Zhang G. Identification of circRNA-miRNA-Immune-Related mRNA Regulatory Network in Gastric Cancer. Front Oncol 2022;12:816884. [PMID: 35280778 DOI: 10.3389/fonc.2022.816884] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
151 Chen Y, Xu W, Li YL, Liu W, Sah BK, Wang L, Xu Z, Wels M, Zheng Y, Yan M, Zhang H, Ma Q, Zhu Z, Li C. CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy. Front Oncol 2022;12:758863. [PMID: 35280802 DOI: 10.3389/fonc.2022.758863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
152 Idowu S, Bertrand PP, Walduck AK. Homeostasis and Cancer Initiation: Organoids as Models to Study the Initiation of Gastric Cancer. Int J Mol Sci 2022;23:2790. [PMID: 35269931 DOI: 10.3390/ijms23052790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
153 Tan D, Zhang Y. Silencing of Nudix type 5 represses proliferation and invasion and enhances chemosensitivity of gastric carcinoma cells by affecting the AKT/GSK-3β/β-catenin pathway. Toxicol Appl Pharmacol 2022;:115968. [PMID: 35247377 DOI: 10.1016/j.taap.2022.115968] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Guan JL, Hu YL, An P, He Q, Long H, Zhou L, Chen ZF, Xiong JG, Wu SS, Ding XW, Luo HS, Li PY. Comparison of high-dose dual therapy with bismuth-containing quadruple therapy in Helicobacter pylori-infected treatment-naive patients: An open-label, multicenter, randomized controlled trial. Pharmacotherapy 2022;42:224-32. [PMID: 35075679 DOI: 10.1002/phar.2662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Cann C, Ciombor KK. Systemic therapy for gastric cancer: Perioperative strategies and beyond. J Surg Oncol 2022. [PMID: 35230696 DOI: 10.1002/jso.26834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Tu RH, Lin JX, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Huang ZN, Lin JL, Zheng HL, Li P, Zheng CH, Huang CM. Assessment of the short-term outcomes of laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: A prospective single-armed clinical trial. Surgery 2022:S0039-6060(22)00031-9. [PMID: 35246330 DOI: 10.1016/j.surg.2022.01.015] [Reference Citation Analysis]
157 Ashfaq M, Talreja N, Chauhan D, Afreen S, Sultana A, Srituravanich W. Two-dimensional (2D) hybrid nanomaterials for diagnosis and treatment of cancer. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103268] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
158 Zhang C, Zhao S, Tan Y, Pan S, An W, Chen Q, Wang X, Xu H. The SKA3-DUSP2 Axis Promotes Gastric Cancer Tumorigenesis and Epithelial-Mesenchymal Transition by Activating the MAPK/ERK Pathway. Front Pharmacol 2022;13:777612. [DOI: 10.3389/fphar.2022.777612] [Reference Citation Analysis]
159 Umeda S, Kanda M, Shimizu D, Nakamura S, Sawaki K, Inokawa Y, Hattori N, Hayashi M, Tanaka C, Nakayama G, Kodera Y. Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells. Gastric Cancer. [DOI: 10.1007/s10120-022-01284-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
160 Wang Y, Ye W, Tian G, Zhang Y. Identification of a new RNA-binding proteins-based signature for prognostic prediction in gastric cancer. Medicine (Baltimore) 2022;101:e28901. [PMID: 35212295 DOI: 10.1097/MD.0000000000028901] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Zhang H, Zhang Y, Xia T, Lu L, Luo M, Chen Y, Liu Y, Li Y. The Role of Keratin17 in Human Tumours. Front Cell Dev Biol 2022;10:818416. [DOI: 10.3389/fcell.2022.818416] [Reference Citation Analysis]
162 Xia X, Zhang Z, Zhu C, Ni B, Wang S, Yang S, Yu F, Zhao E, Li Q, Zhao G. Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications. Nat Commun 2022;13:1017. [PMID: 35197446 DOI: 10.1038/s41467-022-28492-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
163 Cao F, Zheng Y, Yang C, Huang S, He X, Tong S, Khalaf OI. +HOXA10-AS Promotes Malignant Phenotypes of Gastric Cancer via Upregulating HOXA10. Computational and Mathematical Methods in Medicine 2022;2022:1-10. [DOI: 10.1155/2022/1846687] [Reference Citation Analysis]
164 Zhang S, Yang H, Xiang X, Liu L, Huang H, Tang G. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer. Front Genet 2022;13:765569. [PMID: 35154268 DOI: 10.3389/fgene.2022.765569] [Reference Citation Analysis]
165 Shi W, Wang F. circ_AKT3 knockdown suppresses cisplatin resistance in gastric cancer. Open Medicine 2022;17:280-91. [DOI: 10.1515/med-2021-0355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
166 Ke H, Wu S, Zhang Y, Zhang G. miR-139-3p/Kinesin family member 18B axis suppresses malignant progression of gastric cancer. Bioengineered 2022;13:4528-36. [DOI: 10.1080/21655979.2022.2033466] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
167 Hu Y, Gong C, Li Z, Liu J, Chen Y, Huang Y, Luo Q, Wang S, Hou Y, Yang S, Xiao Y. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. Mol Cancer 2022;21:34. [PMID: 35114989 DOI: 10.1186/s12943-022-01522-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
168 Meng D, Li D. Ubiquitin-specific protease 1 overexpression indicates poor prognosis and promotes proliferation, migration, and invasion of gastric cancer cells. Tissue and Cell 2022;74:101723. [DOI: 10.1016/j.tice.2021.101723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Yan Y, Li H, Wu S, Wang G, Luo H, Niu J, Cao L, Hu X, Xu H, Jia W, Sun Y, Yao Y, Chen W, Ke L, Hu B, Ji C, Sun Y, Chen J, Li M, He Y. Efficacy and safety of intermittent versus continuous dose apatinib plus docetaxel as second-line therapy in patients with advanced gastric cancer or gastroesophageal junction adenocarcinoma: a randomized controlled study. Ann Transl Med 2022;10:205. [PMID: 35280426 DOI: 10.21037/atm-22-546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Xiong T, Chen Y, Li M, Long S, Du J, Fan J, Peng X. A benzophenoxazine-dyad as cancer indicator using for fluorescence-guided phototherapy. Sensors and Actuators B: Chemical 2022;352:130990. [DOI: 10.1016/j.snb.2021.130990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
171 Ehlken H, Schmitz R, Riethdorf S, Riethdorf L, Krause J, Karstens KF, Schrader J, Viol F, Giannou A, Sterlacci W, Vieth M, Clauditz T, Kähler C, Mann O, Izbicki JR, Huber S, Pantel K, Rösch T. Possible tumour cell reimplantation during curative endoscopic therapy of superficial Barrett's carcinoma. Gut 2022;71:277-86. [PMID: 33441377 DOI: 10.1136/gutjnl-2020-322723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Shan ZG, Zhao YL, Zhang JY, Yan ZB, Wang TT, Mao FY, Teng YS, Peng LS, Chen WY, Wang P, Cheng P, Tian WQ, Chen J, Chen W, Zhuang Y. FasL+ PD-L2+ Identifies a Novel Immunosuppressive Neutrophil Population in Human Gastric Cancer That Promotes Disease Progression. Adv Sci (Weinh) 2022;9:e2103543. [PMID: 34957697 DOI: 10.1002/advs.202103543] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
173 Roviello G, Catalano M, Iannone LF, Marano L, Brugia M, Rossi G, Aprile G, Antonuzzo L. Current status and future perspectives in HER2 positive advanced gastric cancer. Clin Transl Oncol 2022;24:981-96. [PMID: 35091998 DOI: 10.1007/s12094-021-02760-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
174 Pan T, Chen XL, Liu K, Peng BQ, Zhang WH, Yan MH, Ge R, Zhao LY, Yang K, Chen XZ, Hu JK. Nomogram to Predict Intensive Care Following Gastrectomy for Gastric Cancer: A Useful Clinical Tool to Guide the Decision-Making of Intensive Care Unit Admission. Front Oncol 2021;11:641124. [PMID: 35087739 DOI: 10.3389/fonc.2021.641124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Zhu X, Zhu Y, Chen N, Tang C, Shi J. The drugs screened by OncoVee TM -Mini-PDX have significantly benefited the patient with HER2-positive advanced gastric cancer. J Oncol Pharm Pract. [DOI: 10.1177/10781552221074973] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
176 Esayas Lelisho M, Akessa GM, Kifle Demissie D, Fikadu Yermosa S, Andargie SA, Tareke SA, Pandey D. Application of Parametric Shared Frailty Models to Analyze Time-to-Death of Gastric Cancer Patients. J Gastrointest Canc. [DOI: 10.1007/s12029-021-00775-y] [Reference Citation Analysis]
177 Wu D, Feng M, Shen H, Shen X, Hu J, Liu J, Yang Y, Li Y, Yang M, Wang W, Zhang Q, Song F, Liu B, Chen K, Li X. Prediction of Two Molecular Subtypes of Gastric Cancer Based on Immune Signature. Front Genet 2022;12:793494. [DOI: 10.3389/fgene.2021.793494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
178 Gu H, Zhong Y, Liu J, Shen Q, Wei R, Zhu H, Zhang X, Xia X, Yao M, Ni M. The Role of miR-4256/HOXC8 Signaling Axis in the Gastric Cancer Progression: Evidence From lncRNA-miRNA-mRNA Network Analysis. Front Oncol 2022;11:793678. [DOI: 10.3389/fonc.2021.793678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Melim C, Lauro MR, Pires IM, Oliveira PJ, Cabral C. The Role of Glucosinolates from Cruciferous Vegetables (Brassicaceae) in Gastrointestinal Cancers: From Prevention to Therapeutics. Pharmaceutics 2022;14:190. [PMID: 35057085 DOI: 10.3390/pharmaceutics14010190] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
180 Ma L, Jiang Y, Wu N. Long non-coding RNA CCL2 promoted gastric cancer function via miR-128/ PARP2 signal pathway. Bioengineered 2022;13:1602-11. [PMID: 35000531 DOI: 10.1080/21655979.2021.2020548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
181 Zhang Y, Zhang Y, Huang X. Development and Application of Magnetically Controlled Capsule Endoscopy in Detecting Gastric Lesions. Gastroenterol Res Pract 2021;2021:2716559. [PMID: 35003252 DOI: 10.1155/2021/2716559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
182 Zhang G, Li Z, Dong J, Zhou W, Zhang Z, Que Z, Zhu X, Xu Y, Cao N, Zhao A. Acacetin inhibits invasion, migration and TGF-β1-induced EMT of gastric cancer cells through the PI3K/Akt/Snail pathway. BMC Complement Med Ther 2022;22:10. [PMID: 35000605 DOI: 10.1186/s12906-021-03494-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
183 Li Y, Wu X, Li C, Li X, Chen H, Sun C, Rahaman MM, Yao Y, Zhang Y, Jiang T. A hierarchical conditional random field-based attention mechanism approach for gastric histopathology image classification. Appl Intell. [DOI: 10.1007/s10489-021-02886-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
184 Zhao H, Tong Y, Pan S, Qiu Z, Liu P, Guo P. RBPMS2, as a novel biomarker for predicting lymph node metastasis, guides therapeutic regimens in gastric cancer. Hum Cell 2022. [PMID: 34981466 DOI: 10.1007/s13577-021-00667-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Demirtas TY, Rahman MR, Yurtsever MC, Gov E. Forecasting Gastric Cancer Diagnosis, Prognosis, and Drug Repurposing with Novel Gene Expression Signatures. OMICS 2022;26:64-74. [PMID: 34910889 DOI: 10.1089/omi.2021.0195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 da Silveira Vasconcelos M, de Souza TDFG, Nunes-pinheiro DCS, da Silva Mendes FR, de Sousa FD, de Siqueira Oliveira L, de Paula PC, Gurgel DC, Silva AS, Nabavi SM, de Melo DF. Antioxidants and gastric lesions. Antioxidants Effects in Health 2022. [DOI: 10.1016/b978-0-12-819096-8.00056-2] [Reference Citation Analysis]
187 Baruah S, Maibam B, Kumar S. Biosensor-based early diagnosis of gastric cancer. Biosensor Based Advanced Cancer Diagnostics 2022. [DOI: 10.1016/b978-0-12-823424-2.00023-5] [Reference Citation Analysis]
188 Minciuna C, Tanase M, Manuc TE, Tudor S, Herlea V, Dragomir MP, Calin GA, Vasilescu C. The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers. Computational and Structural Biotechnology Journal 2022;20:5065-75. [DOI: 10.1016/j.csbj.2022.09.010] [Reference Citation Analysis]
189 Prasad D, Prabhavathi V, Santosh Sushma P, Sai Babu M, Aruna P, Khan IA. Role of Circulating MicroRNAs in Prognosis and Diagnosis of Cancers. Role of MicroRNAs in Cancers 2022. [DOI: 10.1007/978-981-16-9186-7_7] [Reference Citation Analysis]
190 Rastogi A, Bihari C, Patil AG, Majumdar K, Das P. Molecular Classifications of Gastrointestinal Tract Tumors. Surgical Pathology of the Gastrointestinal System 2022. [DOI: 10.1007/978-981-16-6395-6_23] [Reference Citation Analysis]
191 Liu X, Xue Z, Yu J, Ma Z, Kang W, Ye X, Li Z. Risk factors for cancer-specific survival in elderly gastric cancer patients after curative gastrectomy. Nutr Res Pract 2022;16:604. [DOI: 10.4162/nrp.2022.16.5.604] [Reference Citation Analysis]
192 Hu J, Ma Z, He X, Wu Y, Chen Q, Song X, Wang G, Li Y, Xu J. Long-acting response of COX-2-mediated metastasis inhibition by oxaliplatin-based CP-L-OHP. New J Chem 2022;46:10637-43. [DOI: 10.1039/d2nj01196d] [Reference Citation Analysis]
193 Lan W, Wu X, Chen Q, Peng W, Wang J, Chen YP. GANLDA: Graph attention network for lncRNA-disease associations prediction. Neurocomputing 2022;469:384-93. [DOI: 10.1016/j.neucom.2020.09.094] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
194 Chahal D, Shahidi N, Byrne MF. Artificial Intelligence for Diagnosing G.I. Tract Lesions. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2022. [DOI: 10.1007/978-3-030-56993-8_31] [Reference Citation Analysis]
195 Pei J, Velu P, Zareian M, Feng Z, Vijayalakshmi A. Effects of Syringic Acid on Apoptosis, Inflammation, and AKT/mTOR Signaling Pathway in Gastric Cancer Cells. Front Nutr 2021;8:788929. [PMID: 34970579 DOI: 10.3389/fnut.2021.788929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Shi L, Wang Z, Wang L, Jia Y, Li J, Qin Y. A Prognostic Nomogram and Heat Map to Predict Survival in Stage II/III Gastric Cancer Patients After Curative Gastrectomy Followed by Adjuvant Chemotherapy. CMAR 2022;Volume 14:287-301. [DOI: 10.2147/cmar.s348890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
197 Ren J, Pan G, Yang J, Xu N, Zhang Q, Li W. Circ_0000620 acts as an oncogenic factor in gastric cancer through regulating MMP2 expression via sponging miR-671-5p. J Biol Res (Thessalon) 2021;28:23. [PMID: 34972532 DOI: 10.1186/s40709-021-00154-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
198 Noh CK, Lee E, Lee GH, Lim SG, Park B, Shin SJ, Cheong JY, Lee KM. Association of Regular Endoscopic Screening with Interval Gastric Cancer Incidence in the National Cancer Screening Program. J Clin Med 2021;11:230. [PMID: 35011973 DOI: 10.3390/jcm11010230] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Koo DH, Ryu MH, Lee MY, Moon MS, Kang YK. New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy. World J Gastroenterol 2021; 27(48): 8357-8369 [DOI: 10.3748/wjg.v27.i48.8357] [Reference Citation Analysis]
200 Zhang Y, Zhou Y, Wei F. circABCB10 Promotes Malignant Progression of Gastric Cancer Cells by Preventing the Degradation of MYC. J Oncol 2021;2021:4625033. [PMID: 34950208 DOI: 10.1155/2021/4625033] [Reference Citation Analysis]
201 Manuel Lopes de Sousa H, Patrícia Costa Ribeiro J, Basílio Timóteo M. Epstein-Barr Virus-Associated Gastric Cancer: Old Entity with New Relevance. Infectious Diseases 2021. [DOI: 10.5772/intechopen.93649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Gong C, Zhou M, Hu Y, Ren Z, Ren J, Yao M. Elastic net-based identification of GAMT as potential diagnostic marker for early-stage gastric cancer. Biochem Biophys Res Commun 2021;591:7-12. [PMID: 34990904 DOI: 10.1016/j.bbrc.2021.12.055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
203 Xue D, Li D, Dou C, Li J. A Comprehensive Bioinformatic Analysis of NOTCH Pathway Involvement in Stomach Adenocarcinoma. Dis Markers 2021;2021:4739868. [PMID: 34925644 DOI: 10.1155/2021/4739868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
204 Liang X, Qin C, Yu G, Guo X, Cheng A, Zhang H, Wang Z. Circular RNA circRAB31 acts as a miR-885-5psponge to suppress gastric cancer progressionvia the PTEN/PI3K/AKT pathway. Mol Ther Oncolytics 2021;23:501-14. [PMID: 34901392 DOI: 10.1016/j.omto.2021.11.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
205 Zhao X, Wu S, Jing J. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing. Pathol Oncol Res 2021;27:1609955. [PMID: 34899080 DOI: 10.3389/pore.2021.1609955] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
206 Kalhori MR, Soleimani M, Arefian E, Alizadeh AM, Mansouri K, Echeverria J. The potential role of miR-1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco-suppressor microRNA? J Cell Biochem 2021. [PMID: 34897783 DOI: 10.1002/jcb.30191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
207 Huang S, Song Y, Liang T, Zhang JR, Zhu JJ. CRISPR System-Linked Self-Assembling Nanoplatforms for Inspection and Screening of Gastric Cancer Stem Cells. Small 2021;:e2104622. [PMID: 34874610 DOI: 10.1002/smll.202104622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
208 Liu SJ, Yang YB, Zhou JX, Lin YJ, Pan YL, Pan JH. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer. Dis Markers 2021;2021:2385406. [PMID: 34868391 DOI: 10.1155/2021/2385406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
209 Rezaei Z, Ranjbaran J, Safarpour H, Nomiri S, Salmani F, Chamani E, Larki P, Brunetti O, Silvestris N, Tavakoli T. Identification of early diagnostic biomarkers via WGCNA in gastric cancer. Biomed Pharmacother 2022;145:112477. [PMID: 34864309 DOI: 10.1016/j.biopha.2021.112477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
210 Guo Z, Zhou C, Zhou L, Wang Z, Zhu X, Mu X. Overexpression of DAPK1-mediated inhibition of IKKβ/CSN5/PD-L1 axis enhances natural killer cell killing ability and inhibits tumor immune evasion in gastric cancer. Cellular Immunology 2021. [DOI: 10.1016/j.cellimm.2021.104469] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
211 Yue F, Peng K, Zhang L, Zhang J. Circ_0004104 Accelerates the Progression of Gastric Cancer by Regulating the miR-539-3p/RNF2 Axis. Dig Dis Sci 2021;66:4290-301. [PMID: 33449226 DOI: 10.1007/s10620-020-06802-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
212 Lin S, Yan Z, Tang Q, Zhang S. Ubiquitin-associated protein 2 like (UBAP2L) enhances growth and metastasis of gastric cancer cells. Bioengineered 2021;12:10232-45. [PMID: 34823423 DOI: 10.1080/21655979.2021.1982308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
213 Mao C, Ma L, Huang Y, Yang X, Huang H, Cai W, Sitrakiniaina A, Gu R, Xue X, Shen X. Immunogenomic Landscape and Immune-Related Gene-Based Prognostic Signature in Asian Gastric Cancer. Front Oncol 2021;11:750768. [PMID: 34804939 DOI: 10.3389/fonc.2021.750768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
214 Xu C, Liu Z, Xiao J. Ferroptosis: A Double-Edged Sword in Gastrointestinal Disease. Int J Mol Sci 2021;22:12403. [PMID: 34830285 DOI: 10.3390/ijms222212403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
215 Cuypers M, Schalk BWM, Boonman AJN, Naaldenberg J, Leusink GL. Cancer-related mortality among people with intellectual disabilities: A nationwide population-based cohort study. Cancer 2021. [PMID: 34787906 DOI: 10.1002/cncr.34030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
216 Niclauss N, Gütgemann I, Dohmen J, Kalff JC, Lingohr P. Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives. Cancers (Basel) 2021;13:5660. [PMID: 34830815 DOI: 10.3390/cancers13225660] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
217 Shen Y, Li XL, Li YX, Shan ZG, Zhao YL, Cheng P, Zhao Z, Zhang JY, Chen W, Zhuang Y, Ma DY, Zou QM, Qiu Y, Peng LS. Distribution, phenotype, functional and clinical relevance of CD8+CD103+ tissue-resident memory T cells in human gastric cancer. Cancer Immunol Immunother 2021. [PMID: 34767045 DOI: 10.1007/s00262-021-03105-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
218 Minhas AA, Fatima Z, Kommineni SK, Ahmad Z, Minhas SA. The Association of Rural-Urban Inhabitation With Gastric Adenocarcinoma Mortality and Treatment: A Surveillance, Epidemiology, and End Results (SEER)-Based Study. Cureus 2021;13:e18571. [PMID: 34760416 DOI: 10.7759/cureus.18571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
219 Ji Z, Tang T, Chen M, Dong B, Sun W, Wu N, Chen H, Feng Q, Yang X, Jin R, Jiang L. C-Myc-activated long non-coding RNA LINC01050 promotes gastric cancer growth and metastasis by sponging miR-7161-3p to regulate SPZ1 expression. J Exp Clin Cancer Res 2021;40:351. [PMID: 34749766 DOI: 10.1186/s13046-021-02155-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
220 Huang H, Xie L, Feng X, Zheng Z, Ouyang J, Li Y, Yu J. An integrated analysis of DNA promoter methylation, microRNA regulation, and gene expression in gastric adenocarcinoma. Ann Transl Med 2021;9:1414. [PMID: 34733966 DOI: 10.21037/atm-21-3211] [Reference Citation Analysis]
221 Huang JT, Chen JN, Bi YH, Gong LP, Zhang JY, DU Y, Shao CK. Comparative Transcriptome Provides a Systematic Perspective on Epstein-Barr Virus-Associated Gastric Carcinoma Cell Lines. Onco Targets Ther 2021;14:5169-82. [PMID: 34720592 DOI: 10.2147/OTT.S332513] [Reference Citation Analysis]
222 Wang S, Dong D, Li H, Feng C, Wang Y, Tian J. Cross-Phase Adversarial Domain Adaptation for Deep Disease-free Survival Prediction with Gastric Cancer CT Images. 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021. [DOI: 10.1109/embc46164.2021.9631004] [Reference Citation Analysis]
223 Liang Z, Lei F, Deng J, Zhang H, Wang Y, Li J, Shi T, Yang X, Wang Z. Design, synthesis and bioactivity evaluation of novel evodiamine derivatives with excellent potency against gastric cancer. Eur J Med Chem 2021;:113960. [PMID: 34774339 DOI: 10.1016/j.ejmech.2021.113960] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
224 Pellino A, Brignola S, Riello E, Niero M, Murgioni S, Guido M, Nappo F, Businello G, Sbaraglia M, Bergamo F, Spolverato G, Pucciarelli S, Merigliano S, Pilati P, Cavallin F, Realdon S, Farinati F, Dei Tos AP, Zagonel V, Lonardi S, Loupakis F, Fassan M. Association of CLDN18 Protein Expression with Clinicopathological Features and Prognosis in Advanced Gastric and Gastroesophageal Junction Adenocarcinomas. J Pers Med 2021;11:1095. [PMID: 34834447 DOI: 10.3390/jpm11111095] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
225 Wu H, Zhou J, Chen S, Zhu L, Jiang M, Liu A. Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer. Front Genet 2021;12:698947. [PMID: 34691143 DOI: 10.3389/fgene.2021.698947] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
226 Yeoh KG, Tan P. Mapping the genomic diaspora of gastric cancer. Nat Rev Cancer 2021. [PMID: 34702982 DOI: 10.1038/s41568-021-00412-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
227 Zhou L, Wang S, Li J, Zhong J, Zhang L, Shen R, Kouken B, Zhou C, Wang Q, Qian Y, Zou D, Chu Y. The Application of Magnetic-Controlled Capsule Gastroscopy in Patients Refusing C-EGD: A Single-Center 5-Year Observational Study. Gastroenterol Res Pract 2021;2021:6934594. [PMID: 34675973 DOI: 10.1155/2021/6934594] [Reference Citation Analysis]
228 Wang Q, Xu C, Fan Q, Yuan H, Zhang X, Chen B, Cai R, Zhang Y, Lin M, Xu M. Positive feedback between ROS and cis-axis of PIASxα/p38α-SUMOylation/MK2 facilitates gastric cancer metastasis. Cell Death Dis 2021;12:986. [PMID: 34686655 DOI: 10.1038/s41419-021-04302-6] [Reference Citation Analysis]
229 Laurino S, Mazzone P, Ruggieri V, Zoppoli P, Calice G, Lapenta A, Ciuffi M, Ignomirelli O, Vita G, Sgambato A, Russi S, Falco G. Cationic Channel TRPV2 Overexpression Promotes Resistance to Cisplatin-Induced Apoptosis in Gastric Cancer Cells. Front Pharmacol 2021;12:746628. [PMID: 34671260 DOI: 10.3389/fphar.2021.746628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
230 Zhang T, Chen H, Zhang Y, Yin X, Man J, Yang X, Lu M. Global changing trends in incidence and mortality of gastric cancer by age and sex, 1990-2019: Findings from Global Burden of Disease Study. J Cancer 2021;12:6695-705. [PMID: 34659559 DOI: 10.7150/jca.62734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
231 You Y, Hu S. Dysregulation of ECRG4 is associated with malignant properties and of prognostic importance in human gastric cancer. Cancer Biomark 2021. [PMID: 34657878 DOI: 10.3233/CBM-210334] [Reference Citation Analysis]
232 Herrera-Pariente C, Montori S, Llach J, Bofill A, Albeniz E, Moreira L. Biomarkers for Gastric Cancer Screening and Early Diagnosis. Biomedicines 2021;9:1448. [PMID: 34680565 DOI: 10.3390/biomedicines9101448] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
233 Wu Y, Zhao H. CTBP1 strengthens the cisplatin resistance of gastric cancer cells by upregulating RAD51 expression. Oncol Lett 2021;22:810. [PMID: 34630717 DOI: 10.3892/ol.2021.13071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
234 Qin Y, Tong X, Fan J, Liu Z, Zhao R, Zhang T, Suo C, Chen X, Zhao G. Global Burden and Trends in Incidence, Mortality, and Disability of Stomach Cancer From 1990 to 2017. Clin Transl Gastroenterol 2021;12:e00406. [PMID: 34608884 DOI: 10.14309/ctg.0000000000000406] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
235 Liu YY, Zhang H, Wang L, Lin SS, Lu H, Liang HJ, Liang P, Li J, Lv PJ, Gao JB. Predicting Response to Systemic Chemotherapy for Advanced Gastric Cancer Using Pre-Treatment Dual-Energy CT Radiomics: A Pilot Study. Front Oncol 2021;11:740732. [PMID: 34604085 DOI: 10.3389/fonc.2021.740732] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
236 Motoo I, Nanjo S, Ando T, Yamashita S, Ushijima T, Yasuda I. Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers. Gastric Cancer 2021. [PMID: 34554345 DOI: 10.1007/s10120-021-01250-0] [Reference Citation Analysis]
237 Lang T, Xu J, Zhou L, Zhang Z, Ma X, Gu J, Liu J, Li Y, Ding D, Qiu J. Disruption of KDM4C-ALDH1A3 feed-forward loop inhibits stemness, tumorigenesis and chemoresistance of gastric cancer stem cells. Signal Transduct Target Ther 2021;6:336. [PMID: 34548470 DOI: 10.1038/s41392-021-00674-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
238 Nguyen NT, Dang NT, Dang QH, Tran VC, Vo HL, Yamaguchi M, Ta TV. Polymorphism of MUC1 Gene in Vietnamese Gastric Cancer Patients: A Multicenter Case-Control Study. Front Oncol 2021;11:694977. [PMID: 34532288 DOI: 10.3389/fonc.2021.694977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
239 Ning FL, Zhang NN, Wang J, Jin YF, Quan HG, Pei JP, Zhao Y, Zeng XT, Abe M, Zhang CD. Prognostic value of modified Lauren classification in gastric cancer. World J Gastrointest Oncol 2021; 13(9): 1184-1195 [PMID: 34616522 DOI: 10.4251/wjgo.v13.i9.1184] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
240 Jin H, Wu Z, Tan B, Liu Z, Zhang B. CircITGA7 Suppresses Gastric Cancer Progression Through miR-1471/MTDH Axis. Front Cell Dev Biol 2021;9:688970. [PMID: 34504842 DOI: 10.3389/fcell.2021.688970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
241 Tong Y, Wang H, Zhao Y, He X, Xu H, Li H, Shuai P, Gong L, Wu H, Xu H, Luo Y, Wang D, Liu S, Song Z. Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study. Front Oncol 2021;11:652574. [PMID: 34504781 DOI: 10.3389/fonc.2021.652574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
242 Shan MJ, Meng LB, Guo P, Zhang YM, Kong D, Liu YB. Screening and Identification of Key Biomarkers of Gastric Cancer: Three Genes Jointly Predict Gastric Cancer. Front Oncol 2021;11:591893. [PMID: 34485109 DOI: 10.3389/fonc.2021.591893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
243 Meng S, Dolo PR, Guo P, Hong J, Li C, Zhu X, Zhou D. Expression of long non-coding RNA LINC01279 in gastric adenocarcinoma and its clinical significance. Asian J Surg 2021:S1015-9584(21)00533-9. [PMID: 34507839 DOI: 10.1016/j.asjsur.2021.08.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
244 Cheng Z, Gao S, Liang X, Lian C, Chen J, Fang C. Inhibiting PP2Acα Promotes the Malignant Phenotype of Gastric Cancer Cells through the ATM/METTL3 Axis. Biomed Res Int 2021;2021:1015293. [PMID: 34485508 DOI: 10.1155/2021/1015293] [Reference Citation Analysis]
245 Zhang Y, Bai X, Zhang Y, Li Y. Daam1 Overexpression Promotes Gastric Cancer Progression and Regulates ERK and AKT Signaling Pathways. Onco Targets Ther 2021;14:4609-19. [PMID: 34475767 DOI: 10.2147/OTT.S316157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
246 Xu S, Xiang C, Wu J, Teng Y, Wu Z, Wang R, Lu B, Zhan Z, Wu H, Zhang J. Tongue Coating Bacteria as a Potential Stable Biomarker for Gastric Cancer Independent of Lifestyle. Dig Dis Sci 2021;66:2964-80. [PMID: 33044677 DOI: 10.1007/s10620-020-06637-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
247 Pang H, Zhang W, Liang X, Zhang Z, Chen X, Zhao L, Liu K, Galiullin D, Yang K, Chen X, Hu J. Prognostic Score System Using Preoperative Inflammatory, Nutritional and Tumor Markers to Predict Prognosis for Gastric Cancer: A Two-Center Cohort Study. Adv Ther 2021;38:4917-34. [PMID: 34379305 DOI: 10.1007/s12325-021-01870-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
248 Bük ÖF, Ocak S. GSTT-1 ve GSTM-1 Gen Delesyonlarının Mide Kanseri Gelişim Riski Üzerine Etkisi. Bolu Abant Izzet Baysal Universitesi Tip Fakultesi Abant Tip Dergisi 2021;10:226-230. [DOI: 10.47493/abantmedj.852513] [Reference Citation Analysis]
249 Shimozaki K, Nakayama I, Takahari D, Kamiimabeppu D, Osumi H, Wakatsuki T, Ooki A, Ogura M, Shinozaki E, Chin K, Yamaguchi K. A novel clinical prognostic index for patients with advanced gastric cancer: possible contribution to the continuum of care. ESMO Open 2021;6:100234. [PMID: 34461485 DOI: 10.1016/j.esmoop.2021.100234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
250 Shih WT, Yang PR, Chen KJ, Yang YH, Lu ML, Chen VC, Shen YC. Antidepressants use is associated with overall survival improvement of patients with gastric cancer after surgery and adjuvant chemotherapy in Taiwan: A large population-based cohort study. Medicine (Baltimore) 2021;100:e27031. [PMID: 34449480 DOI: 10.1097/MD.0000000000027031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
251 Samare-najaf M, Samareh A, Jamali N, Abbasi A, Clark CC, Khorchani MJ, Zal F. Adverse Effects and Safety of Etirinotecan Pegol, a Novel Topoisomerase Inhibitor, in Cancer Treatment: A Systematic Review. CCTR 2021;17:234-43. [DOI: 10.2174/1573394717666210202103502] [Reference Citation Analysis]
252 Jiang S, Zhang Y, Zhang X, Lu B, Sun P, Wu Q, Ding X, Huang J. GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of Gastric Cancer. Front Immunol 2021;12:660397. [PMID: 34421887 DOI: 10.3389/fimmu.2021.660397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
253 Reyes DA, Sarría VMS, Salazar-Viedma M, D'Afonseca V. Histone Methyltransferases Useful in Gastric Cancer Research. Cancer Inform 2021;20:11769351211039862. [PMID: 34413625 DOI: 10.1177/11769351211039862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
254 Zhang H, Wu J, Yuan J, Li H, Zhang Y, Wu W, Chen W, Wang C, Meng S, Chen S, Huo M, He Y, Zhang C. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer. J Exp Clin Cancer Res 2021;40:260. [PMID: 34412665 DOI: 10.1186/s13046-021-02052-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
255 Kouzu K, Tsujimoto H, Kishi Y, Ueno H, Shinomiya N. Role of Microbial Infection-Induced Inflammation in the Development of Gastrointestinal Cancers. Medicines (Basel) 2021;8:45. [PMID: 34436224 DOI: 10.3390/medicines8080045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
256 Lin TY, Lan WH, Chiu YF, Feng CL, Chiu CH, Kuo CJ, Lai CH. Statins' Regulation of the Virulence Factors of Helicobacter pylori and the Production of ROS May Inhibit the Development of Gastric Cancer. Antioxidants (Basel) 2021;10:1293. [PMID: 34439541 DOI: 10.3390/antiox10081293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
257 Miao YD, Mu LJ, Mi DH. Metabolism-associated genes in occurrence and development of gastrointestinal cancer: Latest progress and future prospect. World J Gastrointest Oncol 2021; 13(8): 758-771 [PMID: 34457185 DOI: 10.4251/wjgo.v13.i8.758] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
258 Geng H, Liu G, Hu J, Li J, Wang D, Zou S, Xu X. HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway. Mol Med Rep 2021;24:722. [PMID: 34396425 DOI: 10.3892/mmr.2021.12361] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
259 Zhang X, Huang H, Yang D, Wang P, Huang X, Hu Z, Zhang Y, Yan R, Zhu Z, Cai Q. Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis. Technol Cancer Res Treat 2021;20:15330338211036310. [PMID: 34328799 DOI: 10.1177/15330338211036310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
260 Lv Y, Shan Y, Song L, Zhao Y, Lai R, Su J, Zhang X. Type I collagen promotes tumor progression of integrin β1 positive gastric cancer through a BCL9L/β-catenin signaling pathway. Aging (Albany NY) 2021;13:19064-76. [PMID: 34319913 DOI: 10.18632/aging.203355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
261 Guo Z, Zhou K, Wang Q, Huang Y, Ji J, Peng Y, Zhang X, Zheng T, Zhang Z, Chong D, Yang Z. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis. Cancer Sci 2021;112:3533-44. [PMID: 34160112 DOI: 10.1111/cas.15045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
262 Wen Z, Liang W, Zhong Y, Sun F, Zhang Q. [Expression of nicotinamide-N-methyltransferase in gastric cancer and its biological and clinicopathological significance]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:828-38. [PMID: 34238734 DOI: 10.12122/j.issn.1673-4254.2021.06.04] [Reference Citation Analysis]
263 Huang W, Zhan D, Li Y, Zheng N, Wei X, Bai B, Zhang K, Liu M, Zhao X, Ni X, Xia X, Shi J, Zhang C, Lu Z, Ji J, Wang J, Wang S, Ji G, Li J, Nie Y, Liang W, Wu X, Cui J, Meng Y, Cao F, Shi T, Zhu W, Wang Y, Chen L, Zhao Q, Wang H, Shen L, Qin J. Proteomics provides individualized options of precision medicine for patients with gastric cancer. Sci China Life Sci 2021;64:1199-211. [PMID: 34258712 DOI: 10.1007/s11427-021-1966-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
264 Yu Z, Rong Z, Sheng J, Luo Z, Zhang J, Li T, Zhu Z, Fu Z, Qiu Z, Huang C. Aberrant Non-Coding RNA Expressed in Gastric Cancer and Its Diagnostic Value. Front Oncol 2021;11:606764. [PMID: 34295803 DOI: 10.3389/fonc.2021.606764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
265 Chen B, Xu X, Lin DD, Chen X, Xu YT, Liu X, Dong WG. KRT18 Modulates Alternative Splicing of Genes Involved in Proliferation and Apoptosis Processes in Both Gastric Cancer Cells and Clinical Samples. Front Genet 2021;12:635429. [PMID: 34290732 DOI: 10.3389/fgene.2021.635429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
266 Shi R, Gao S, Zhang J, Xu J, Graham LM, Yang X, Li C. Collagen prolyl 4-hydroxylases modify tumor progression. Acta Biochim Biophys Sin (Shanghai) 2021;53:805-14. [PMID: 34009234 DOI: 10.1093/abbs/gmab065] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
267 Han J, Fu R, Chen C, Cheng X, Guo T, Huangfu L, Li X, Du H, Xing X, Ji J. CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways. Int J Biol Sci 2021;17:2841-52. [PMID: 34345211 DOI: 10.7150/ijbs.57826] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
268 Wei XL, Luo TQ, Li JN, Xue ZC, Wang Y, Zhang Y, Chen YB, Peng C. Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes in Gastric Cancer. Front Mol Biosci 2021;8:691143. [PMID: 34277706 DOI: 10.3389/fmolb.2021.691143] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
269 Weidle UH, Birzele F, Brinkmann U, Auslaender S. Gastric Cancer: Identification of microRNAs Inhibiting Druggable Targets and Mediating Efficacy in Preclinical In Vivo Models. Cancer Genomics Proteomics 2021;18:497-514. [PMID: 34183383 DOI: 10.21873/cgp.20275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
270 Shan ZG, Chen J, Liu JS, Zhang JY, Wang TT, Teng YS, Mao FY, Cheng P, Zou QM, Zhou WY, Peng LS, Zhao YL, Zhuang Y. Activated neutrophils polarize protumorigenic interleukin-17A-producing T helper subsets through TNF-α-B7-H2-dependent pathway in human gastric cancer. Clin Transl Med 2021;11:e484. [PMID: 34185422 DOI: 10.1002/ctm2.484] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
271 Feng HY, Yuan Y, Zhang Y, Liu HJ, Dong X, Yang SC, Liu XL, Lai X, Zhu MH, Wang J, Lu Q, Lin Q, Chen HZ, Lovell JF, Sun P, Fang C. Targeted Micellar Phthalocyanine for Lymph Node Metastasis Homing and Photothermal Therapy in an Orthotopic Colorectal Tumor Model. Nanomicro Lett 2021;13:145. [PMID: 34146159 DOI: 10.1007/s40820-021-00666-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
272 Yano Y, Akiba J, Naito Y, Sadashima E, Cho H, Hishima T, Yano H. Sulfite Oxidase Is a Novel Prognostic Biomarker of Advanced Gastric Cancer. In Vivo 2021;35:229-37. [PMID: 33402469 DOI: 10.21873/invivo.12251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
273 Wei XL, Liu QW, Liu FR, Yuan SS, Li XF, Li JN, Yang AL, Ling YH. The clinicopathological significance and predictive value for immunotherapy of programmed death ligand-1 expression in Epstein-Barr virus-associated gastric cancer. Oncoimmunology 2021;10:1938381. [PMID: 34235004 DOI: 10.1080/2162402X.2021.1938381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
274 Liu B, Zhang Y, Suo J. Increased Expression of PDK4 Was Displayed in Gastric Cancer and Exhibited an Association With Glucose Metabolism. Front Genet 2021;12:689585. [PMID: 34220962 DOI: 10.3389/fgene.2021.689585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
275 Huang YJ, Cao ZF, Wang J, Yang J, Wei YJ, Tang YC, Cheng YX, Zhou J, Zhang ZX. Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort. World J Clin Cases 2021; 9(17): 4143-4158 [PMID: 34141777 DOI: 10.12998/wjcc.v9.i17.4143] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
276 Lu XQ, Zhang JQ, Zhang SX, Qiao J, Qiu MT, Liu XR, Chen XX, Gao C, Zhang HH. Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis. BMC Cancer 2021;21:697. [PMID: 34126961 DOI: 10.1186/s12885-021-08358-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
277 Zhou L, Zhou Q, Wu Y, Xin L. Integrating 13 Microarrays to Construct a 6 RNA-binding proteins Prognostic Signature for Gastric Cancer patients. J Cancer 2021;12:4971-84. [PMID: 34234866 DOI: 10.7150/jca.57225] [Reference Citation Analysis]
278 Wu R, Guo S, Lai S, Pan G, Zhang L, Liu H. A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer. BMC Cancer 2021;21:684. [PMID: 34112138 DOI: 10.1186/s12885-021-08444-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
279 Zhai J, Wu J, Wang Y, Fan R, Xie G, Wu F, He Y, Qian S, Tan A, Yao X, He M, Shen L. Prediction of Sensitivity and Efficacy of Clinical Chemotherapy Using Larval Zebrafish Patient-Derived Xenografts of Gastric Cancer. Front Cell Dev Biol 2021;9:680491. [PMID: 34164399 DOI: 10.3389/fcell.2021.680491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
280 Shu X, Zhan PP, Sun LX, Yu L, Liu J, Sun LC, Yang ZH, Ran YL, Sun YM. BCAT1 Activates PI3K/AKT/mTOR Pathway and Contributes to the Angiogenesis and Tumorigenicity of Gastric Cancer. Front Cell Dev Biol 2021;9:659260. [PMID: 34164393 DOI: 10.3389/fcell.2021.659260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
281 Wang Y, Xu L, Ai D. A Sparse and Low-Rank Regression Model for Identifying the Relationships Between DNA Methylation and Gene Expression Levels in Gastric Cancer and the Prediction of Prognosis. Genes (Basel) 2021;12:854. [PMID: 34199440 DOI: 10.3390/genes12060854] [Reference Citation Analysis]
282 Wang XK, Zhang YW, Wang CM, Li B, Zhang TZ, Zhou WJ, Cheng LJ, Huo MY, Zhang CH, He YL. METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer. J Cell Mol Med 2021;25:6602-17. [PMID: 34075693 DOI: 10.1111/jcmm.16664] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
283 Sun P, Lu Q, Li Z, Qin N, Jiang Y, Ma H, Jin G, Yu H, Dai J. Assessment of prognostic prediction models for gastric cancer using genomic and transcriptomic profiles. Meta Gene 2021;28:100890. [DOI: 10.1016/j.mgene.2021.100890] [Reference Citation Analysis]
284 Wang G, Sun Q, Zhu H, Bi Y, Zhu H, Xu A. The stabilization of yes-associated protein by TGFβ-activated kinase 1 regulates the self-renewal and oncogenesis of gastric cancer stem cells. J Cell Mol Med 2021;25:6584-601. [PMID: 34075691 DOI: 10.1111/jcmm.16660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
285 Zhao LJ, Li YY, Zhang YT, Fan QQ, Ren HM, Zhang C, Mardinoglu A, Chen WC, Pang JR, Shen DD, Wang JW, Zhao LF, Zhang JY, Wang ZY, Zheng YC, Liu HM. Lysine demethylase LSD1 delivered via small extracellular vesicles promotes gastric cancer cell stemness. EMBO Rep 2021;22:e50922. [PMID: 34060205 DOI: 10.15252/embr.202050922] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
286 Hu X, Wu L, Liu B, Chen K. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction. Front Immunol 2021;12:651056. [PMID: 34122409 DOI: 10.3389/fimmu.2021.651056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
287 Yan T, Wong PK, Qin YY. Deep learning for diagnosis of precancerous lesions in upper gastrointestinal endoscopy: A review. World J Gastroenterol 2021; 27(20): 2531-2544 [PMID: 34092974 DOI: 10.3748/wjg.v27.i20.2531] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
288 Chen C, Chen L, Lin L, Jin D, Du Y, Lyu J. Research progress on gut microbiota in patients with gastric cancer, esophageal cancer, and small intestine cancer. Appl Microbiol Biotechnol 2021;105:4415-25. [PMID: 34037843 DOI: 10.1007/s00253-021-11358-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
289 Yang M, Arai E, Takahashi Y, Totsuka H, Chiku S, Taniguchi H, Katai H, Sakamoto H, Yoshida T, Kanai Y. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways. Carcinogenesis 2020;41:1473-84. [PMID: 32710740 DOI: 10.1093/carcin/bgaa079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
290 Zheng L, Kang L, Cheng Y, Cao J, Liu L, Xu H, Gao L. Tumor Inhibitory Effect of Long Non-coding RNA LOC100505817 on Gastric Cancer. Pathol Oncol Res 2021;27:581542. [PMID: 34385891 DOI: 10.3389/pore.2021.581542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
291 Li L, Lai Q, Zhang M, Jia J. Long non-coding RNA DLGAP1-AS1 promotes the progression of gastric cancer via miR-515-5p/MARK4 axis. Braz J Med Biol Res 2021;54:e10062. [PMID: 34037089 DOI: 10.1590/1414-431X2020e10062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
292 Fu Q, Tan X, Tang H, Liu J. CCL21 activation of the MALAT1/SRSF1/mTOR axis underpins the development of gastric carcinoma. J Transl Med 2021;19:210. [PMID: 34001131 DOI: 10.1186/s12967-021-02806-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
293 Shi W, Zhang G, Ma Z, Li L, Liu M, Qin L, Yu Z, Zhao L, Liu Y, Zhang X, Qin J, Ye H, Jiang X, Zhou H, Sun H, Jiao Z. Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer. Nat Commun 2021;12:2812. [PMID: 33990570 DOI: 10.1038/s41467-021-23053-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
294 Zhou C, Yang Q. Value of HMGB1 expression for assessing gastric cancer severity: a systematic meta-analysis. J Int Med Res 2021;49:300060521993312. [PMID: 33682495 DOI: 10.1177/0300060521993312] [Reference Citation Analysis]
295 Ma R, Shimura T, Yin C, Okugawa Y, Kitajima T, Koike Y, Okita Y, Ohi M, Uchida K, Goel A, Yao L, Zhang X, Toiyama Y. Antitumor effects of Andrographis via ferroptosis-associated genes in gastric cancer. Oncol Lett 2021;22:523. [PMID: 34025790 DOI: 10.3892/ol.2021.12784] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
296 Fei Y, Cao Y, Gu Y, Fang H, Chen Y, Wang J, Liu X, Lv K, He X, Lin C, Liu H, Li H, He H, Li R, Zhang H, Zhang W. Intratumoral Foxp3+RORγt+ T cell infiltration determines poor prognosis and immunoevasive contexture in gastric cancer patients. Cancer Immunol Immunother 2021. [PMID: 33978826 DOI: 10.1007/s00262-021-02950-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
297 Tedaldi G, Molinari C, São José C, Barbosa-Matos R, André A, Danesi R, Arcangeli V, Ravegnani M, Saragoni L, Morgagni P, Rebuzzi F, Canale M, Pignatta S, Ferracci E, Martinelli G, Ranzani GN, Oliveira C, Calistri D, Ulivi P. Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer. Pharmaceuticals (Basel) 2021;14:457. [PMID: 34066170 DOI: 10.3390/ph14050457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
298 Acikgoz Y, Aktürk Esen S, Ucar G, Dirikoc M, Ergun Y, Bal O, Uncu D. The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer. Cureus 2021;13:e14882. [PMID: 34104608 DOI: 10.7759/cureus.14882] [Reference Citation Analysis]
299 Ungerleider N, Bullard W, Kara M, Wang X, Roberts C, Renne R, Tibbetts S, Flemington EK. EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape. PLoS Pathog 2021;17:e1009217. [PMID: 33956915 DOI: 10.1371/journal.ppat.1009217] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
300 Singh HM, Leber MF, Bossow S, Engeland CE, Dessila J, Grossardt C, Zaoui K, Bell JC, Jäger D, von Kalle C, Ungerechts G. MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer. Mol Ther Oncolytics 2021;21:340-55. [PMID: 34141871 DOI: 10.1016/j.omto.2021.04.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
301 Wang M, Sun L, Wang L, Sun Y. Effects of Berberine on Circular RNA Expression Profiles in Human Gastric Cancer Cells. Evid Based Complement Alternat Med 2021;2021:6688629. [PMID: 34055022 DOI: 10.1155/2021/6688629] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
302 Yu D, Zhang C. Circular RNA PTK2 Accelerates Cell Proliferation and Inhibits Cell Apoptosis in Gastric Carcinoma via miR-139-3p. Dig Dis Sci 2021;66:1499-509. [PMID: 32504353 DOI: 10.1007/s10620-020-06358-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
303 So JBY, Kapoor R, Zhu F, Koh C, Zhou L, Zou R, Tang YC, Goo PCK, Rha SY, Chung HC, Yoong J, Yap CT, Rao J, Chia CK, Tsao S, Shabbir A, Lee J, Lam KP, Hartman M, Yong WP, Too HP, Yeoh KG. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population. Gut 2021;70:829-37. [PMID: 33028667 DOI: 10.1136/gutjnl-2020-322065] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 20.0] [Reference Citation Analysis]
304 Li J, Ren M, Yang J, Zhao Y, Li Y, Zhang D, Wu F, Zhang Z, Lu X, Ren L, He S, Lu G. Screening value for gastrointestinal lesions of magnetic-controlled capsule endoscopy in asymptomatic individuals. J Gastroenterol Hepatol 2021;36:1267-75. [PMID: 33000488 DOI: 10.1111/jgh.15282] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
305 Huo J, Wu L, Zang Y. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer. J Immunol Res 2021;2021:5554342. [PMID: 34007851 DOI: 10.1155/2021/5554342] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
306 Cui Y, Li L, Li Z, Yin J, Lane J, Ji J, Jiang WG. Dual effects of targeting S100A11 on suppressing cellular metastatic properties and sensitizing drug response in gastric cancer. Cancer Cell Int 2021;21:243. [PMID: 33931048 DOI: 10.1186/s12935-021-01949-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
307 Yokoyama D, Hisamori S, Deguchi Y, Nishigori T, Okabe H, Kanaya S, Manaka D, Kadokawa Y, Hata H, Minamiguchi S, Tsunoda S, Obama K, Sakai Y. PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma. Sci Rep 2021;11:9013. [PMID: 33907203 DOI: 10.1038/s41598-021-88331-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
308 Ren C, Wu C, Wang N, Lian C, Yang C. Clonal Architectures Predict Clinical Outcome in Gastric Adenocarcinoma Based on Genomic Variation, Tumor Evolution, and Heterogeneity. Cell Transplant 2021;30:963689721989606. [PMID: 33900127 DOI: 10.1177/0963689721989606] [Reference Citation Analysis]
309 Yu J, Liu H, Zeng X, Zhao Y, Jiang D, Lu H, Qian J. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis. PLoS One 2021;16:e0250295. [PMID: 33901218 DOI: 10.1371/journal.pone.0250295] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
310 Fu Y, Hu C, Du P, Huang G. E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes. J Oncol 2021;2021:6611327. [PMID: 33986804 DOI: 10.1155/2021/6611327] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
311 Kato T, Nakamori M, Matsumura S, Nakamura M, Ojima T, Fukuhara H, Ino Y, Todo T, Yamaue H. Oncolytic virotherapy with human telomerase reverse transcriptase promoter regulation enhances cytotoxic effects against gastric cancer. Oncol Lett 2021;21:490. [PMID: 33968206 DOI: 10.3892/ol.2021.12751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
312 Chang L, Gao H, Wang L, Wang N, Zhang S, Zhou X, Yang H. Exosomes derived from miR-1228 overexpressing bone marrow-mesenchymal stem cells promote growth of gastric cancer cells. Aging (Albany NY) 2021;13:11808-21. [PMID: 33883305 DOI: 10.18632/aging.202878] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
313 Cui S, Wei Y, Bian Q, Zhu Y, Chen X, Zhuang Y, Cai M, Tang J, Yu L, Ding J. Injectable Thermogel Generated by the "Block Blend" Strategy as a Biomaterial for Endoscopic Submucosal Dissection. ACS Appl Mater Interfaces 2021;13:19778-92. [PMID: 33881817 DOI: 10.1021/acsami.1c03849] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
314 An J, Wang H, Ma X, Hu B, Yan Y, Yan Y, Su Z. Musk ketone induces apoptosis of gastric cancer cells via downregulation of sorbin and SH3 domain containing 2. Mol Med Rep 2021;23:450. [PMID: 33880576 DOI: 10.3892/mmr.2021.12089] [Reference Citation Analysis]
315 Tang D, Zhou J, Wang L, Ni M, Chen M, Hassan S, Luo R, Chen X, He X, Zhang L, Ding X, Yu H, Xu G, Zou X. A Novel Model Based on Deep Convolutional Neural Network Improves Diagnostic Accuracy of Intramucosal Gastric Cancer (With Video). Front Oncol 2021;11:622827. [PMID: 33959495 DOI: 10.3389/fonc.2021.622827] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
316 Yang L, Hou Y, Du YE, Li Q, Zhou F, Li Y, Zeng H, Jin T, Wan X, Guan S, Wang R, Liu M. Mirtronic miR-4646-5p promotes gastric cancer metastasis by regulating ABHD16A and metabolite lysophosphatidylserines. Cell Death Differ 2021. [PMID: 33875796 DOI: 10.1038/s41418-021-00779-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
317 Wang D, Zou J, Dai J, Cheng Z. Absent in melanoma 2 suppresses gastric cancer cell proliferation and migration via inactivation of AKT signaling pathway. Sci Rep 2021;11:8235. [PMID: 33859277 DOI: 10.1038/s41598-021-87744-4] [Reference Citation Analysis]
318 Palrasu M, Zaika E, El-Rifai W, Que J, Zaika AI. Role of Bacterial and Viral Pathogens in Gastric Carcinogenesis. Cancers (Basel) 2021;13:1878. [PMID: 33919876 DOI: 10.3390/cancers13081878] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
319 Tanaka H, Kanda M, Miwa T, Umeda S, Sawaki K, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer. Br J Cancer 2021;125:220-8. [PMID: 33854208 DOI: 10.1038/s41416-021-01366-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
320 Xie N, Pan Y, Wu J, Bai Y, Xiao C, Gao X, Wang J, Liu N. MicroRNA-302s Might Regulate ARL4C-Mediated Gastric Cancer Progression via p53 Signaling: Bioinformatics Analysis and Experiments Validation. Onco Targets Ther 2021;14:2541-53. [PMID: 33880033 DOI: 10.2147/OTT.S282992] [Reference Citation Analysis]
321 Lee JS, Lee JH, Kim J, Na HK, Ahn JY, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY. Predictive Role of Endoscopic Surveillance after Total Gastrectomy with R0 Resection for Gastric Cancer. J Korean Med Sci 2021;36:e88. [PMID: 33847079 DOI: 10.3346/jkms.2021.36.e88] [Reference Citation Analysis]
322 Wu SY, Ho MH, Chang HM, Hsu KF, Yu JC, Chan DC. Long-term oncologic result of laparoscopic versus open gastrectomy for gastric cancer: a propensity score matching analysis. World J Surg Oncol 2021;19:101. [PMID: 33827601 DOI: 10.1186/s12957-021-02217-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
323 Zhong X, Wen X, Chen L, Gu N, Yu X, Sui K. Long non-coding RNA KCNQ1OT1 promotes the progression of gastric cancer via the miR-145-5p/ARF6 axis.J Gene Med. 2021;23:e3330. [PMID: 33682985 DOI: 10.1002/jgm.3330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
324 Zheng Z, Bu FD, Chen H, Yin J, Xu R, Cai J, Zhang J, Yao HW, Zhang ZT. Factors associated with overall survival in early gastric cancer patients who underwent additional surgery after endoscopic submucosal dissection. World J Clin Cases 2021; 9(10): 2192-2204 [PMID: 33869595 DOI: 10.12998/wjcc.v9.i10.2192] [Reference Citation Analysis]
325 Chen Q, Hu Z, Zhang X, Wei Z, Fu H, Yang D, Cai Q. A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer. Open Med (Wars) 2021;16:540-52. [PMID: 33869776 DOI: 10.1515/med-2021-0241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
326 Meng Q, Lu YX, Ruan DY, Yu K, Chen YX, Xiao M, Wang Y, Liu ZX, Xu RH, Ju HQ, Qiu MZ. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer. Mol Ther Nucleic Acids 2021;24:695-710. [PMID: 33996253 DOI: 10.1016/j.omtn.2021.03.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
327 Wan Y, Qiu S, Yin L, Gao X, Jiang Y, Feng S, Tang C. CAP2 contributes to tumorigenesis in gastric cancer by targeting transcription factor SOX9. J Gastrointest Oncol 2021;12:268-77. [PMID: 34012625 DOI: 10.21037/jgo-20-234] [Reference Citation Analysis]
328 Qaria MA, Qumar S, Sepe LP, Ahmed N. Cholesterol glucosylation-based survival strategy in Helicobacter pylori. Helicobacter 2021;26:e12777. [PMID: 33368895 DOI: 10.1111/hel.12777] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
329 Wang Q, Gu M, Zhuang Y, Chen J. The Long Noncoding RNA MAGI1-IT1 Regulates the miR-302d-3p/IGF1 Axis to Control Gastric Cancer Cell Proliferation. Cancer Manag Res 2021;13:2959-67. [PMID: 33833579 DOI: 10.2147/CMAR.S305108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
330 Asplund J, Gottlieb-Vedi E, Leijonmarck W, Mattsson F, Lagergren J. Prognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS). Acta Oncol 2021;60:513-20. [PMID: 33502275 DOI: 10.1080/0284186X.2021.1874619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
331 Tang D, Ni M, Zhu H, Cao J, Zhou L, Shen S, Peng C, Lv Y, Xu G, Wang L, Zou X. Differential prognostic implications of gastric adenocarcinoma based on Lauren's classification: a Surveillance, Epidemiology, and End Results (SEER)-based cohort study. Ann Transl Med 2021;9:646. [PMID: 33987344 DOI: 10.21037/atm-20-7953] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
332 Li J, Ge YG, Yang YF, Zhang J. Comparison of delta-shaped anastomosis and Billroth I reconstruction after laparoscopic distal gastrectomy for gastric cancer. J Gastrointest Oncol 2021;12:259-67. [PMID: 34012624 DOI: 10.21037/jgo-21-109] [Reference Citation Analysis]
333 Ricci AD, Rizzo A, Rojas Llimpe FL, Di Fabio F, De Biase D, Rihawi K. Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift? Cancers (Basel) 2021;13:1664. [PMID: 33916206 DOI: 10.3390/cancers13071664] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 19.5] [Reference Citation Analysis]
334 Tsuji T, Maeda Y, Kita K, Murakami K, Saya H, Takemura H, Inaki N, Oshima M, Oshima H. FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells. Oncogene 2021;40:3072-86. [PMID: 33795838 DOI: 10.1038/s41388-021-01757-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
335 Su H, Li X, Huang L, Cao J, Zhang M, Vedarethinam V, Di W, Hu Z, Qian K. Plasmonic Alloys Reveal a Distinct Metabolic Phenotype of Early Gastric Cancer. Adv Mater 2021;33:e2007978. [PMID: 33742513 DOI: 10.1002/adma.202007978] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 22.5] [Reference Citation Analysis]
336 Ran T, Chen Z, Zhao L, Ran W, Fan J, Hong S, Yang Z. LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer. Technol Cancer Res Treat 2021;20:15330338211004944. [PMID: 33784890 DOI: 10.1177/15330338211004944] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
337 Chen S, Liu W, Huang Y. Identification and external validation of a prognostic signature associated with DNA repair genes in gastric cancer. Sci Rep 2021;11:7141. [PMID: 33785812 DOI: 10.1038/s41598-021-86504-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
338 Takashima H, Koga Y, Manabe S, Ohnuki K, Tsumura R, Anzai T, Iwata N, Wang Y, Yokokita T, Komori Y, Mori D, Usuda S, Haba H, Fujii H, Matsumura Y, Yasunaga M. Radioimmunotherapy with an 211 At-labeled anti-tissue factor antibody protected by sodium ascorbate. Cancer Sci 2021;112:1975-86. [PMID: 33606344 DOI: 10.1111/cas.14857] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
339 Yang Z, OuYang X, Zheng L, Dai L, Luo W. Long intergenic noncoding RNA00265 promotes proliferation of gastric cancer via the microRNA-144-3p/Chromobox 4 axis. Bioengineered 2021;12:1012-25. [PMID: 33464142 DOI: 10.1080/21655979.2021.1876320] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
340 Sun M, Hua J, Liu G, Huang P, Liu N, He X. Myrrh induces the apoptosis and inhibits the proliferation and migration of gastric cancer cells through down-regulating cyclooxygenase-2 expression. Biosci Rep 2020;40:BSR20192372. [PMID: 32364228 DOI: 10.1042/BSR20192372] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
341 Liu H, Zhang Z, Han Y, Fan A, Liu H, Zhang X, Liu Y, Zhang R, Liu W, Lu Y, Fan D, Zhao X, Nie Y. The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis. Front Oncol 2021;11:634579. [PMID: 33869020 DOI: 10.3389/fonc.2021.634579] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
342 Roviello G, Aprile G, D'Angelo A, Iannone LF, Roviello F, Polom K, Mini E, Catalano M. Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? Gastric Cancer 2021;24:765-79. [PMID: 33742317 DOI: 10.1007/s10120-021-01182-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
343 Kwon MJ, Kim JN, Park J, Kim YT, Lee MJ, Kim BJ. Alisma canaliculatum Extract Affects AGS Gastric Cancer Cells by Inducing Apoptosis. Int J Med Sci 2021;18:2155-61. [PMID: 33859522 DOI: 10.7150/ijms.55212] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
344 Hong C, Yang S, Wang Q, Zhang S, Wu W, Chen J, Zhong D, Li M, Li L, Li J, Yu H, Chen H, Zeng Q, Zhang C. Epigenetic Age Acceleration of Stomach Adenocarcinoma Associated With Tumor Stemness Features, Immunoactivation, and Favorable Prognosis. Front Genet 2021;12:563051. [PMID: 33815458 DOI: 10.3389/fgene.2021.563051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
345 Zhang J, Fan J, Zeng X, Nie M, Chen W, Wang Y, Luan J, Zhu Z, Chang X, Ju D, Feng L, Yin K. Targeting the autophagy promoted antitumor effect of T-DM1 on HER2-positive gastric cancer. Cell Death Dis 2021;12:288. [PMID: 33731670 DOI: 10.1038/s41419-020-03349-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
346 Jin MH, Nam AR, Bang JH, Oh KS, Seo HR, Kim JM, Yoon J, Kim TY, Oh DY. WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers. Gastric Cancer 2021;24:1003-20. [PMID: 33723720 DOI: 10.1007/s10120-021-01176-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
347 Pinto F, Santos-Ferreira L, Pinto MT, Gomes C, Reis CA. The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness. Cancers (Basel) 2021;13:1330. [PMID: 33809543 DOI: 10.3390/cancers13061330] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
348 Fornaro L, Spallanzani A, de Vita F, D'Ugo D, Falcone A, Lorenzon L, Tirino G, Cascinu S; GAIN (GAstric Cancer Italian Network). Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). Cancers (Basel) 2021;13:1304. [PMID: 33804024 DOI: 10.3390/cancers13061304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
349 Zhu H, Wang G, Zhu H, Xu A. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors. BMC Cancer 2021;21:269. [PMID: 33711961 DOI: 10.1186/s12885-021-07996-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
350 Qiu Y, Zhang Z, Chen Y. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Gastric Cancer: A Meta-Analysis. Front Oncol 2021;11:537140. [PMID: 33777726 DOI: 10.3389/fonc.2021.537140] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
351 Ni Q, Zhang Y, Tao R, Li X, Zhu J. MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling. Aging (Albany NY) 2021;13:8665-87. [PMID: 33714198 DOI: 10.18632/aging.202679] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
352 Ehara T, Uehara T, Nakajima T, Kinugawa Y, Kobayashi S, Iwaya M, Ota H, Soejima Y. LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma. BMC Cancer 2021;21:228. [PMID: 33676447 DOI: 10.1186/s12885-021-07913-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
353 Kaiyuan D, Lijuan H, Xueyuan S, Yunhui Z. The role and underlying mechanism of miR-1299 in cancer. Future Sci OA 2021;7:FSO693. [PMID: 34046198 DOI: 10.2144/fsoa-2021-0014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
354 Ouyang J, Xie Z, Lei X, Tang G, Gan R, Yang X. Clinical crosstalk between microRNAs and gastric cancer (Review). Int J Oncol 2021;58:7. [PMID: 33649806 DOI: 10.3892/ijo.2021.5187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
355 Domanchuk TI, Chornenka ZA, Hrytsiuk MI. COMPARATIVE ANALYSIS OF INCIDENCE AND MORTALITY FROM GASTRIC CANCER AMONG THE POPULATION OF EUROPE AND UKRAINE. Wiad Lek 2021;74:596-602. [DOI: 10.36740/wlek202103206] [Reference Citation Analysis]
356 Wang K, Gu C, Hu D. Stevens–Johnson syndrome associated with TS‐1 in a patient with gastric cancer: A case report. Br J Clin Pharmacol 2021;87:1554-60. [DOI: 10.1111/bcp.14493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
357 Zhang T, Chen H, Yin X, He Q, Man J, Yang X, Lu M. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease Study. Chin J Cancer Res 2021;33:11-26. [PMID: 33707924 DOI: 10.21147/j.issn.1000-9604.2021.01.02] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
358 Yuan Y, Yao S, Luo GH, Zhang XY. Impact of metabolism-related mutations on the heart rate of gastric cancer patients after peritoneal lavage. World J Clin Cases 2021; 9(6): 1318-1328 [PMID: 33644198 DOI: 10.12998/wjcc.v9.i6.1318] [Reference Citation Analysis]
359 Zhang H, Fu T, Zhang C. MicroRNA-1249 Targets G Protein Subunit Alpha 11 and Facilitates Gastric Cancer Cell Proliferation, Motility and Represses Cell Apoptosis. Onco Targets Ther 2021;14:1249-59. [PMID: 33658793 DOI: 10.2147/OTT.S272599] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
360 Lou S, Zhang J, Zhai Z, Yin X, Wang Y, Fang T, Xue Y. Development and validation of an individual alternative splicing prognostic signature in gastric cancer. Aging (Albany NY) 2021;13:5824-44. [PMID: 33612482 DOI: 10.18632/aging.202507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
361 Song Y, Wang J, Sun J, Chen X, Shi J, Wu Z, Yu D, Zhang F, Wang Z. Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis. Genomics Proteomics Bioinformatics 2020;18:679-95. [PMID: 33607292 DOI: 10.1016/j.gpb.2020.06.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
362 Li D, Yin Y, He M, Wang J. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis. Med Sci Monit 2021;27:e929104. [PMID: 33582701 DOI: 10.12659/MSM.929104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
363 Teng F, Zhang JX, Chen Y, Shen XD, Su C, Guo YJ, Wang PH, Shi CC, Lei M, Cao YO, Liu SQ. LncRNA NKX2-1-AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR-2 signaling pathway in gastric cancer. Mol Oncol 2021;15:1234-55. [PMID: 33512745 DOI: 10.1002/1878-0261.12911] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
364 Suzuki S, Kanaji S, Urakawa N, Takiguchi G, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Nakamura T, Kakeji Y. Impact of chronic kidney disease stage on morbidity after gastrectomy for gastric cancer. Ann Gastroenterol Surg 2021;5:519-27. [PMID: 34337301 DOI: 10.1002/ags3.12441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
365 Wang G, Wang X, Han M, Wang X. Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer. Onco Targets Ther 2021;14:979-88. [PMID: 33603402 DOI: 10.2147/OTT.S289722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
366 Ren Z, Rajani C, Jia W. The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers. Cancers (Basel) 2021;13:720. [PMID: 33578739 DOI: 10.3390/cancers13040720] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
367 Song C, Zhou C. HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis. J Exp Clin Cancer Res 2021;40:62. [PMID: 33563300 DOI: 10.1186/s13046-021-01859-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
368 Pan T, Galiullin D, Chen XL, Zhang WH, Yang K, Liu K, Zhao LY, Chen XZ, Hu JK. Incidence of adhesive small bowel obstruction after gastrectomy for gastric cancer and its risk factors: a long-term retrospective cohort study from a high-volume institution in China. Updates Surg 2021;73:615-26. [PMID: 33550510 DOI: 10.1007/s13304-021-00983-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
369 Grunberg N, Pevsner-Fischer M, Goshen-Lago T, Diment J, Stein Y, Lavon H, Mayer S, Levi-Galibov O, Friedman G, Ofir-Birin Y, Syu LJ, Migliore C, Shimoni E, Stemmer SM, Brenner B, Dlugosz AA, Lyden D, Regev-Rudzki N, Ben-Aharon I, Scherz-Shouval R. Cancer-Associated Fibroblasts Promote Aggressive Gastric Cancer Phenotypes via Heat Shock Factor 1-Mediated Secretion of Extracellular Vesicles. Cancer Res 2021;81:1639-53. [PMID: 33547159 DOI: 10.1158/0008-5472.CAN-20-2756] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
370 Wallander K, Eisfeldt J, Lindblad M, Nilsson D, Billiau K, Foroughi H, Nordenskjöld M, Liedén A, Tham E. Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients. PLoS One 2021;16:e0245488. [PMID: 33539436 DOI: 10.1371/journal.pone.0245488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
371 Liu Z, Shi M, Li X, Song S, Liu N, Du H, Ye J, Li H, Zhang Z, Zhang L. HER2 copy number as predictor of disease-free survival in HER2-positive resectable gastric adenocarcinoma. J Cancer Res Clin Oncol 2021;147:1315-24. [PMID: 33543328 DOI: 10.1007/s00432-021-03522-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
372 Liu F, Huang C, Xu Z, Su X, Zhao G, Ye J, Du X, Huang H, Hu J, Li G, Yu P, Li Y, Suo J, Zhao N, Zhang W, Li H, He H, Sun Y;  Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group. Morbidity and Mortality of Laparoscopic vs Open Total Gastrectomy for Clinical Stage I Gastric Cancer: The CLASS02 Multicenter Randomized Clinical Trial. JAMA Oncol. 2020;6:1590-1597. [PMID: 32815991 DOI: 10.1001/jamaoncol.2020.3152] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 36.0] [Reference Citation Analysis]
373 Wang M, Jing J, Li H, Liu J, Yuan Y, Sun L. The expression characteristics and prognostic roles of autophagy-related genes in gastric cancer. PeerJ 2021;9:e10814. [PMID: 33604190 DOI: 10.7717/peerj.10814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
374 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
375 Yu L, Luan W, Feng Z, Jia J, Wu Z, Wang M, Li F, Li Z. Long non-coding RNA HAND2-AS1 inhibits gastric cancer progression by suppressing TCEAL7 expression via targeting miR-769-5p. Dig Liver Dis 2021;53:238-44. [PMID: 32952069 DOI: 10.1016/j.dld.2020.08.045] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
376 Wang Y, Jiang R, Wang Q, Li Y, Sun Z, Zhao H. Silencing LINC01021 inhibits gastric cancer through upregulation of KISS1 expression by blocking CDK2-dependent phosphorylation of CDX2. Mol Ther Nucleic Acids 2021;24:832-44. [PMID: 34026327 DOI: 10.1016/j.omtn.2021.01.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
377 Yan HZ, Wang HF, Yin Y, Zou J, Xiao F, Yi LN, He Y, He BS. GHR is involved in gastric cell growth and apoptosis via PI3K/AKT signalling. J Cell Mol Med 2021;25:2450-8. [PMID: 33492754 DOI: 10.1111/jcmm.16160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
378 Qian Y, Liu H, Pan J, Yu W, Lv J, Yan J, Gao J, Wang X, Ge X, Zhou W. Preoperative Controlling Nutritional Status (CONUT) score predicts short-term outcomes of patients with gastric cancer after laparoscopy-assisted radical gastrectomy. World J Surg Oncol 2021;19:25. [PMID: 33485347 DOI: 10.1186/s12957-021-02132-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
379 Lourenço BN, Pereira RF, Barrias CC, Fischbach C, Oliveira C, Granja PL. Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells. Nanomaterials (Basel) 2021;11:295. [PMID: 33498669 DOI: 10.3390/nano11020295] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
380 Wang J, Sun Y, Zhang X, Cai H, Zhang C, Qu H, Liu L, Zhang M, Fu J, Zhang J, Wang J, Zhang G. Oxidative stress activates NORAD expression by H3K27ac and promotes oxaliplatin resistance in gastric cancer by enhancing autophagy flux via targeting the miR-433-3p. Cell Death Dis 2021;12:90. [PMID: 33462197 DOI: 10.1038/s41419-020-03368-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
381 Chen W, Zhang K, Yang Y, Guo Z, Wang X, Teng B, Zhao Q, Huang C, Qiu Z. MEF2A-mediated lncRNA HCP5 Inhibits Gastric Cancer Progression via MiR-106b-5p/p21 Axis. Int J Biol Sci 2021;17:623-34. [PMID: 33613117 DOI: 10.7150/ijbs.55020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
382 Li J, Yang Y, Xu D, Cao L. hsa_circ_0023409 Accelerates Gastric Cancer Cell Growth and Metastasis Through Regulating the IRS4/PI3K/AKT Pathway. Cell Transplant 2021;30:963689720975390. [PMID: 33439739 DOI: 10.1177/0963689720975390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
383 Weidle UH, Birzele F, Nopora A. microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis. Cancer Genomics Proteomics 2021;18:1-15. [PMID: 33419892 DOI: 10.21873/cgp.20237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
384 Zhang X, Yang F, Wang Z. Tumor microenvironment characterization in stage IV gastric cancer. Biosci Rep. 2021;41. [PMID: 33416081 DOI: 10.1042/bsr20201248] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
385 Chen D, Liu Z, Liu W, Fu M, Jiang W, Xu S, Wang G, Chen F, Lu J, Chen H, Dong X, Li G, Chen G, Zhuo S, Yan J. Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram. Nat Commun 2021;12:179. [PMID: 33420057 DOI: 10.1038/s41467-020-20429-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 17.5] [Reference Citation Analysis]
386 Sun KK, Shen XJ, Yang D, Jiao Y, Wu XY. Integrated Profiling Revealed Potential Regulatory Networks Among Long Noncoding RNAs and mRNAs in Mucosal Gastric Cancer. Technol Cancer Res Treat 2020;19:1533033820930119. [PMID: 32468960 DOI: 10.1177/1533033820930119] [Reference Citation Analysis]
387 Shi M, Gu Y, Jin K, Fang H, Chen Y, Cao Y, Liu X, Lv K, He X, Lin C, Liu H, Li H, He H, Qin J, Li R, Zhang H, Zhang W. CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration. Cancer Immunol Immunother 2021;70:1831-40. [PMID: 33389016 DOI: 10.1007/s00262-020-02806-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
388 Mallath MK. Gastric Cancer. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_77] [Reference Citation Analysis]
389 Shao J, Li Z, Wang Y, Xiong Y, Hu X. Synthesis and Bioactivity of Tropone Derivatives as Potential Compounds against Human Gastric Cancer Cells Growth. Chinese Journal of Organic Chemistry 2021;41:3675. [DOI: 10.6023/cjoc202105014] [Reference Citation Analysis]
390 Malli IA. From Inflammation to Cancer: Role of Genetic Polymorphisms of Inflammatory Pathway Molecules in Gastric Cancer. Genetic Polymorphism and cancer susceptibility 2021. [DOI: 10.1007/978-981-33-6699-2_4] [Reference Citation Analysis]
391 Wang J, Zhang W, Wu T, Wu H, Zhang Y, Wang S, Ji Y, Jiang H, Zhang Z, Tang C, Tang Q, Li X, Xu H. Photodynamic antitumor activity of aggregation-induced emission luminogens as chemosensitizers for paclitaxel by concurrent induction of apoptosis and autophagic cell death. Mater Chem Front 2021;5:3448-57. [DOI: 10.1039/d1qm00089f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
392 Chahal D, Shahidi N, Byrne MF. Artificial Intelligence for Diagnosing G.I. Tract Lesions. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy 2021. [DOI: 10.1007/978-3-030-29964-4_31-1] [Reference Citation Analysis]
393 Debnath N, Yadav AK. Potential Correlation Between Homeostasis Control and Tumor Microenvironment Regulation of Probiotic as a Therapeutic Agent to Manage Gastrointestinal Cancer. Probiotic Research in Therapeutics 2021. [DOI: 10.1007/978-981-33-6236-9_7] [Reference Citation Analysis]
394 Mallath MK. Gastric Cancer. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-319-90761-1_77-1] [Reference Citation Analysis]
395 Zhang Y, Yu C. Bibliometric Evaluation of Publications (2000-2020) on the Prognosis of Gastric Cancer. Inquiry 2021;58:469580211056015. [PMID: 34875913 DOI: 10.1177/00469580211056015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
396 Xu J, Ou X, Li J, Cai Q, Sun K, Ye J, Peng J. Overexpression of TC2N is associated with poor prognosis in gastric cancer. J Cancer 2021;12:807-17. [PMID: 33403038 DOI: 10.7150/jca.50653] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
397 Chen J, Bu Z, Ji J. Surgical treatment of gastric cancer: Current status and future directions. Chin J Cancer Res 2021;33:159-67. [PMID: 34158736 DOI: 10.21147/j.issn.1000-9604.2021.02.04] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
398 Yang C, Gong A. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer. Int J Med Sci 2021;18:792-800. [PMID: 33437215 DOI: 10.7150/ijms.47339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
399 Wang T, Chen Y, Zhao L, Zhou H, Wu C, Zhang X, Zhou A, Jin J, Zhao D. The Effect of Neoadjuvant Therapies for Patients with Locally Advanced Gastric Cancer: A Propensity Score Matching Study. J Cancer 2021;12:379-86. [PMID: 33391434 DOI: 10.7150/jca.46847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
400 Kyriazanos I, Limouris GS. Cytoreductive Surgery in Peritoneal Neuroendocrine Neoplasm Metastases: The Adjuvant Endoperitoneal PRRT with 111In-Octreotide Perspective. Liver Intra-arterial PRRT with 111In-Octreotide 2021. [DOI: 10.1007/978-3-030-70773-6_19] [Reference Citation Analysis]
401 Hayashi M, Fujita T, Matsushita H. Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies. Eur J Surg Oncol 2021;47:1996-2003. [PMID: 33353828 DOI: 10.1016/j.ejso.2020.12.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
402 Jenke R, Holzhäuser-Rein M, Mueller-Wilke S, Lordick F, Aigner A, Büch T. SATB1-Mediated Upregulation of the Oncogenic Receptor Tyrosine Kinase HER3 Antagonizes MET Inhibition in Gastric Cancer Cells. Int J Mol Sci 2020;22:E82. [PMID: 33374770 DOI: 10.3390/ijms22010082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
403 Zhao J, Li X, Fu L, Zhang N, Yang J, Cai J. lncRNA LIFR‑AS1 inhibits gastric carcinoma cell proliferation, migration and invasion by sponging miR‑4698. Mol Med Rep 2021;23:153. [PMID: 33355363 DOI: 10.3892/mmr.2020.11792] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
404 Ungerleider N, Bullard W, Kara M, Wang X, Roberts C, Renne R, Tibbetts S, Flemington E. EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape.. [DOI: 10.1101/2020.12.21.423766] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
405 Wang B, Zhang Y. An immune-relevant signature of nine genes as a prognostic biomarker in patients with gastric carcinoma. Open Med (Wars) 2020;15:850-9. [PMID: 33336043 DOI: 10.1515/med-2020-0142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
406 Xiang A, Lin X, Xu L, Chen H, Guo J, Zhou F. PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer. Front Mol Biosci 2020;7:544895. [PMID: 33392251 DOI: 10.3389/fmolb.2020.544895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
407 Fang H, Li R, Gu Y, Fei Y, Jin K, Chen Y, Cao Y, Liu X, Lv K, Wang J, Yu K, Lin C, Liu H, Li H, He H, Zhang W, Zhang H, Shen Z. Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response. Oncoimmunology 2020;9:1856468. [PMID: 33354409 DOI: 10.1080/2162402X.2020.1856468] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
408 Huang X, Zhang J, Zheng Y. ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer. Front Mol Biosci 2020;7:598221. [PMID: 33385012 DOI: 10.3389/fmolb.2020.598221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
409 Chen Y, Zhang J, Gong W, Dai W, Xu X, Xu S. miR-588 is a prognostic marker in gastric cancer. Aging (Albany NY) 2020;13:2101-17. [PMID: 33323542 DOI: 10.18632/aging.202212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
410 Zhang C, Chen Z, Chong X, Chen Y, Wang Z, Yu R, Sun T, Chen X, Shao Y, Zhang X, Gao J, Shen L. Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2-targeted therapies. Clin Transl Med 2020;10:e254. [PMID: 33377634 DOI: 10.1002/ctm2.254] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
411 Chen H, Xu L, Shan ZL, Chen S, Hu H. GPX8 is transcriptionally regulated by FOXC1 and promotes the growth of gastric cancer cells through activating the Wnt signaling pathway. Cancer Cell Int 2020;20:596. [PMID: 33317536 DOI: 10.1186/s12935-020-01692-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
412 Siveen KS, Nizamuddin PB, Uddin S, Al-Thani M, Frenneaux MP, Janahi IA, Steinhoff M, Azizi F. TRPV2: A Cancer Biomarker and Potential Therapeutic Target. Dis Markers 2020;2020:8892312. [PMID: 33376561 DOI: 10.1155/2020/8892312] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
413 Guo Q, Li X, Cui MN, Sun JL, Ji HY, Ni BB, Yan MX. CD13: A Key Player in Multidrug Resistance in Cancer Chemotherapy. Oncol Res 2020;28:533-40. [PMID: 32532363 DOI: 10.3727/096504020X15919605976853] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
414 Kou Y, Tong B, Wu W, Liao X, Zhao M. Berberine Improves Chemo-Sensitivity to Cisplatin by Enhancing Cell Apoptosis and Repressing PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer. Front Pharmacol 2020;11:616251. [PMID: 33362566 DOI: 10.3389/fphar.2020.616251] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
415 Ren H, Zhu J, Yu H, Bazhin AV, Westphalen CB, Renz BW, Jacob SN, Lampert C, Werner J, Angele MK, Bösch F. Angiogenesis-Related Gene Expression Signatures Predicting Prognosis in Gastric Cancer Patients. Cancers (Basel) 2020;12:E3685. [PMID: 33302481 DOI: 10.3390/cancers12123685] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
416 Xie S, Chen W, Chen K, Chang Y, Yang F, Lin A, Shu Q, Zhou T, Yan X. Emerging roles of RNA methylation in gastrointestinal cancers. Cancer Cell Int 2020;20:585. [PMID: 33372610 DOI: 10.1186/s12935-020-01679-w] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 9.7] [Reference Citation Analysis]
417 Kanda M, Kasahara Y, Shimizu D, Miwa T, Umeda S, Sawaki K, Nakamura S, Kodera Y, Obika S. Amido-Bridged Nucleic Acid-Modified Antisense Oligonucleotides Targeting SYT13 to Treat Peritoneal Metastasis of Gastric Cancer. Mol Ther Nucleic Acids 2020;22:791-802. [PMID: 33230476 DOI: 10.1016/j.omtn.2020.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
418 Lu Y, Wu T, Sheng Y, Dai Y, Xia B, Xue Y. Correlation between Claudin-18 expression and clinicopathological features and prognosis in patients with gastric cancer. J Gastrointest Oncol 2020;11:1253-60. [PMID: 33456998 DOI: 10.21037/jgo-20-463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
419 Wang W, Ning J, He Y, Zhai L, Xiang F, Yao L, Ye L, Wu L, Ji T, Tang Z. Unveiling the mechanism of Astragalus membranaceus in the treatment of gastrointestinal cancers based on network pharmacology. European Journal of Integrative Medicine 2020;40:101249. [DOI: 10.1016/j.eujim.2020.101249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
420 Pakbin B, Pishkhan Dibazar S, Allahyari S, Javadi M, Farasat A, Darzi S. Probiotic Saccharomyces cerevisiae var. boulardii supernatant inhibits survivin gene expression and induces apoptosis in human gastric cancer cells. Food Sci Nutr 2021;9:692-700. [PMID: 33598154 DOI: 10.1002/fsn3.2032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
421 Zhang J, Piao HY, Wang Y, Lou MY, Guo S, Zhao Y. Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer. World J Gastroenterol 2020; 26(44): 6929-6944 [PMID: 33311941 DOI: 10.3748/wjg.v26.i44.6929] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
422 Wang S, Zhu W, Qiu J, Chen F. lncRNA SNHG4 promotes cell proliferation, migration, invasion and the epithelial-mesenchymal transition process via sponging miR-204-5p in gastric cancer. Mol Med Rep 2021;23:85. [PMID: 33236157 DOI: 10.3892/mmr.2020.11724] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
423 Gu Y, Chen Y, Jin K, Cao Y, Liu X, Lv K, He X, Lin C, Liu H, Li H, He H, Qin J, Li R, Zhang H, Zhang W. Intratumoral CD103+CD4+ T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients. Oncoimmunology 2020;9:1844402. [PMID: 33312758 DOI: 10.1080/2162402X.2020.1844402] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
424 Zhang Q, Liu S, Zhang J, Ma X, Dong M, Sun B, Xin Y. Roles and regulatory mechanisms of miR-30b in cancer, cardiovascular disease, and metabolic disorders (Review). Exp Ther Med 2021;21:44. [PMID: 33273973 DOI: 10.3892/etm.2020.9475] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
425 Ping MH. Hyperin Controls the Development and Therapy of Gastric Cancer via Regulating Wnt/β-Catenin Signaling. Cancer Manag Res 2020;12:11773-82. [PMID: 33235505 DOI: 10.2147/CMAR.S270544] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
426 Sun G, Li Z, He Z, Wang W, Wang S, Zhang X, Cao J, Xu P, Wang H, Huang X, Xia Y, Lv J, Xuan Z, Jiang T, Fang L, Yang J, Zhang D, Xu H, Xu Z. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression. J Exp Clin Cancer Res. 2020;39:246. [PMID: 33198772 DOI: 10.1186/s13046-020-01758-w] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 11.3] [Reference Citation Analysis]
427 Yao L, Ye PC, Tan W, Luo YJ, Xiang WP, Liu ZL, Fu ZM, Lu F, Tang LH, Xiao JW. Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and activating PI3K/Akt signaling pathway. World J Gastrointest Oncol 2020; 12(11): 1237-1254 [PMID: 33250958 DOI: 10.4251/wjgo.v12.i11.1237] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
428 Zhang T, Zhang K, Ji K, Zhang C, Jiang Y, Zhang Q, Tian Z, Wang X, Zhang M, Li X. microRNA-365 inhibits YAP through TLR4-mediated IRF3 phosphorylation and thereby alleviates gastric precancerous lesions. Cancer Cell Int 2020;20:549. [PMID: 33292210 DOI: 10.1186/s12935-020-01578-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
429 Zhao S, Fan N, Li H, Liu J, Huang F, Chen Y, Zhou M, Yu J, Lin R. Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer: a single-arm exploratory study. Ann Transl Med 2020;8:1233. [PMID: 33178765 DOI: 10.21037/atm-20-5841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
430 Chung HC, Bang YJ, S Fuchs C, Qin SK, Satoh T, Shitara K, Tabernero J, Van Cutsem E, Alsina M, Cao ZA, Lu J, Bhagia P, Shih CS, Janjigian YY. First-line pembrolizumab/placebo plus trastuzumab and chemotherapy in HER2-positive advanced gastric cancer: KEYNOTE-811. Future Oncol 2021;17:491-501. [PMID: 33167735 DOI: 10.2217/fon-2020-0737] [Cited by in Crossref: 52] [Cited by in F6Publishing: 59] [Article Influence: 17.3] [Reference Citation Analysis]
431 Bian J, Long JY, Yang X, Yang XB, Xu YY, Lu X, Sang XT, Zhao HT. Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer. World J Gastroenterol 2020; 26(41): 6414-6430 [PMID: 33244202 DOI: 10.3748/wjg.v26.i41.6414] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
432 Zhang H, Li Z, Ruan Y, Sun W, Yu R. Low expression of hsa_circ_0001811 in gastric cancer and its role in clinical diagnosis. J Clin Lab Anal 2021;35:e23642. [PMID: 33159345 DOI: 10.1002/jcla.23642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
433 Han T, Cheng Z, Xu M, Wang X, Wu J, Fang X. Yes-Associated Protein Contributes to Cell Proliferation and Migration of Gastric Cancer via Activation of Gli1. Onco Targets Ther 2020;13:10867-76. [PMID: 33149604 DOI: 10.2147/OTT.S266449] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
434 Pan T, Wang H, Liu K, Chen XZ, Zhang WH, Chen XL, Yang K, Zhang B, Zhou ZG, Hu JK. Closure of Petersen's defect in gastrectomy for gastric cancer: an interrupted time series analysis from a high-volume institution in China. Langenbecks Arch Surg 2021;406:427-36. [PMID: 33151418 DOI: 10.1007/s00423-020-02019-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
435 Moradzadeh R, Anoushirvani AA. Trend of Gastric Cancer Incidence in an Area Located in the Center of Iran: 2009-2014. J Gastrointest Cancer 2020;51:159-64. [PMID: 30911981 DOI: 10.1007/s12029-019-00227-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
436 Richard N, Sefrioui D, Di Fiore F, Michel P. Cáncer de estómago. EMC - Tratado de Medicina 2020;24:1-7. [DOI: 10.1016/s1636-5410(20)44312-0] [Reference Citation Analysis]
437 Zhu Z, Fu H, Wang S, Yu X, You Q, Shi M, Dai C, Wang G, Cha W, Wang W. Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer. Ann Transl Med 2020;8:1484. [PMID: 33313229 DOI: 10.21037/atm-20-6620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
438 Wang J, Li Q, Cheng X, Zhang B, Lin J, Tang Y, Li F, Yang CS, Wang TC, Tu S. Bone Marrow-Derived Myofibroblasts Promote Gastric Cancer Metastasis by Activating TGF-β1 and IL-6/STAT3 Signalling Loop. Onco Targets Ther 2020;13:10567-80. [PMID: 33116635 DOI: 10.2147/OTT.S266506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
439 Li W, Duan J, Shi W, Lei L, Lv P. Long Non-Coding RNA NCK1-AS1 Serves an Oncogenic Role in Gastric Cancer by Regulating miR-137/NUP43 Axis. Onco Targets Ther 2020;13:9929-39. [PMID: 33116577 DOI: 10.2147/OTT.S259336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
440 Xian XS, Wang YT, Jiang XM. Propofol Inhibits Proliferation and Invasion of Stomach Cancer Cells by Regulating miR-205/YAP1 Axis. Cancer Manag Res 2020;12:10771-9. [PMID: 33149682 DOI: 10.2147/CMAR.S270344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
441 Li T, Chen X, Gu M, Deng A, Qian C. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis. Clin Epigenetics 2020;12:161. [PMID: 33115518 DOI: 10.1186/s13148-020-00940-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
442 Zhang J, Piao HY, Wang Y, Meng XY, Yang D, Zhao Y, Zheng ZC. To Develop and Validate the Combination of RNA Methylation Regulators for the Prognosis of Patients with Gastric Cancer. Onco Targets Ther. 2020;13:10785-10795. [PMID: 33122917 DOI: 10.2147/ott.s276239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
443 Lee J, Chung SJ, Choi JM, Han YM, Kim JS. Clinicopathologic Characteristics and Long-Term Outcome of Gastric Cancer Patients with Family History: Seven-Year Follow-Up Study for Korean Health Check-Up Subjects. Gastroenterol Res Pract 2020;2020:4028136. [PMID: 33144855 DOI: 10.1155/2020/4028136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
444 Wang J, Yu Z, Wang J, Shen Y, Qiu J, Zhuang Z. LncRNA NUTM2A-AS1 positively modulates TET1 and HIF-1A to enhance gastric cancer tumorigenesis and drug resistance by sponging miR-376a. Cancer Med 2020;9:9499-510. [PMID: 33089970 DOI: 10.1002/cam4.3544] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
445 Tsang ES, Lim HJ, Renouf DJ, Davies JM, Loree JM, Gill S. Real-world treatment attrition rates in advanced esophagogastric cancer. World J Gastroenterol 2020; 26(39): 6027-6036 [PMID: 33132652 DOI: 10.3748/wjg.v26.i39.6027] [Reference Citation Analysis]
446 Yang L, Li H, Yang M, Zhang W, Li M, Xu Y, Li J, Kang J, Zhang J, Guo S. Exploration in the Mechanism of Kaempferol for the Treatment of Gastric Cancer Based on Network Pharmacology. Biomed Res Int 2020;2020:5891016. [PMID: 33145355 DOI: 10.1155/2020/5891016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
447 Wang X, Che X, Yu Y, Cheng Y, Bai M, Yang Z, Guo Q, Xie X, Li D, Guo M, Hou K, Guo W, Qu X, Cao L. Hypoxia-autophagy axis induces VEGFA by peritoneal mesothelial cells to promote gastric cancer peritoneal metastasis through an integrin α5-fibronectin pathway. J Exp Clin Cancer Res 2020;39:221. [PMID: 33081836 DOI: 10.1186/s13046-020-01703-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
448 Tan JW, Wang L, Chen Y, Xi W, Ji J, Xu X, Zou LK, Feng JX, Zhang J, Zhang H. Predicting Chemotherapeutic Response for Far-advanced Gastric Cancer by Radiomics with Deep Learning Semi-automatic Segmentation. J Cancer. 2020;11:7224-7236. [PMID: 33193886 DOI: 10.7150/jca.46704] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
449 Kauppila JH, Ohtonen P, Rantanen T, Tyrväinen T, Toikkanen V, Pääaho M, Valtola A, Räsänen J, Kallio R, Sihvo E, Saarnio J, Karttunen TJ, Pohjanen VM, Ristimäki A, Laine S, Kokkola A. Cohort profile: gastric cancer in the population-based, Finnish National Esophago-Gastric Cancer Cohort (FINEGO) Study. BMJ Open 2020;10:e039574. [PMID: 33067296 DOI: 10.1136/bmjopen-2020-039574] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
450 Yang Y, Ma Y, Xiang X, Xing P, Wu Y, Zhang L, Tian Y. The prognostic value of the lymph node ratio for local advanced gastric cancer patients with intensity-modulated radiation therapy and concurrent chemotherapy after radical gastrectomy in China. Radiat Oncol 2020;15:237. [PMID: 33054848 DOI: 10.1186/s13014-020-01687-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
451 Yang Z, Jiang X, Li D, Jiang X. HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification. Aging (Albany NY) 2020;12:24967-82. [PMID: 33048840 DOI: 10.18632/aging.103767] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
452 Yao X, He Z, Qin C, Deng X, Bai L, Li G, Shi J. SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer. Cancer Cell Int 2020;20:503. [PMID: 33061855 DOI: 10.1186/s12935-020-01599-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
453 Mandleywala K, Shmuel S, Pereira PMR, Lewis JS. Antibody-Targeted Imaging of Gastric Cancer. Molecules 2020;25:E4621. [PMID: 33050602 DOI: 10.3390/molecules25204621] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
454 Sun Y, Li S, Yu W, Zhao Z, Gao J, Chen C, Wei M, Liu T, Li L, Liu L. N6-methyladenosine-dependent pri-miR-17-92 maturation suppresses PTEN/TMEM127 and promotes sensitivity to everolimus in gastric cancer. Cell Death Dis 2020;11:836. [PMID: 33037176 DOI: 10.1038/s41419-020-03049-w] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
455 Koo DH, Ryu MH, Lee MY, Chae H, Kim EJ, Moon MS, Kang YK. Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2-Targeted Agent in the Real-World Setting. Cancer Res Treat 2021;53:436-44. [PMID: 33070558 DOI: 10.4143/crt.2020.725] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
456 Pan Y, Fang Y, Xie M, Liu Y, Yu T, Wu X, Xu T, Ma P, Shu Y. LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer. Mol Ther Nucleic Acids 2020;22:766-78. [PMID: 33230474 DOI: 10.1016/j.omtn.2020.09.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
457 Ma B, Guo Y, Hu W, Yuan F, Zhu Z, Yu Y, Zou H. Artificial Intelligence-Based Multiclass Classification of Benign or Malignant Mucosal Lesions of the Stomach. Front Pharmacol. 2020;11:572372. [PMID: 33132910 DOI: 10.3389/fphar.2020.572372] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
458 Peng D, Cheng YX, Zhang W. Does Roux-en-Y Construction Really Bring Benefit of Type 2 Diabetes Mellitus Remission After Gastrectomy in Patients with Gastric Cancer?Diabetes Ther. 2020;11:2863-2872. [PMID: 33006131 DOI: 10.1007/s13300-020-00934-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
459 Wang Y, Zhong C, Zheng Y. Logistic big data prediction of gastric cancer. J Phys : Conf Ser 2020;1650:032164. [DOI: 10.1088/1742-6596/1650/3/032164] [Reference Citation Analysis]
460 Lin K, Zhu J, Hu C, Bu F, Luo C, Zhu X, Zhu Z. Comprehensive analysis of the prognosis for chromobox family in gastric cancer. J Gastrointest Oncol 2020;11:932-51. [PMID: 33209489 DOI: 10.21037/jgo-20-208] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
461 Chahal D, Byrne MF. A primer on artificial intelligence and its application to endoscopy. Gastrointest Endosc 2020;92:813-820.e4. [PMID: 32387497 DOI: 10.1016/j.gie.2020.04.074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
462 Sonkar C, Verma T, Chatterji D, Jain AK, Jha HC. Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells. BMC Cancer 2020;20:925. [PMID: 32993565 DOI: 10.1186/s12885-020-07377-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
463 Cai Y, Li Y, Sun B, Wang H, Zhang W, Zhao Y, Zhao H, Zhang J, Xu J, Wang Y. LncRNA PTCSC3 and lncRNA HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer. Cancer Manag Res 2020;12:8535-43. [PMID: 32982446 DOI: 10.2147/CMAR.S254944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
464 Huang C, Hu C, Zhu J, Zhang W, Huang J, Zhu Z. Establishment of Decision Rules and Risk Assessment Model for Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer. Front Oncol 2020;10:1638. [PMID: 32984033 DOI: 10.3389/fonc.2020.01638] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
465 Li Q, Qi L, Feng QX, Liu C, Sun SW, Zhang J, Yang G, Ge YQ, Zhang YD, Liu XS. Machine Learning-Based Computational Models Derived From Large-Scale Radiographic-Radiomic Images Can Help Predict Adverse Histopathological Status of Gastric Cancer. Clin Transl Gastroenterol. 2019;10:e00079. [PMID: 31577560 DOI: 10.14309/ctg.0000000000000079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
466 Yang L, Huang X, Wang W, Jiang T, Ding F. XEDAR inhibits the proliferation and induces apoptosis of gastric cancer cells by regulating JNK signaling pathway. Biosci Rep 2019;39:BSR20192726. [PMID: 31829409 DOI: 10.1042/BSR20192726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
467 Ma R, He Q. A Variant of Leptin Gene Decreases the Risk of Gastric Cancer in Chinese Individuals: Evidence from a Case-Control Study. Pharmgenomics Pers Med 2020;13:397-404. [PMID: 33061532 DOI: 10.2147/PGPM.S258672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
468 Tseng LL, Cheng HH, Yeh TS, Huang SC, Syu YY, Chuu CP, Yuh CH, Kung HJ, Wang WC. Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer. Proc Natl Acad Sci U S A 2020;117:24859-66. [PMID: 32958674 DOI: 10.1073/pnas.1919766117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
469 Wu W, Zhen T, Yu J, Yang Q. Circular RNAs as New Regulators in Gastric Cancer: Diagnosis and Cancer Therapy. Front Oncol 2020;10:1526. [PMID: 33072546 DOI: 10.3389/fonc.2020.01526] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
470 Zhou Q, Zhou LQ, Li SH, Yuan YW, Liu L, Wang JL, Wu DZ, Wu Y, Xin L. Identification of subtype-specific genes signature by WGCNA for prognostic prediction in diffuse type gastric cancer. Aging (Albany NY) 2020;12:17418-35. [PMID: 32915770 DOI: 10.18632/aging.103743] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
471 Zhang K, Zhang L, Mi Y, Tang Y, Ren F, Liu B, Zhang Y, Zheng P. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration. Cancer Sci 2020;111:4041-50. [PMID: 32860283 DOI: 10.1111/cas.14634] [Cited by in Crossref: 25] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
472 Liang LB, Huang XY, He H, Liu JY. Prognostic Values of Radiosensitivity Genes and CD19 Status in Gastric Cancer: A Retrospective Study Using TCGA Database. Pharmgenomics Pers Med 2020;13:365-73. [PMID: 32982372 DOI: 10.2147/PGPM.S265121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
473 Ning K, Shao Y, He Y, Wang F, Cui X, Liu F, Li D, Li F. Histone demethylase Jumonji domain-containing 1A inhibits proliferation and progression of gastric cancer by upregulating runt-related transcription factor 3. Cancer Sci 2020;111:3679-92. [PMID: 32762126 DOI: 10.1111/cas.14594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
474 Li Y, Zhu Z, Ma F, Xue L, Tian Y. Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges. Cancer Manag Res 2020;12:7973-81. [PMID: 32943931 DOI: 10.2147/CMAR.S268032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
475 Zhang N, Bai H, Deng J, Wang W, Sun Z, Wang Z, Xu H, Zhou Z, Liang H. Impact of examined lymph node count on staging and long-term survival of patients with node-negative stage III gastric cancer: a retrospective study using a Chinese multi-institutional registry with Surveillance, Epidemiology, and End Results (SEER) data validation. Ann Transl Med 2020;8:1075. [PMID: 33145294 DOI: 10.21037/atm-20-1358a] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
476 Zhang Z, Li B, Huang J, Huang S, He D, Peng W, Zhang S. A Network Pharmacology Analysis of the Active Components of the Traditional Chinese Medicine Zuojinwan in Patients with Gastric Cancer. Med Sci Monit 2020;26:e923327. [PMID: 32866138 DOI: 10.12659/MSM.923327] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
477 De Marco MO, Tustumi F, Brunaldi VO, Resende RH, Matsubayashi CO, Baba ER, Chaves DM, Bernardo WM, de Moura EGH. Prognostic factors for ESD of early gastric cancers: a systematic review and meta-analysis. Endosc Int Open 2020;8:E1144-55. [PMID: 32904802 DOI: 10.1055/a-1201-3089] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
478 Kanda M, Shimizu D, Sawaki K, Nakamura S, Umeda S, Miwa T, Tanaka H, Tanaka C, Hayashi M, Iguchi Y, Yamada S, Katsuno M, Kodera Y. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer. Mol Cancer 2020;19:131. [PMID: 32847597 DOI: 10.1186/s12943-020-01251-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
479 Dang S, Malik A, Chen J, Qu J, Yin K, Cui L, Gu M. LncRNA SNHG15 Contributes to Immuno-Escape of Gastric Cancer Through Targeting miR141/PD-L1. Onco Targets Ther 2020;13:8547-56. [PMID: 32943878 DOI: 10.2147/OTT.S251625] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
480 Sun F, Liu S, Song P, Zhang C, Liu Z, Guan W, Wang M. Impact of retrieved lymph node count on short-term complications in patients with gastric cancer. World J Surg Oncol 2020;18:224. [PMID: 32838799 DOI: 10.1186/s12957-020-02000-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
481 Zhang Y, Ma S, Niu Q, Han Y, Liu X, Jiang J, Chen S, Lin H. Features of alternative splicing in stomach adenocarcinoma and their clinical implication: a research based on massive sequencing data. BMC Genomics 2020;21:580. [PMID: 32831016 DOI: 10.1186/s12864-020-06997-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
482 Hayashi M, Yoshikawa T, Yura M, Otsuki S, Yamagata Y, Morita S, Katai H, Nishida T. Intraoperative blood loss as an independent prognostic factor for curative resection after neoadjuvant chemotherapy for gastric cancer: a single-center retrospective cohort study. Surg Today 2021;51:293-302. [PMID: 32839832 DOI: 10.1007/s00595-020-02114-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
483 Huang K, Chen S, Xie R, Jiang P, Yu C, Fang J, Liu X, Yu F. Identification of three predictors of gastric cancer progression and prognosis. FEBS Open Bio 2020;10:1891-9. [PMID: 32735728 DOI: 10.1002/2211-5463.12943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
484 Che K, Liu F, Wu N, Liu Q, Yuan L, Wei J. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer. Cancer Med 2020;9:7137-50. [PMID: 32810384 DOI: 10.1002/cam4.3350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
485 Chang TS, Lu CK, Hsieh YY, Wei KL, Chen WM, Tung SY, Wu CS, Chan MWY, Chiang MK. 2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis. Int J Mol Sci 2020;21:E5901. [PMID: 32824603 DOI: 10.3390/ijms21165901] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
486 Tanaka H, Kanda M, Miwa T, Umeda S, Sawaki K, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. G protein subunit gamma 4 expression has potential of detection, prediction, and therapeutic target for liver metastasis of gastric cancer.. [DOI: 10.1101/2020.08.14.20175034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
487 Hu Y, Pan X, Nie M, Liu Y, Zou X, Liu S, Liu Q, Wang R, Zhang L. A clinical study of Yiqi Huayu Jiedu decoction reducing the risk of postoperative gastric cancer recurrence and metastasis: Study protocol for a randomized controlled trail. Medicine (Baltimore) 2020;99:e21775. [PMID: 32872077 DOI: 10.1097/MD.0000000000021775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
488 Al-Sadik H, Sugathan S, Saseedharan P, Sulaiman S, Beegam S, Nemmar A, Attoub S, Karam SM. Effects of Diesel Exhaust Particles on Mouse Gastric Stem Cells. Life (Basel) 2020;10:E149. [PMID: 32806566 DOI: 10.3390/life10080149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
489 Shen Y, Teng Y, Lv Y, Zhao Y, Qiu Y, Chen W, Wang L, Wang Y, Mao F, Cheng P, Ma D, Zhuang Y, Zou Q, Peng L. PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer. J Immunother Cancer 2020;8:e000422. [PMID: 32753468 DOI: 10.1136/jitc-2019-000422] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
490 Chen QY, Liu ZY, Zhong Q, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Li P, Zheng CH, Huang CM. Clinical Impact of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Stage II/III Gastric Cancer: Can We Do Better? Front Oncol 2020;10:1149. [PMID: 32850326 DOI: 10.3389/fonc.2020.01149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
491 Ren M, Zhou X, Gu M, Jiao W, Yu M, Wang Y, Liu S, Yang J, Ji F. Resveratrol synergizes with cisplatin in antineoplastic effects against AGS gastric cancer cells by inducing endoplasmic reticulum stress‑mediated apoptosis and G2/M phase arrest. Oncol Rep 2020;44:1605-15. [PMID: 32945472 DOI: 10.3892/or.2020.7708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
492 Canale M, Casadei-Gardini A, Ulivi P, Arechederra M, Berasain C, Lollini PL, Fernández-Barrena MG, Avila MA. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. Int J Mol Sci 2020;21:E5500. [PMID: 32752096 DOI: 10.3390/ijms21155500] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
493 Li Z, Ji K, Bai L, Wang C, Hu Y, Shi Y, Zhan P, Song L, Li X, Duan X, Han X. A novel application of drug-eluting transarterial chemoembolization in treating non-liver cancers. Medicine 2020;99:e20878. [DOI: 10.1097/md.0000000000020878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
494 Wang Y, Li G. Effects of S-1 combined with palliative care on immune function and quality of life of patients with advanced stomach cancer. Oncol Lett 2020;20:2021-7. [PMID: 32724449 DOI: 10.3892/ol.2020.11720] [Reference Citation Analysis]
495 Zhang X, Huang H, Wei Z, Zhu Z, Yang D, Fu H, Xu J, Hu Z, Zhang Y, You Q, Huang X, Yan R, Wang W, Cai Q. Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis. Cancer Manag Res 2020;12:6641-53. [PMID: 32801898 DOI: 10.2147/CMAR.S258360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
496 Cao T, Yi S, Yang X, Wu Q. Clinical Significance of Polo-Like Kinase 4 as a Marker for Advanced Tumor Stage and Dismal Prognosis in Patients With Surgical Gastric Cancer. Technol Cancer Res Treat 2020;19:1533033820935531. [PMID: 32715931 DOI: 10.1177/1533033820935531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
497 Yang PR, Tsai YY, Chen KJ, Yang YH, Shih WT. Statin Use Improves Overall Survival of Patients with Gastric Cancer after Surgery and Adjuvant Chemotherapy in Taiwan: A Nationwide Matched Cohort Study. Cancers (Basel) 2020;12:E2055. [PMID: 32722425 DOI: 10.3390/cancers12082055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
498 Lv J, Guo T, Qu X, Che X, Li C, Wang S, Gong J, Wu P, Liu Y, Liu Y, Xu L. PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR. Front Oncol 2020;10:1067. [PMID: 32775300 DOI: 10.3389/fonc.2020.01067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
499 Zheng X, Wang X, Zheng L, Zhao H, Li W, Wang B, Xue L, Tian Y, Xie Y. Construction and Analysis of the Tumor-Specific mRNA-miRNA-lncRNA Network in Gastric Cancer. Front Pharmacol 2020;11:1112. [PMID: 32848739 DOI: 10.3389/fphar.2020.01112] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
500 Yang C, Shi Y, Xie S, Chen J, Zhao Y, Qian F, Hao Y, Tang B, Yu P. Short-term outcomes of robotic- versus laparoscopic-assisted Total Gastrectomy for advanced gastric Cancer: a propensity score matching study. BMC Cancer 2020;20:669. [PMID: 32680479 DOI: 10.1186/s12885-020-07160-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
501 Lin R, Zhao S, Su L, Chen X, Xu C, He Q, Zhuo C, Ye Y. A kinase-interacting protein 1 may serve as a potential biomarker for deteriorative tumor features and poor prognosis in gastric cancer patients. J Clin Lab Anal 2020;34:e23350. [PMID: 32672362 DOI: 10.1002/jcla.23350] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
502 Li L, Liu P, Wang J, Niu X, He C. Clinicopathologic Characteristics and Risk Factors of Lymph Node Metastasis in Patients with Early Gastric Cancer in the Wannan Region. Med Sci Monit 2020;26:e923525. [PMID: 32661219 DOI: 10.12659/MSM.923525] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
503 Tan H, Zhang S, Zhang J, Zhu L, Chen Y, Yang H, Chen Y, An Y, Liu B. Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implications. Theranostics 2020;10:8880-902. [PMID: 32754285 DOI: 10.7150/thno.47548] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 11.7] [Reference Citation Analysis]
504 Ding XQ, Wang ZY, Xia D, Wang RX, Pan XR, Tong JH. Proteomic Profiling of Serum Exosomes From Patients With Metastatic Gastric Cancer. Front Oncol 2020;10:1113. [PMID: 32754443 DOI: 10.3389/fonc.2020.01113] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
505 Li Z, Shan F, Ying X, Zhang Y, E JY, Wang Y, Ren H, Su X, Ji J. Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial. JAMA Surg 2019;154:1093-101. [PMID: 31553463 DOI: 10.1001/jamasurg.2019.3473] [Cited by in Crossref: 61] [Cited by in F6Publishing: 68] [Article Influence: 20.3] [Reference Citation Analysis]
506 Cai WY, Dong ZN, Fu XT, Lin LY, Wang L, Ye GD, Luo QC, Chen YC. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer. Theranostics 2020;10:8633-47. [PMID: 32754268 DOI: 10.7150/thno.47938] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
507 Yang X, Xie Z, Lei X, Gan R. Long non-coding RNA GAS5 in human cancer. Oncol Lett 2020;20:2587-94. [PMID: 32782576 DOI: 10.3892/ol.2020.11809] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 12.7] [Reference Citation Analysis]
508 Chen J, Dang Y, Feng W, Qiao C, Liu D, Zhang T, Wang Y, Tian D, Fan D, Nie Y, Wu K, Xia L. SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7. Oncogene 2020;39:5536-52. [PMID: 32616889 DOI: 10.1038/s41388-020-1378-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
509 Puhr HC, Karner A, Taghizadeh H, Jomrich G, Schoppmann SF, Preusser M, Ilhan-Mutlu A. Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma. J Cancer Res Clin Oncol 2020;146:3313-22. [PMID: 32617700 DOI: 10.1007/s00432-020-03302-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
510 Li Y, Ma D, Li T, Yin Y. Identification of functional long non-coding RNAs in gastric cancer by bioinformatics analysis. Int J Exp Pathol 2020;101:96-105. [PMID: 32608553 DOI: 10.1111/iep.12350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
511 Gao J, Yu T, Xuan Y, Zhu Z. High expression of GNB4 predicts poor prognosis in patients with Helicobacter pylori-positive advanced gastric cancer. Transl Cancer Res 2020;9:4224-38. [PMID: 35117790 DOI: 10.21037/tcr-19-2914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
512 Liang L, Li L. Down-Regulation of circNRIP1 Promotes the Apoptosis and Inhibits the Migration and Invasion of Gastric Cancer Cells by miR-182/ROCK1 Axis. Onco Targets Ther 2020;13:6279-88. [PMID: 32636647 DOI: 10.2147/OTT.S221633] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
513 Wang T, Zhong H, Qin Y, Wei W, Li Z, Huang M, Luo X. ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma. Biomed Res Int 2020;2020:3575038. [PMID: 32685472 DOI: 10.1155/2020/3575038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
514 Guo X, Dai X, Liu J, Cheng A, Qin C, Wang Z. Circular RNA circREPS2 Acts as a Sponge of miR-558 to Suppress Gastric Cancer Progression by Regulating RUNX3/β-catenin Signaling. Mol Ther Nucleic Acids 2020;21:577-91. [PMID: 32721878 DOI: 10.1016/j.omtn.2020.06.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
515 Liu H, Xu J, Yao Q, Zhang Z, Guo Q, Lin J. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells. Med Sci Monit 2020;26:e922217. [PMID: 32591494 DOI: 10.12659/MSM.922217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
516 Zhou L, Huang W, Yu HF, Feng YJ, Teng X. Exploring TCGA database for identification of potential prognostic genes in stomach adenocarcinoma. Cancer Cell Int 2020;20:264. [PMID: 32581654 DOI: 10.1186/s12935-020-01351-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
517 Bian J, Li G, Zhang Z, Liu B. Downregulation of lncRNA PMS2L2 in patients with gastric adenocarcinoma predicts poor prognosis. Oncol Lett 2020;20:495-500. [PMID: 32565974 DOI: 10.3892/ol.2020.11578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
518 Dalhammar K, Malmström M, Schelin M, Falkenback D, Kristensson J. The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study. PLoS One 2020;15:e0235045. [PMID: 32569329 DOI: 10.1371/journal.pone.0235045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
519 Rehkaemper J, Korenkov M, Quaas A, Rueschoff J, Pamuk A, Zander T, Hillmer AM, Buettner R, Hoelscher AH, Bruns CJ, Loeser H, Alakus H, Schoemig-Markiefka B. Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas. BMC Cancer 2020;20:587. [PMID: 32571252 DOI: 10.1186/s12885-020-06996-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
520 Yin H, Chu A, Liu S, Yuan Y, Gong Y. Identification of DEGs and transcription factors involved in H. pylori-associated inflammation and their relevance with gastric cancer. PeerJ 2020;8:e9223. [PMID: 32547867 DOI: 10.7717/peerj.9223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
521 Zhu J, Wang X, Guan H, Xiao Q, Wu Z, Shi J, Zhang F, Gao P, Song Y, Wang Z. HIP1R acts as a tumor suppressor in gastric cancer by promoting cancer cell apoptosis and inhibiting migration and invasion through modulating Akt. J Clin Lab Anal 2020;34:e23425. [PMID: 32548851 DOI: 10.1002/jcla.23425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
522 Wang X, Wu X, Xin J, Li S, Zheng R, Guan D, Gong W, Zhao Q, Wang M, Chu H, Du M, Tao G, Zhang H, Zhang Z. Genetic variants in Ras/Raf/MEK/ERK pathway are associated with gastric cancer risk in Chinese Han population. Arch Toxicol 2020;94:2683-90. [DOI: 10.1007/s00204-020-02771-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
523 Deng BB, Jiao BP, Liu YJ, Li YR, Wang GJ. BIX-01294 enhanced chemotherapy effect in gastric cancer by inducing GSDME-mediated pyroptosis. Cell Biol Int 2020;44:1890-9. [PMID: 32437063 DOI: 10.1002/cbin.11395] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
524 Chen GM, Yuan SQ, Nie RC, Luo TQ, Jiang KM, Liang CC, Li YF, Zhang DY, Yu JH, Hou F, Wang Y, Chen YB. Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer. Ann Surg Oncol 2020;27:4250-60. [PMID: 32506192 DOI: 10.1245/s10434-020-08559-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
525 Han J, Nie Z, Li P, Shi H, Wang S, Li Q, Zhang R, Qiao Y, Huang K, Fu Z. Comparison of Treatment Modalities for Locally Advanced Gastric Cancer: A Propensity Score Matching Analysis. J Cancer 2020;11:4421-30. [PMID: 32489461 DOI: 10.7150/jca.41082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
526 Türeci O, Sahin U, Schulze-Bergkamen H, Zvirbule Z, Lordick F, Koeberle D, Thuss-Patience P, Ettrich T, Arnold D, Bassermann F, Al-Batran SE, Wiechen K, Dhaene K, Maurus D, Gold M, Huber C, Krivoshik A, Arozullah A, Park JW, Schuler M. A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study. Ann Oncol 2019;30:1487-95. [PMID: 31240302 DOI: 10.1093/annonc/mdz199] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 19.3] [Reference Citation Analysis]
527 Zhou Y, Liu C, Huang Y. Wireless Power Transfer for Implanted Medical Application: A Review. Energies 2020;13:2837. [DOI: 10.3390/en13112837] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
528 Yang SJ, Li HR, Zhang WH, Liu K, Zhang DY, Sun LF, Chen XL, Zhao LY, Chen XZ, Yang K, Chen ZX, Zhou ZG, Hu JK. Visceral Fat Area (VFA) Superior to BMI for Predicting Postoperative Complications After Radical Gastrectomy: a Prospective Cohort Study. J Gastrointest Surg 2020;24:1298-306. [PMID: 31161593 DOI: 10.1007/s11605-019-04259-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
529 Koushyar S, Powell AG, Vincan E, Phesse TJ. Targeting Wnt Signaling for the Treatment of Gastric Cancer. Int J Mol Sci 2020;21:E3927. [PMID: 32486243 DOI: 10.3390/ijms21113927] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
530 Han C, Jin L, Ma X, Hao Q, Lin H, Zhang Z. Identification of the hub genes RUNX2 and FN1 in gastric cancer. Open Med (Wars) 2020;15:403-12. [PMID: 33313404 DOI: 10.1515/med-2020-0405] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
531 Zhang Y, Wu X, Zhang C, Wang J, Fei G, Di X, Lu X, Feng L, Cheng S, Yang A. Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis. J Pathol 2020;251:135-46. [PMID: 32207854 DOI: 10.1002/path.5434] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
532 Fang QL, Li KC, Wang L, Gu XL, Song RJ, Lu S. Targeted Inhibition of CCL22 by miR-130a-5p Can Enhance the Sensitivity of Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy. Cancer Manag Res 2020;12:3865-75. [PMID: 32547223 DOI: 10.2147/CMAR.S249738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
533 Iwasaki K, Suda T, Takano Y, Ohno Y, Yamada E, Okazaki N, Takahashi K, Watanabe T, Makuuchi Y, Ota Y, Osaka Y, Seshimo A, Katsumata K, Tsuchida A. Postoperative outcomes of gastric carcinoma with lymphoid stroma. World J Surg Oncol 2020;18:102. [PMID: 32438924 DOI: 10.1186/s12957-020-01878-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
534 Feng Z, Qiao R, Ren Z, Hou X, Feng J, He X, Chen D. Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia?-a microarray analysis based on regional population. J Gastrointest Oncol 2020;11:386-401. [PMID: 32399279 DOI: 10.21037/jgo.2020.03.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
535 Wang Z, Yang Y, Hu S, He J, Wu Z, Qi Z, Huang M, Liu R, Lin Y, Tan C, Xu M, Zhang Z. Short-form RON (sf-RON) enhances glucose metabolism to promote cell proliferation via activating β-catenin/SIX1 signaling pathway in gastric cancer. Cell Biol Toxicol 2021;37:35-49. [PMID: 32399910 DOI: 10.1007/s10565-020-09525-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
536 Zheng P, Zhang H, Gao H, Sun J, Li J, Zhang X, Gao L, Ma P, Li S. Plasma Exosomal Long Noncoding RNA lnc-SLC2A12-10:1 as a Novel Diagnostic Biomarker for Gastric Cancer. Onco Targets Ther 2020;13:4009-18. [PMID: 32494155 DOI: 10.2147/OTT.S253600] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
537 Shi L, Wang Z, Geng X, Zhang Y, Xue Z. Exosomal miRNA-34 from cancer-associated fibroblasts inhibits growth and invasion of gastric cancer cells in vitro and in vivo. Aging (Albany NY) 2020;12:8549-64. [PMID: 32391804 DOI: 10.18632/aging.103157] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
538 Wang M, Huang YK, Kong JC, Sun Y, Tantalo DG, Yeang HXA, Ying L, Yan F, Xu D, Halse H, Di Costanzo N, Gordon IR, Mitchell C, Mackay LK, Busuttil RA, Neeson PJ, Boussioutas A. High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancer. Clin Transl Immunology 2020;9:e1127. [PMID: 32377339 DOI: 10.1002/cti2.1127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
539 Zheng Y, Guo C, Zhang X, Wang X, Ma A. Garcinol acts as an antineoplastic agent in human gastric cancer by inhibiting the PI3K/AKT signaling pathway. Oncol Lett 2020;20:667-76. [PMID: 32565991 DOI: 10.3892/ol.2020.11585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
540 Fu J, Zhao W, Guo D, Li Z. LncRNA E2F-Mediated Cell Proliferation Enhancing lncRNA Regulates Cancer Cell Behaviors and Affects Prognosis of Gastric Cancer. Dig Dis Sci 2020;65:1348-54. [PMID: 31584135 DOI: 10.1007/s10620-019-05855-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
541 Däster S, Eppenberger-Castori S, Mele V, Schäfer HM, Schmid L, Weixler B, Soysal SD, Droeser RA, Spagnoli GC, Kettelhack C, Oertli D, Terracciano L, Tornillo L, von Holzen U. Low Expression of Programmed Death 1 (PD-1), PD-1 Ligand 1 (PD-L1), and Low CD8+ T Lymphocyte Infiltration Identify a Subgroup of Patients With Gastric and Esophageal Adenocarcinoma With Severe Prognosis. Front Med (Lausanne) 2020;7:144. [PMID: 32411711 DOI: 10.3389/fmed.2020.00144] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
542 Shoka M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Systemic Inflammation Score as a Predictor of Pneumonia after Radical Resection of Gastric Cancer: Analysis of a Multi-Institutional Dataset. Dig Surg 2020;37:401-10. [PMID: 32344400 DOI: 10.1159/000506940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
543 Xue X, Li Y, Zhang Y, Wang P, Li X, Wei H, Zhou W. Assessment of Elastic Fibers in Tumor Stroma as a New Method to Predict 6-Year Outcomes for Gastric Cancer Patients. Front Oncol 2020;10:395. [PMID: 32373506 DOI: 10.3389/fonc.2020.00395] [Reference Citation Analysis]
544 Luo M, Liang C. LncRNA LINC00483 promotes gastric cancer development through regulating MAPK1 expression by sponging miR-490-3p. Biol Res 2020;53:14. [PMID: 32293550 DOI: 10.1186/s40659-020-00283-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
545 Zhu M, Zhang N, He S, Lu X. Exosomal miR-106a derived from gastric cancer promotes peritoneal metastasis via direct regulation of Smad7. Cell Cycle 2020;19:1200-21. [PMID: 32267797 DOI: 10.1080/15384101.2020.1749467] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
546 Dai Q, Zhang T, Pan J, Li C. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway. J Cancer 2020;11:3882-92. [PMID: 32328192 DOI: 10.7150/jca.43446] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
547 Chen X, Yang Z, Yang J, Liao Y, Pang P, Fan W, Chen X. Radiomics analysis of contrast-enhanced CT predicts lymphovascular invasion and disease outcome in gastric cancer: a preliminary study. Cancer Imaging 2020;20:24. [PMID: 32248822 DOI: 10.1186/s40644-020-00302-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
548 Akin EA, Qazi ZN, Osman M, Zeman RK. Clinical impact of FDG PET/CT in alimentary tract malignancies: an updated review. Abdom Radiol (NY) 2020;45:1018-35. [PMID: 32152644 DOI: 10.1007/s00261-020-02447-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
549 Ko M, Yang J, Jeon H, Cho C, Lee Y, Park S, Yoo H. A Case Report of FOLFOX-induced Adverse Events in a Patient with Recurrent Advanced Gastric Cancer Treated with Korean Medicine. J Int Korean Med 2020;41:81-87. [DOI: 10.22246/jikm.2020.41.1.81] [Reference Citation Analysis]
550 Kawagoe K, Wada M, Idichi T, Okada R, Yamada Y, Moriya S, Okubo K, Matsushita D, Arigami T, Kurahara H, Maemura K, Natsugoe S, Seki N. Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer. J Hum Genet 2020;65:647-56. [PMID: 32235846 DOI: 10.1038/s10038-020-0746-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
551 Cheng J, Zhuo H, Wang L, Zheng W, Chen X, Hou J, Zhao J, Cai J. Identification of the Combinatorial Effect of miRNA Family Regulatory Network in Different Growth Patterns of GC. Mol Ther Oncolytics 2020;17:531-46. [PMID: 32637572 DOI: 10.1016/j.omto.2020.03.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
552 Li Y, Wang P, Wu LL, Yan J, Pang XY, Liu SJ. miR-26a-5p Inhibit Gastric Cancer Cell Proliferation and Invasion Through Mediated Wnt5a. Onco Targets Ther 2020;13:2537-50. [PMID: 32273724 DOI: 10.2147/OTT.S241199] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
553 Gonçalves WGE, Dos Santos MHP, Lobato FMF, Ribeiro-Dos-Santos Â, de Araújo GS. Deep learning in gastric tissue diseases: a systematic review. BMJ Open Gastroenterol 2020;7:e000371. [PMID: 32337060 DOI: 10.1136/bmjgast-2019-000371] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
554 Zhang Y, Chen L, Cao Y, Chen S, Xu C, Xing J, Zhang K. LETM1 Promotes Gastric Cancer Cell Proliferation, Migration, and Invasion via the PI3K/Akt Signaling Pathway. J Gastric Cancer 2020;20:139-51. [PMID: 32595998 DOI: 10.5230/jgc.2020.20.e12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
555 Ning P, Sun L, Dong N, Yuan Y. PGC-MG7 combination could be used as a follow-up panel for monitoring dynamical progression of gastric precancerous diseases. Chin J Cancer Res 2020;32:89-95. [PMID: 32194308 DOI: 10.21147/j.issn.1000-9604.2020.01.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
556 Li C, Zheng Y, Pu K, Zhao D, Wang Y, Guan Q, Zhou Y. A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer. Cancer Cell Int 2020;20:88. [PMID: 32206039 DOI: 10.1186/s12935-020-1156-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
557 Wang X, Zhang R, Du N, Yang M, Zang A, Liu L, Yu J, Gao J, Zhang J, Fu Z, Ren Y, Ma L, Guo J, Li Q, Li X, Fan Z, Song X, Liu Z, Zhang Y, Li G, Yu Z, Diao J, Jia J, Liang F, Wang H, Sun J, Gao Y, Yang P, Bai C, Ren X, Zhong D. An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202). Ther Adv Med Oncol 2020;12:1758835920905424. [PMID: 32218807 DOI: 10.1177/1758835920905424] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
558 Dai Q, Zhang T, Li C. LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway. Cancer Manag Res 2020;12:1929-39. [PMID: 32214850 DOI: 10.2147/CMAR.S243796] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 10.7] [Reference Citation Analysis]
559 Du J, Liang Y, Li J, Zhao JM, Wang ZN, Lin XY. Gastric Cancer Cell-Derived Exosomal microRNA-23a Promotes Angiogenesis by Targeting PTEN. Front Oncol 2020;10:326. [PMID: 32232005 DOI: 10.3389/fonc.2020.00326] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 10.7] [Reference Citation Analysis]
560 Song Y, Wang J, Sun J, Chen X, Shi J, Wu Z, Yu D, Zhang F, Wang Z. Screening of Potential Biomarkers for Gastric Cancer with Diagnostic Value Using Label-free Global Proteome Analysis.. [DOI: 10.1101/2020.03.08.20031930] [Reference Citation Analysis]
561 Wang P, Zhou X. Association of IGF-1 gene rs2195239 polymorphism with the risk and clinical features of gastric cancer in a Chinese Han population. J Clin Lab Anal 2020;34:e23284. [PMID: 32147868 DOI: 10.1002/jcla.23284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
562 Stokłosa P, Borgström A, Kappel S, Peinelt C. TRP Channels in Digestive Tract Cancers. Int J Mol Sci 2020;21:E1877. [PMID: 32182937 DOI: 10.3390/ijms21051877] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
563 Zhang J, Xing L, Xu H, Wang K, She J, Shi F, Wu H, Sun Y, Gao J, He S. miR-204-5p Suppress Lymph Node Metastasis via Regulating CXCL12 and CXCR4 in Gastric Cancer. J Cancer 2020;11:3199-206. [PMID: 32231725 DOI: 10.7150/jca.33273] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
564 Astudillo P. Wnt5a Signaling in Gastric Cancer. Front Cell Dev Biol 2020;8:110. [PMID: 32195251 DOI: 10.3389/fcell.2020.00110] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
565 Tabernero J, Alsina M, Shitara K, Doi T, Dvorkin M, Mansoor W, Arkenau HT, Prokharau A, Ghidini M, Faustino C, Gorbunova V, Zhavrid E, Nishikawa K, Ando T, Yalçın Ş, Van Cutsem E, Sabater J, Skanji D, Leger C, Amellal N, Ilson DH. Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS. Gastric Cancer 2020;23:689-98. [PMID: 32128634 DOI: 10.1007/s10120-020-01053-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
566 Zhao Y, Zhang J, Cheng ASL, Yu J, To KF, Kang W. Gastric cancer: genome damaged by bugs. Oncogene 2020;39:3427-42. [PMID: 32123313 DOI: 10.1038/s41388-020-1241-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
567 Ge Y, Ma G, Liu H, Lin Y, Zhang G, Du M, Wang M, Chu H, Zhang H, Zhang Z. MUC1 is associated with TFF2 methylation in gastric cancer. Clin Epigenetics 2020;12:37. [PMID: 32122390 DOI: 10.1186/s13148-020-00832-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
568 Xiao J, Lin L, Luo D, Shi L, Chen W, Fan H, Li Z, Ma X, Ni P, Yang L, Xu Z. Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance. Oncogenesis 2020;9:29. [PMID: 32123162 DOI: 10.1038/s41389-020-0215-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 11.7] [Reference Citation Analysis]
569 Min J, Han TS, Sohn Y, Shimizu T, Choi B, Bae SW, Hur K, Kong SH, Suh YS, Lee HJ, Kim JS, Min JK, Kim WH, Kim VN, Choi E, Goldenring JR, Yang HK. microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2. Gastric Cancer 2020;23:600-13. [PMID: 32112274 DOI: 10.1007/s10120-020-01052-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
570 Shang W, Liang X, Li S, Li T, Zheng L, Shao W, Wang Y, Liu F, Ma L, Jia J. Orphan nuclear receptor Nurr1 promotes Helicobacter pylori-associated gastric carcinogenesis by directly enhancing CDK4 expression. EBioMedicine 2020;53:102672. [PMID: 32114387 DOI: 10.1016/j.ebiom.2020.102672] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
571 Cong X, Zhang Y, Zhu Z, Li S, Yin X, Zhai Z, Zhang Y, Xue Y. CD66b+ neutrophils and α-SMA+ fibroblasts predict clinical outcomes and benefits from postoperative chemotherapy in gastric adenocarcinoma. Cancer Med 2020;9:2761-73. [PMID: 32096331 DOI: 10.1002/cam4.2939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
572 Dai W, Liu J, Liu B, Li Q, Sang Q, Li YY. Systematical Analysis of the Cancer Genome Atlas Database Reveals EMCN/MUC15 Combination as a Prognostic Signature for Gastric Cancer. Front Mol Biosci 2020;7:19. [PMID: 32175327 DOI: 10.3389/fmolb.2020.00019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
573 Zhou YJ, Zhu GQ, Lu XF, Zheng KI, Wang QW, Chen JN, Zhang QW, Yan FR, Li XB. Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications. Cancer Immunol Immunother 2020;69:1057-69. [PMID: 32100076 DOI: 10.1007/s00262-020-02525-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
574 Wang X, Chen X, Tian Y, Jiang D, Song Y. Long Noncoding RNA RGMB-AS1 Acts as a microRNA-574 Sponge Thereby Enhancing the Aggressiveness of Gastric Cancer via HDAC4 Upregulation. Onco Targets Ther 2020;13:1691-704. [PMID: 32158233 DOI: 10.2147/OTT.S234144] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
575 Wang W, He Y, Zhao Q, Zhao X, Li Z. Identification of potential key genes in gastric cancer using bioinformatics analysis. Biomed Rep. 2020;12:178-192. [PMID: 32190306 DOI: 10.3892/br.2020.1281] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
576 Li C, Wu R, Xing Y. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer. Cell Cycle 2020;19:601-9. [PMID: 32079456 DOI: 10.1080/15384101.2020.1728017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
577 Sun Y, Li S, Yu W, Chen C, Liu T, Li L, Zhang D, Zhao Z, Gao J, Wang X, Shi D, Liu L. CD148 Serves as a Prognostic Marker of Gastric Cancer and Hinders Tumor Progression by Dephosphorylating EGFR. J Cancer 2020;11:2667-78. [PMID: 32201537 DOI: 10.7150/jca.40955] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
578 Wang J, Lv W, Lin Z, Wang X, Bu J, Su Y. Hsa_circ_0003159 inhibits gastric cancer progression by regulating miR-223-3p/NDRG1 axis. Cancer Cell Int 2020;20:57. [PMID: 32099530 DOI: 10.1186/s12935-020-1119-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
579 Cai C, Dang W, Liu S, Huang L, Li Y, Li G, Yan S, Jiang C, Song X, Hu Y, Gu J. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway. Cancer Sci. 2020;111:1132-1145. [PMID: 31977138 DOI: 10.1111/cas.14326] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
580 Yoon JH, Min K, Lee SK. Epstein-Barr Virus miR-BART17-5p Promotes Migration and Anchorage-Independent Growth by Targeting Kruppel-Like Factor 2 in Gastric Cancer. Microorganisms 2020;8:E258. [PMID: 32075248 DOI: 10.3390/microorganisms8020258] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
581 Shi L, Zhu H, Shen Y, Dou X, Guo H, Wang P, Zhang S, Zhou L, Zou X. Regulation of E2F Transcription Factor 3 by microRNA-152 Modulates Gastric Cancer Invasion and Metastasis. Cancer Manag Res 2020;12:1187-97. [PMID: 32110093 DOI: 10.2147/CMAR.S239752] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
582 Wu P, Hu H, Li J, Gong W. Upregulation of Cullin 4B Promotes Gastric Cancer and Predicts Poor Prognosis. Onco Targets Ther 2020;13:1235-43. [PMID: 32103991 DOI: 10.2147/OTT.S234706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
583 Chen M, Lu Y, Zhang R, Bi T, Zhou S. Effects of Huaier Polysaccharide SP1 on Gastric Cancer Cell Proliferation, Apoptosis, Migration, and Invasion by Regulating TGF- β /SMAD Signaling Pathway. Advances in Polymer Technology 2020;2020:1-7. [DOI: 10.1155/2020/8486039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
584 Shen J, Zhai J, You Q, Zhang G, He M, Yao X, Shen L. Cancer-associated fibroblasts-derived VCAM1 induced by H. pylori infection facilitates tumor invasion in gastric cancer. Oncogene 2020;39:2961-74. [PMID: 32034307 DOI: 10.1038/s41388-020-1197-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
585 Hirano T, Shinsato Y, Tanabe K, Higa N, Kamil M, Kawahara K, Yamamoto M, Minami K, Shimokawa M, Arigami T, Yanagita S, Matushita D, Uenosono Y, Ishigami S, Kijima Y, Maemura K, Kitazono I, Tanimoto A, Furukawa T, Natsugoe S. FARP1 boosts CDC42 activity from integrin αvβ5 signaling and correlates with poor prognosis of advanced gastric cancer. Oncogenesis 2020;9:13. [PMID: 32029704 DOI: 10.1038/s41389-020-0190-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
586 Zhao R, Liu Z, Xu W, Song L, Ren H, Ou Y, Liu Y, Wang S. Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism. Cancer Med 2020;9:2551-63. [PMID: 32017451 DOI: 10.1002/cam4.2892] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
587 Fu Y, Chen Y, Huang J, Cai Z, Wang Y. RYK, a receptor of noncanonical Wnt ligand Wnt5a, is positively correlated with gastric cancer tumorigenesis and potential of liver metastasis. Am J Physiol Gastrointest Liver Physiol 2020;318:G352-60. [PMID: 31869240 DOI: 10.1152/ajpgi.00228.2019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
588 Leal A, van Grieken NCT, Palsgrove DN, Phallen J, Medina JE, Hruban C, Broeckaert MAM, Anagnostou V, Adleff V, Bruhm DC, Canzoniero JV, Fiksel J, Nordsmark M, Warmerdam FARM, Verheul HMW, van Spronsen DJ, Beerepoot LV, Geenen MM, Portielje JEA, Jansen EPM, van Sandick J, Meershoek-Klein Kranenbarg E, van Laarhoven HWM, van der Peet DL, van de Velde CJH, Verheij M, Fijneman R, Scharpf RB, Meijer GA, Cats A, Velculescu VE. White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer. Nat Commun 2020;11:525. [PMID: 31988276 DOI: 10.1038/s41467-020-14310-3] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 27.7] [Reference Citation Analysis]
589 Bin Y, Ding Y, Xiao W, Liao A. RASSF1A: A promising target for the diagnosis and treatment of cancer. Clin Chim Acta 2020;504:98-108. [PMID: 31981586 DOI: 10.1016/j.cca.2020.01.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
590 Lai Y, Xu P, Wang J, Xu K, Wang L, Meng Y. Tumour suppressive long non-coding RNA AFDN-DT inhibits gastric cancer invasion via transcriptional regulation. J Cell Mol Med 2020;24:3157-66. [PMID: 31981317 DOI: 10.1111/jcmm.14988] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
591 Kuai X, Jia L, Yang T, Huang X, Zhao W, Zhang M, Chen Y, Zhu J, Feng Z, Tang Q. Trop2 Promotes Multidrug Resistance by Regulating Notch1 Signaling Pathway in Gastric Cancer Cells. Med Sci Monit 2020;26:e919566. [PMID: 31964857 DOI: 10.12659/MSM.919566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
592 Balmaña M, Diniz F, Feijão T, Barrias CC, Mereiter S, Reis CA. Analysis of the Effect of Increased α2,3-Sialylation on RTK Activation in MKN45 Gastric Cancer Spheroids Treated with Crizotinib. Int J Mol Sci 2020;21:E722. [PMID: 31979110 DOI: 10.3390/ijms21030722] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
593 Peng Y, Wu Q, Wang L, Wang H, Yin F. A DNA methylation signature to improve survival prediction of gastric cancer. Clin Epigenetics 2020;12:15. [PMID: 31959204 DOI: 10.1186/s13148-020-0807-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
594 Wu M, Ding Y, Jiang X, Chen Y, Wu N, Li L, Wang H, Huang Y, Xu N, Teng L. Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer. Front Oncol 2019;9:1544. [PMID: 32010630 DOI: 10.3389/fonc.2019.01544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
595 Wang XZ, Zeng ZY, Ye X, Sun J, Zhang ZM, Kang WM. Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines. World J Gastrointest Oncol 2020; 12(1): 37-53 [PMID: 31966912 DOI: 10.4251/wjgo.v12.i1.37] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
596 Yang J, Lian Y, Yang R, Lian Y, Wu J, Liu J, Wang K, Xu H. Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes. Mol Ther Nucleic Acids 2020;19:1164-75. [PMID: 32059342 DOI: 10.1016/j.omtn.2019.12.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
597 Rajamanickam V, Yan T, Wu L, Zhao Y, Xu X, Zhu H, Chen X, Wang M, Liu Z, Liu Z, Liang G, Wang Y. Allylated Curcumin Analog CA6 Inhibits TrxR1 and Leads to ROS-Dependent Apoptotic Cell Death in Gastric Cancer Through Akt-FoxO3a. Cancer Manag Res 2020;12:247-63. [PMID: 32021440 DOI: 10.2147/CMAR.S227415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
598 Borggreve AS, den Boer RB, van Boxel GI, de Jong PA, Veldhuis WB, Steenhagen E, van Hillegersberg R, Ruurda JP. The Predictive Value of Low Muscle Mass as Measured on CT Scans for Postoperative Complications and Mortality in Gastric Cancer Patients: A Systematic Review and Meta-Analysis. J Clin Med 2020;9:E199. [PMID: 31940770 DOI: 10.3390/jcm9010199] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
599 Gao H, Li P, Hei Y, Li S, Wang J, Lv X, Zhang J. Long non-coding RNA-ZNF281 promotes cancer cell migration and invasion in gastric cancer via downregulation of microRNA-124. Oncol Lett 2020;19:1849-55. [PMID: 32194679 DOI: 10.3892/ol.2020.11286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
600 Qi M, Yu B, Yu H, Li F. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer. Cancer Med 2020;9:1798-817. [PMID: 31923354 DOI: 10.1002/cam4.2760] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
601 Zhang C, Lin X, Zhao Q, Wang Y, Jiang F, Ji C, Li Y, Gao J, Li J, Shen L. YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling. J Cancer Res Clin Oncol 2020;146:329-42. [PMID: 31912229 DOI: 10.1007/s00432-019-03115-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
602 Alhadid D, AlShammari A, Almana H, Aburahmah M. Missed Gastric Cancer Metastasis to the Appendix: Case Report and Literature Review. Am J Case Rep 2020;21:e920010. [PMID: 31901929 DOI: 10.12659/AJCR.920010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
603 Dore MP, Manca A, Alfonso Pensamiento MC, Delitala AP, Fanciulli G, Piana AF, Pes GM. Male Predominance of Gastric Cancer among Patients with Hypothyroidism from a Defined Geographic Area. J Clin Med 2020;9:E135. [PMID: 31947827 DOI: 10.3390/jcm9010135] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
604 Altay SB, Akkurt G, Yılmaz N, Özdemir N. Clinicopathological Evaluation of Gastric Signet Ring Cell Carcinoma: Our Experience. Euroasian J Hepatogastroenterol 2020;10:76-84. [PMID: 33511069 DOI: 10.5005/jp-journals-10018-1325] [Reference Citation Analysis]
605 Zou J, Wu K, Lin C, Jie ZG. LINC00319 acts as a microRNA-335-5p sponge to accelerate tumor growth and metastasis in gastric cancer by upregulating ADCY3. Am J Physiol Gastrointest Liver Physiol 2020;318:G10-22. [PMID: 31433213 DOI: 10.1152/ajpgi.00405.2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
606 杨 正. Integrating Multiple Omics Data to Search for Driver Genes for Gastric Cancer. CSA 2020;10:1820-1833. [DOI: 10.12677/csa.2020.1010192] [Reference Citation Analysis]
607 孙 立. Endostar Given at Different Times Combined with Radiotherapy to the Effect of Gastric Cancer Transplanted in Mice and Its Possible Mechanism. ACM 2020;10:399-405. [DOI: 10.12677/acm.2020.103063] [Reference Citation Analysis]
608 Mccracken E, Hatch S, Blazer DG. Gastric Cancer in the Elderly. Principles and Practice of Geriatric Surgery 2020. [DOI: 10.1007/978-3-319-47771-8_61] [Reference Citation Analysis]
609 Shukla D, Saxena S, Prabhakar PK. Recent Development in the Biomarkers for the Gastric Cancer. Novel therapeutic approaches for gastrointestinal malignancies 2020. [DOI: 10.1007/978-981-15-5471-1_8] [Reference Citation Analysis]
610 宋 晓. Case-Control Study of Risk Factors for Gastric Cancer. ACM 2020;10:537-545. [DOI: 10.12677/acm.2020.104084] [Reference Citation Analysis]
611 Xue J, Li Y, Yi J, Jiang H. HAVCR1 Affects the MEK/ERK Pathway in Gastric Adenocarcinomas and Influences Tumor Progression and Patient Outcome. Gastroenterol Res Pract 2019;2019:6746970. [PMID: 31885544 DOI: 10.1155/2019/6746970] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
612 Sun P, Wang XS, Liu Q, Luan YS, Tian YT. Natural orifice specimen extraction with laparoscopic radical gastrectomy for distal gastric cancer: A case report. World J Clin Cases 2019; 7(24): 4314-4320 [PMID: 31911913 DOI: 10.12998/wjcc.v7.i24.4314] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
613 Huang B, Jin G, Qu C, Ma H, Ding C, Zhang Y, Liu W, Li W. Elevated Expression of NOTCH1 Associates with Lymph Node Metastasis of Gastric Cancer and Knock-Down of NOTCH1 Attenuates Tumor Cell Progression. Med Sci Monit 2019;25:9939-48. [PMID: 31874951 DOI: 10.12659/MSM.918703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
614 Wang Y, Liu Y, Tang T, Luo Y, Stevens MFG, Cheng X, Yang Y, Shi D, Zhang J, Bradshaw TD. The antitumour activity of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole in human gastric cancer models is mediated by AhR signalling. J Cell Mol Med 2020;24:1750-9. [PMID: 31876059 DOI: 10.1111/jcmm.14869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
615 Zhao X, Hu GF, Shi YF, Xu W. Research Progress in microRNA-Based Therapy for Gastric Cancer. Onco Targets Ther 2019;12:11393-411. [PMID: 31920330 DOI: 10.2147/OTT.S221354] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
616 Dong Y, Li X, Lin Z, Zou W, Liu Y, Qian H, Jia J. HOXC-AS1-MYC regulatory loop contributes to the growth and metastasis in gastric cancer. J Exp Clin Cancer Res 2019;38:502. [PMID: 31870402 DOI: 10.1186/s13046-019-1482-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
617 Rohde C, Yamaguchi R, Mukhina S, Sahin U, Itoh K, Türeci Ö. Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma. Jpn J Clin Oncol 2019;49:870-6. [PMID: 31087075 DOI: 10.1093/jjco/hyz068] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
618 Liu D, Zhang B, Matsunaga T, Miyatani K, Shishido Y, Kono Y, Fujiwara Y. A Comparison of Gastric Cancer Surgery Between Japan and China. Yonago Acta Med 2019;62:268-72. [PMID: 31849565 DOI: 10.33160/yam.2019.11.001] [Reference Citation Analysis]
619 Wang Y, Wang F, He J, Du J, Zhang H, Shi H, Chen Y, Wei Y, Xue W, Yan J, Feng Y, Gao Y, Li D, Han J, Zhang J. miR-30a-3p Targets MAD2L1 and Regulates Proliferation of Gastric Cancer Cells. Onco Targets Ther 2019;12:11313-24. [PMID: 31908496 DOI: 10.2147/OTT.S222854] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
620 Spillane J. Gastric neoplasms. Textbook of Surgery 2019. [DOI: 10.1002/9781119468189.ch17] [Reference Citation Analysis]
621 Ma F, Li Y, Li W, Kang W, Liu H, Ma S, Xie Y, Zhong Y, Xu Q, Wang B, Xue L, Tian Y. Metastasectomy Improves the Survival of Gastric Cancer Patients with Krukenberg Tumors: A Retrospective Analysis of 182 patients. Cancer Manag Res 2019;11:10573-80. [PMID: 31908529 DOI: 10.2147/CMAR.S227684] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
622 Sun T, Wang D, Ping Y, Sang Y, Dai Y, Wang Y, Liu Z, Duan X, Tao Z, Liu W. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients. Int J Oncol 2020;56:460-9. [PMID: 31894266 DOI: 10.3892/ijo.2019.4944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
623 Haiyu Z, Xiaofeng P, Xiangqiong M, Junlan Q, Xiaobin Z, Shuncong W, Huanhuan S, Haiqing M. Incidence and Survival Changes in Patients with Esophageal Adenocarcinoma during 1984-2013. Biomed Res Int 2019;2019:7431850. [PMID: 31915702 DOI: 10.1155/2019/7431850] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
624 Ge L, Wang Y, Duan QH, Liu SS, Liu GJ. MicroRNA-760 acts as a tumor suppressor in gastric cancer development via inhibiting G-protein-coupled receptor kinase interacting protein-1 transcription. World J Gastroenterol 2019; 25(45): 6619-6633 [PMID: 31832002 DOI: 10.3748/wjg.v25.i45.6619] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
625 Luo Z, Rong Z, Huang C. Surgery Strategies for Gastric Cancer With Liver Metastasis. Front Oncol 2019;9:1353. [PMID: 31921626 DOI: 10.3389/fonc.2019.01353] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
626 Wang Y, Yang F, Yang Q. The regulatory roles and potential prognosis implications of long non-coding RNAs in gastric cancer. Histol Histopathol 2020;35:433-42. [PMID: 31793657 DOI: 10.14670/HH-18-188] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
627 Wu L, Zhang J, Zhou W, An P, Shen L, Liu J, Jiang X, Huang X, Mu G, Wan X, Lv X, Gao J, Cui N, Hu S, Chen Y, Hu X, Li J, Chen D, Gong D, He X, Ding Q, Zhu X, Li S, Wei X, Li X, Wang X, Zhou J, Zhang M, Yu HG. Randomised controlled trial of WISENSE, a real-time quality improving system for monitoring blind spots during esophagogastroduodenoscopy. Gut 2019;68:2161-9. [PMID: 30858305 DOI: 10.1136/gutjnl-2018-317366] [Cited by in Crossref: 156] [Cited by in F6Publishing: 125] [Article Influence: 39.0] [Reference Citation Analysis]
628 He SN, Guan SH, Wu MY, Li W, Xu MD, Tao M. Down-regulated hsa_circ_0067934 facilitated the progression of gastric cancer by sponging hsa-mir-4705 to downgrade the expression of BMPR1B. Transl Cancer Res 2019;8:2691-703. [PMID: 35117027 DOI: 10.21037/tcr.2019.10.32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
629 Lim SH, Sa JK, Lee DW, Kim J, Kim ST, Park SH, Ku B, Park JO, Park YS, Lim H, Kang WK, Nam DH, Lee J. Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening. Front Oncol 2019;9:1327. [PMID: 31850215 DOI: 10.3389/fonc.2019.01327] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
630 Kim SK, Kim HJ, Park JL, Heo H, Kim SY, Lee SI, Song KS, Kim WH, Kim YS. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer. Gastric Cancer. 2020;23:473-482. [PMID: 31773340 DOI: 10.1007/s10120-019-01029-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
631 Guo X, Zhao F, Ma X, Shen G, Ren D, Zheng F, Du F, Wang Z, Ahmad R, Yuan X, Zhao J, Zhao J. A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis. BMC Cancer 2019;19:1125. [PMID: 31747911 DOI: 10.1186/s12885-019-6294-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
632 Yang L, Yu Y, Yu X, Zhou J, Zhang Z, Ying S, Guo J, Yan Z. Downregulated Expression of hsa_circ_0005556 in Gastric Cancer and Its Clinical Significance. Dis Markers 2019;2019:2624586. [PMID: 31827632 DOI: 10.1155/2019/2624586] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
633 Nagaraja AK, Kikuchi O, Bass AJ. Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma. Cancer Discov 2019;9:1656-72. [PMID: 31727671 DOI: 10.1158/2159-8290.CD-19-0487] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
634 Ren DL, Ghoorun RA, Wu XH, Chen HL, Zhou Q, Wu XB. Oridonin induces apoptosis in HGC-27 cells by activating the JNK signaling pathway. Oncol Lett 2020;19:255-60. [PMID: 31897137 DOI: 10.3892/ol.2019.11104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
635 Yang F, Hu A, Li D, Wang J, Guo Y, Liu Y, Li H, Chen Y, Wang X, Huang K, Zheng L, Tong Q. Circ-HuR suppresses HuR expression and gastric cancer progression by inhibiting CNBP transactivation. Mol Cancer 2019;18:158. [PMID: 31718709 DOI: 10.1186/s12943-019-1094-z] [Cited by in Crossref: 97] [Cited by in F6Publishing: 105] [Article Influence: 24.3] [Reference Citation Analysis]
636 Wang S, Liu Y, Feng Y, Zhang J, Swinnen J, Li Y, Ni Y. A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed. Cancers (Basel) 2019;11:E1782. [PMID: 31766180 DOI: 10.3390/cancers11111782] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
637 y Orea MAD, Díaz Hernández HA, Lopez RG, Conde EG, Cárdenas Perea ME, Montaño MH, de los Ángeles Tapia Roldán MJ, Juarez Alvarado EM. Evaluation of the concentration and profile of serum proteins and immunoglobulins in Mexican patients with advanced gastric cancer.. [DOI: 10.1101/19011759] [Reference Citation Analysis]
638 Lin JX, Tang YH, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Huang CM, Li P, Zheng CH, Xie JW. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients. World J Gastroenterol 2019; 25(41): 6258-6272 [PMID: 31749596 DOI: 10.3748/wjg.v25.i41.6258] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
639 Ma FH, Liu H, Ma S, Li Y, Tian YT. Current controversies in treating remnant gastric cancer: Are minimally invasive approaches feasible? World J Clin Cases 2019; 7(21): 3384-3393 [PMID: 31750323 DOI: 10.12998/wjcc.v7.i21.3384] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
640 Nakagawa T, Sato Y, Tanahashi T, Mitsui Y, Kida Y, Fujino Y, Hirata M, Kitamura S, Miyamoto H, Okamoto K, Muguruma N, Bando Y, Takayama T. JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8. Gastric Cancer 2020;23:426-36. [PMID: 31677131 DOI: 10.1007/s10120-019-01024-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
641 Zhao L, Li J, Bai C, Nie Y, Lin G. Multi-Modality Treatment for Patients With Metastatic Gastric Cancer: A Real-World Study in China. Front Oncol 2019;9:1155. [PMID: 31737573 DOI: 10.3389/fonc.2019.01155] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
642 Afzal A, Qayyum MA, Shah MH. Study of Trace Metal Imbalances in the Scalp Hair of Stomach Cancer Patients with Different Types and Stages. Biol Trace Elem Res 2020;196:365-74. [PMID: 31659649 DOI: 10.1007/s12011-019-01926-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
643 Yao L, Yan J, Gan L, Huang S, Cheng F, Fang N. Upregulation of MANCR predicts poor survival in patients with gastric cancer. Oncol Lett 2019;18:6801-6. [PMID: 31807188 DOI: 10.3892/ol.2019.11026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
644 Tjulandin SA, Tryakin AA, Besova NS, Sholokhova E, Ivanova JI, Cheng WY, Schmerold LM, Thompson-Leduc P, Novick D. Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study. J Drug Assess 2019;8:150-8. [PMID: 31656688 DOI: 10.1080/21556660.2019.1669610] [Reference Citation Analysis]
645 Kohmoto T, Masuda K, Shoda K, Takahashi R, Ujiro S, Tange S, Ichikawa D, Otsuji E, Imoto I. Claudin-6 is a single prognostic marker and functions as a tumor-promoting gene in a subgroup of intestinal type gastric cancer. Gastric Cancer 2020;23:403-17. [PMID: 31654186 DOI: 10.1007/s10120-019-01014-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
646 Wen C, Wang H, Wu X, He L, Zhou Q, Wang F, Chen S, Huang L, Chen J, Wang H, Ye W, Li W, Yang X, Liu H, Peng J. ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocin. Cell Death Dis 2019;10:809. [PMID: 31649256 DOI: 10.1038/s41419-019-2035-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
647 GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017. Lancet Gastroenterol Hepatol. 2020;5:42-54. [PMID: 31648970 DOI: 10.1016/s2468-1253(19)30328-0] [Cited by in Crossref: 199] [Cited by in F6Publishing: 233] [Article Influence: 49.8] [Reference Citation Analysis]
648 Huang L, Cai C, Dang W, Lu JH, Hu GF, Gu J. Propyl isothiocyanate induces apoptosis in gastric cancer cells by oxidative stress via glutathione depletion. Oncol Lett 2019;18:5490-8. [PMID: 31612057 DOI: 10.3892/ol.2019.10875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
649 Yue B, Song C, Yang L, Cui R, Cheng X, Zhang Z, Zhao G. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol Cancer 2019;18:142. [PMID: 31607270 DOI: 10.1186/s12943-019-1065-4] [Cited by in Crossref: 227] [Cited by in F6Publishing: 250] [Article Influence: 56.8] [Reference Citation Analysis]
650 Fujiwara K, Tsuji AB, Sudo H, Sugyo A, Akiba H, Iwanari H, Kusano-Arai O, Tsumoto K, Momose T, Hamakubo T, Higashi T. 111In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis. Ann Nucl Med 2020;34:13-23. [PMID: 31605356 DOI: 10.1007/s12149-019-01408-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
651 Huang Y, Yang L, Lin Y, Chang X, Wu H, Chen Y. Prognostic value of non-invasive serum Cytokeratin 18 detection in gastrointestinal cancer: a meta-analysis. J Cancer 2019;10:4814-23. [PMID: 31598152 DOI: 10.7150/jca.31408] [Reference Citation Analysis]
652 Lopes LO, Maués JH, Ferreira-Fernandes H, Yoshioka FK, Júnior SCS, Santos AR, Ribeiro HF, Rey JA, Soares PC, Burbano RR, Pinto GR. New prognostic markers revealed by RNA-Seq transcriptome analysis after MYC silencing in a metastatic gastric cancer cell line. Oncotarget 2019;10:5768-79. [PMID: 31645899 DOI: 10.18632/oncotarget.27208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
653 Zheng J, Xie SH, Santoni G, Lagergren J. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study. Br J Cancer. 2019;121:877-882. [PMID: 31591459 DOI: 10.1038/s41416-019-0598-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
654 Hu Z, Niu G, Ren J, Wang X, Chen L, Hong R, Ke C. TAFA5 promotes proliferation and migration in gastric cancer. Mol Med Rep 2019;20:4477-88. [PMID: 31702029 DOI: 10.3892/mmr.2019.10724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
655 Fang H, Yuan C, Gu X, Chen Q, Huang D, Li H, Sun M. Association between TIM-3 polymorphisms and cancer risk: a meta-analysis. Ann Transl Med 2019;7:550. [PMID: 32133384 DOI: 10.21037/atm.2019.09.101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
656 Sanz Álvarez L, Turienzo Santos E, Rodicio Miravalles JL, Moreno Gijón M, Amoza Pais S, Sanz Navarro S, Rizzo Ramos A. Evidence in Follow-up and Prognosis of Esophagogastric Junction Cancer. Cirugía Española (English Edition) 2019;97:465-469. [DOI: 10.1016/j.cireng.2019.09.003] [Reference Citation Analysis]
657 Yao Y, Wang Y, Li L, Xiang X, Li J, Chen J, Liu Z, Huang S, Xiong J, Deng J. Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor. J Cell Mol Med 2019;23:8076-89. [PMID: 31559693 DOI: 10.1111/jcmm.14677] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
658 Cheng J, Cai M, Shuai X, Gao J, Wang G, Tao K. First-line systemic therapy for advanced gastric cancer: a systematic review and network meta-analysis. Ther Adv Med Oncol 2019;11:1758835919877726. [PMID: 31632469 DOI: 10.1177/1758835919877726] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
659 Li Y, Sun H, Guan J, Ji T, Wang X. Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer. Yonsei Med J 2019;60:720-6. [PMID: 31347326 DOI: 10.3349/ymj.2019.60.8.720] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
660 Tsutsuyama M, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Tumor size  ≥50 mm as an Independent Prognostic Factor for Patients with Stage II or III Gastric Cancer After Postoperative S-1 Monotherapy: Analysis of a Multi-institution Dataset. World J Surg 2020;44:194-201. [PMID: 31552460 DOI: 10.1007/s00268-019-05198-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
661 Cheng B, Tong G, Wu X, Cai W, Li Z, Tong Z, He L, Yu S, Wang S. Enumeration And Characterization Of Circulating Tumor Cells And Its Application In Advanced Gastric Cancer. Onco Targets Ther 2019;12:7887-96. [PMID: 31576146 DOI: 10.2147/OTT.S223222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
662 Figueroa-Protti L, Soto-Molinari R, Calderón-Osorno M, Mora J, Alpízar-Alpízar W. Gastric Cancer in the Era of Immune Checkpoint Blockade. J Oncol 2019;2019:1079710. [PMID: 31662748 DOI: 10.1155/2019/1079710] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
663 You X, Zhou Q, Song J, Gan L, Chen J, Shen H. Preoperative albumin-to-fibrinogen ratio predicts severe postoperative complications in elderly gastric cancer subjects after radical laparoscopic gastrectomy. BMC Cancer 2019;19:931. [PMID: 31533682 DOI: 10.1186/s12885-019-6143-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
664 Kanda M. Preoperative predictors of postoperative complications after gastric cancer resection. Surg Today 2020;50:3-11. [PMID: 31535226 DOI: 10.1007/s00595-019-01877-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
665 Xuan Y, Wang Y. Long non-coding RNA SNHG3 promotes progression of gastric cancer by regulating neighboring MED18 gene methylation. Cell Death Dis. 2019;10:694. [PMID: 31534128 DOI: 10.1038/s41419-019-1940-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 12.0] [Reference Citation Analysis]
666 Wang XQ, Terry PD, Li Y, Zhang Y, Kou WJ, Wang MX. Association of XPG rs2094258 polymorphism with gastric cancer prognosis. World J Gastroenterol 2019; 25(34): 5152-5161 [PMID: 31558863 DOI: 10.3748/wjg.v25.i34.5152] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
667 Shi Y, Wang Z, Zhu X, Chen L, Ma Y, Wang J, Yang X, Liu Z. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer. Int J Clin Oncol 2020;25:89-99. [PMID: 31506750 DOI: 10.1007/s10147-019-01532-9] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 13.0] [Reference Citation Analysis]
668 Zhuo YJ, Shi Y, Wu T. NRP-1 and KDR polymorphisms are associated with survival time in patients with advanced gastric cancer. Oncol Lett 2019;18:4629-38. [PMID: 31611971 DOI: 10.3892/ol.2019.10842] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
669 Zhang P, Shi L, Zhang T, Hong L, He W, Cao P, Shen X, Zheng P, Xia Y, Zou P. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells. Cell Oncol (Dordr) 2019;42:847-60. [PMID: 31493144 DOI: 10.1007/s13402-019-00471-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
670 Xue F, An C, Chen L, Liu G, Ren F, Guo X, Sun H, Mei L, Sun X, Li J, Tang Y, An X, Zheng P. 4.1B suppresses cancer cell proliferation by binding to EGFR P13 region of intracellular juxtamembrane segment. Cell Commun Signal 2019;17:115. [PMID: 31492173 DOI: 10.1186/s12964-019-0431-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
671 Conradi LC, Spitzner M, Metzger AL, Kisly M, Middel P, Bohnenberger H, Gaedcke J, Ghadimi MB, Liersch T, Rüschoff J, Beißbarth T, König A, Grade M. Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer. BMC Cancer 2019;19:880. [PMID: 31488078 DOI: 10.1186/s12885-019-6051-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
672 Lu Z, Luo T, Pang T, Du Z, Yin X, Cui H, Fang G, Xue X. MALAT1 promotes gastric adenocarcinoma through the MALAT1/miR-181a-5p/AKT3 axis. Open Biol 2019;9:190095. [PMID: 31480991 DOI: 10.1098/rsob.190095] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
673 Brito-Gonçalves G, Libânio D, Marcos P, Pita I, Castro R, Sá I, Dinis-Ribeiro M, Pimentel-Nunes P. Clinicopathologic Characteristics of Patients with Gastric Superficial Neoplasia and Risk Factors for Multiple Lesions after Endoscopic Submucosal Dissection in a Western Country. GE Port J Gastroenterol 2020;27:76-89. [PMID: 32266305 DOI: 10.1159/000501939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
674 Zhang Z, Huang JY, Wang PL, Hou WB, Yin SC, Xu HM. Should All Stage N3b Patients with Advanced Gastric Cancer Be Considered Equivalent? A 30-Year Single Center Study. J Gastrointest Surg 2019;23:1742-7. [PMID: 30238247 DOI: 10.1007/s11605-018-3945-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
675 Song H, Wang T, Tian L, Bai S, Chen L, Zuo Y, Xue Y. Macrophages on the Peritoneum are involved in Gastric Cancer Peritoneal Metastasis. J Cancer 2019;10:5377-87. [PMID: 31632482 DOI: 10.7150/jca.31787] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
676 Sun Q, Li J, Li F, Li H, Bei S, Zhang X, Feng L. LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p/USF1 pathway. Cell Prolif 2019;52:e12687. [PMID: 31468594 DOI: 10.1111/cpr.12687] [Cited by in Crossref: 31] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
677 Qi H, Xiao Z, Wang Y. Long non-coding RNA LINC00665 gastric cancer tumorigenesis by regulation miR-149-3p/RNF2 axis. Onco Targets Ther 2019;12:6981-90. [PMID: 31695413 DOI: 10.2147/OTT.S214588] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
678 Ma T, Wu ZJ, Xu H, Wu CH, Xu J, Peng WR, Fan LL, Sun GP. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy. BMC Cancer 2019;19:852. [PMID: 31462229 DOI: 10.1186/s12885-019-6075-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
679 Komatsu S, Otsuji E. Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan. Ann Gastroenterol Surg 2019;3:581-91. [PMID: 31788646 DOI: 10.1002/ags3.12284] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
680 Zong W, Feng W, Jiang Y, Cao Y, Ke Y, Shi X, Ju S, Cong H, Wang X, Cui M, Jing R. LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway. Gastric Cancer 2020;23:228-40. [PMID: 31451992 DOI: 10.1007/s10120-019-00998-w] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
681 Russi S, Calice G, Ruggieri V, Laurino S, La Rocca F, Amendola E, Lapadula C, Compare D, Nardone G, Musto P, De Felice M, Falco G, Zoppoli P. Gastric Normal Adjacent Mucosa Versus Healthy and Cancer Tissues: Distinctive Transcriptomic Profiles and Biological Features. Cancers (Basel) 2019;11:E1248. [PMID: 31454993 DOI: 10.3390/cancers11091248] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
682 Wang Q, Han A, Chen L, Sun J, Lin Z, Zhang X, Ren X. Paip1 overexpression is involved in the progression of gastric cancer and predicts shorter survival of diagnosed patients. Onco Targets Ther 2019;12:6565-76. [PMID: 31496746 DOI: 10.2147/OTT.S202698] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
683 Jeon J, Cheong JH. Clinical Implementation of Precision Medicine in Gastric Cancer. J Gastric Cancer 2019;19:235-53. [PMID: 31598369 DOI: 10.5230/jgc.2019.19.e25] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
684 Yu XW, Wei D, Gao YS, Du HZ, Yu BY, Li RM, Qian CM, Luo XJ, Yuan ST, Wang JS, Sun L. Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis. J Cell Mol Med 2019;23:6622-34. [PMID: 31397978 DOI: 10.1111/jcmm.14523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
685 Tong H, Liu Y, Jiang L, Wang J. Multi-Targeting by β-Elemene and Its Anticancer Properties: A Good Choice for Oncotherapy and Radiochemotherapy Sensitization. Nutr Cancer 2020;72:554-67. [PMID: 31387393 DOI: 10.1080/01635581.2019.1648694] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
686 Yoon JH, Park YG, Nam SW, Park WS. The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancer. Cancer Med 2019;8:5507-14. [PMID: 31376239 DOI: 10.1002/cam4.2457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
687 Kanda M, Suh YS, Park DJ, Tanaka C, Ahn SH, Kong SH, Lee HJ, Kobayashi D, Fujiwara M, Shimada H, Cho B, Murotani K, Kim HH, Yang HK, Kodera Y. Serum levels of ANOS1 serve as a diagnostic biomarker of gastric cancer: a prospective multicenter observational study. Gastric Cancer 2020;23:203-11. [PMID: 31377880 DOI: 10.1007/s10120-019-00995-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
688 Iizuka A, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Proposal of a Scoring Scale to Estimate Risk of the Discontinuation of S-1 Adjuvant Monotherapy in Patients with Stage II to III Gastric Cancer: A Multi-Institutional Dataset Analysis. World J Surg 2019;43:2016-24. [PMID: 30737551 DOI: 10.1007/s00268-019-04942-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
689 Jiang Y, Jin S, Tan S, Shen Q, Xue Y. MiR-203 acts as a radiosensitizer of gastric cancer cells by directly targeting ZEB1. Onco Targets Ther 2019;12:6093-104. [PMID: 31440062 DOI: 10.2147/OTT.S197539] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
690 Niu G, Yang Y, Ren J, Song T, Hu Z, Chen L, Hong R, Xia J, Ke C, Wang X. Overexpression of CPXM2 predicts an unfavorable prognosis and promotes the proliferation and migration of gastric cancer. Oncol Rep 2019;42:1283-94. [PMID: 31364750 DOI: 10.3892/or.2019.7254] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
691 Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer. Cancer Med. 2019;8:5194-5201. [PMID: 31353821 DOI: 10.1002/cam4.2439] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
692 Wang T, Qin Y, Lai H, Wei W, Li Z, Yang Y, Huang M, Chen J. The prognostic value of ADRA1 subfamily genes in gastric carcinoma. Oncol Lett 2019;18:3150-8. [PMID: 31452791 DOI: 10.3892/ol.2019.10660] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
693 Zhang Q, Sui Y, Sui X. MicroRNA-761 inhibits the metastasis of gastric cancer by negatively regulating Ras and Rab interactor 1. Oncol Lett 2019;18:3097-103. [PMID: 31452787 DOI: 10.3892/ol.2019.10645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
694 Gong X, Xu B, Zi L, Chen X. miR-625 reverses multidrug resistance in gastric cancer cells by directly targeting ALDH1A1. Cancer Manag Res. 2019;11:6615-6624. [PMID: 31410057 DOI: 10.2147/cmar.s208708] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
695 Yang XH, Zhuang MK, Xie WH, Du F, Huang YH, Chen ZX, Chen FL, Wang XZ. 12-Lipoxygenase promotes epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway in gastric cancer cells. Onco Targets Ther 2019;12:5551-61. [PMID: 31371993 DOI: 10.2147/OTT.S201373] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
696 Parisi A, Cortellini A, Roberto M, Venditti O, Santini D, Dell'Aquila E, Stellato M, Marchetti P, Occhipinti MA, Zoratto F, Mazzuca F, Tinari N, De Tursi M, Iezzi L, Natoli C, Ratti M, Pizzo C, Ghidini M, Porzio G, Ficorella C, Cannita K. Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study. J Cancer Res Clin Oncol 2019;145:2365-73. [PMID: 31280347 DOI: 10.1007/s00432-019-02971-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
697 Cheung KS, Leung WK, Seto WK. Application of Big Data analysis in gastrointestinal research. World J Gastroenterol 2019; 25(24): 2990-3008 [PMID: 31293336 DOI: 10.3748/wjg.v25.i24.2990] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
698 Suzuki S, Kanaji S, Yamamoto M, Oshikiri T, Nakamura T, Kakeji Y. Controlling Nutritional Status (CONUT) Score Predicts Outcomes of Curative Resection for Gastric Cancer in the Elderly. World J Surg 2019;43:1076-84. [PMID: 30569221 DOI: 10.1007/s00268-018-04889-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
699 Ito Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Intraoperative Blood Loss is Associated with Shortened Postoperative Survival of Patients with Stage II/III Gastric Cancer: Analysis of a Multi-institutional Dataset. World J Surg. 2019;43:870-877. [PMID: 30377722 DOI: 10.1007/s00268-018-4834-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
700 Nie S, Zhao Y, Qiu X, Wang W, Yao Y, Yi M, Wang D. Metabolomic Study on Nude Mice Models of Gastric Cancer Treated with Modified Si Jun Zi Tang via HILIC UHPLC-Q-TOF/MS Analysis. Evid Based Complement Alternat Med 2019;2019:3817879. [PMID: 31341492 DOI: 10.1155/2019/3817879] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
701 Liu Y, Zhang YM, Ma FB, Pan SR, Liu BZ. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion via SRSF1 and functions as a biomarker in gastric cancer. World J Gastroenterol 2019; 25(22): 2763-2775 [PMID: 31235999 DOI: 10.3748/wjg.v25.i22.2763] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
702 Xu B, Bai Z, Yin J, Zhang Z. Global transcriptomic analysis identifies SERPINE1 as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer. PeerJ 2019;7:e7091. [PMID: 31218131 DOI: 10.7717/peerj.7091] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
703 Liu B, Zhang Y, Fan Y, Wang S, Li Z, Deng M, Li C, Wang J, Ma R, Wang X, Wang Y, Xu L, Hou K, Che X, Liu Y, Qu X. Leucine-rich repeat neuronal protein-1 suppresses apoptosis of gastric cancer cells through regulation of Fas/FasL. Cancer Sci 2019;110:2145-55. [PMID: 31087525 DOI: 10.1111/cas.14042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
704 Guo J, Li Y, Duan H, Yuan L. LncRNA TUBA4B functions as a competitive endogenous RNA to inhibit gastric cancer progression by elevating PTEN via sponging miR-214 and miR-216a/b. Cancer Cell Int 2019;19:156. [PMID: 31198405 DOI: 10.1186/s12935-019-0879-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
705 Yin S, Wang P, Xu X, Tan Y, Huang J, Xu H. The optimal strategy of multimodality therapies for resectable gastric cancer: evidence from a network meta-analysis. J Cancer. 2019;10:3094-3101. [PMID: 31289579 DOI: 10.7150/jca.30456] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
706 Lee MR, Lai CL, Chan KA. Intensive Care Unit Admission and Survival in Stage IV Cancer Patients with Septic Shock: A Population-Based Cohort Study. J Cancer 2019;10:3179-87. [PMID: 31289588 DOI: 10.7150/jca.30278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
707 Pan J, Dai Q, Xiang Z, Liu B, Li C. Three Biomarkers Predict Gastric Cancer Patients' Susceptibility To Fluorouracil-based Chemotherapy. J Cancer 2019;10:2953-60. [PMID: 31281472 DOI: 10.7150/jca.31120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
708 Lott PC, Carvajal-Carmona LG. Resolving gastric cancer aetiology: an update in genetic predisposition. Lancet Gastroenterol Hepatol. 2018;3:874-883. [PMID: 30507471 DOI: 10.1016/s2468-1253(18)30237-1] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 12.0] [Reference Citation Analysis]
709 Zhang Z, Zhao W, Lin X, Gao J, Zhang Z, Shen L. Voltage-dependent calcium channel α2δ1 subunit is a specific candidate marker for identifying gastric cancer stem cells. Cancer Manag Res 2019;11:4707-18. [PMID: 31213895 DOI: 10.2147/CMAR.S199329] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
710 Jiang L, Liu JY, Shi Y, Tang B, He T, Liu JJ, Fan JY, Wu B, Xu XH, Zhao YL, Qian F, Cui YH, Yu PW. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling. J Exp Clin Cancer Res 2019;38:206. [PMID: 31113461 DOI: 10.1186/s13046-019-1186-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
711 Xu XF, Gao F, Wang JJ, Long C, Chen X, Tao L, Yang L, Ding L, Ji Y. BMX-ARHGAP fusion protein maintains the tumorigenicity of gastric cancer stem cells by activating the JAK/STAT3 signaling pathway. Cancer Cell Int 2019;19:133. [PMID: 31130822 DOI: 10.1186/s12935-019-0847-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
712 Dai H, Chen H, Xu J, Zhou J, Shan Z, Yang H, Zhou X, Guo F. The ubiquitin ligase CHIP modulates cellular behaviors of gastric cancer cells by regulating TRAF2. Cancer Cell Int 2019;19:132. [PMID: 31130821 DOI: 10.1186/s12935-019-0832-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
713 Rahbari M, Pecqueux M, Aust D, Stephan H, Tiebel O, Chatzigeorgiou A, Tonn T, Baenke F, Rao V, Ziegler N, Greif H, Lin K, Weitz J, Rahbari NN, Kahlert C. Expression of Glypican 3 is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes. J Clin Med 2019;8:E696. [PMID: 31100935 DOI: 10.3390/jcm8050696] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
714 Cui HW, Han WY, Hou LN, Yang L, Li X, Su XL. miR-1915-3p inhibits Bcl-2 expression in the development of gastric cancer. Biosci Rep 2019;39:BSR20182321. [PMID: 31036603 DOI: 10.1042/BSR20182321] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
715 Chen J, Bell J, Lau BT, Whittaker T, Stapleton D, Ji HP. A functional CRISPR/Cas9 screen identifies kinases that modulate FGFR inhibitor response in gastric cancer. Oncogenesis 2019;8:33. [PMID: 31076567 DOI: 10.1038/s41389-019-0145-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
716 Shu X, Liu H, Pan Y, Sun L, Yu L, Sun L, Yang Z, Ran Y. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines. Mol Cell Biochem 2019;459:35-47. [PMID: 31073886 DOI: 10.1007/s11010-019-03548-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
717 Nakanishi K, Kanda M, Umeda S, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Kodera Y. The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer. Gastric Cancer 2019;22:1143-52. [PMID: 31055693 DOI: 10.1007/s10120-019-00967-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
718 Pennathur A, Godfrey TE, Luketich JD. The Molecular Biologic Basis of Esophageal and Gastric Cancers. Surg Clin North Am 2019;99:403-18. [PMID: 31047032 DOI: 10.1016/j.suc.2019.02.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
719 Chiang TH, Chiu SY, Chen SL, Yen AM, Fann JC, Liu CY, Chou CK, Chiu HM, Shun CT, Wu MS, Lin JT, Lee YC, Chen TH, Lin MW. Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study. J Clin Gastroenterol 2019;53:e186-93. [PMID: 29369241 DOI: 10.1097/MCG.0000000000000992] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
720 Wang YC, Pan J, Jiang X, Su XJ, Zhou W, Zou WB, Qian YY, Chen YZ, Liu X, Yu J, Yan XN, Zhao AJ, Li ZS, Liao Z. Repetitive Position Change Improves Gastric Cleanliness for Magnetically Controlled Capsule Gastroscopy. Dig Dis Sci 2019;64:1297-304. [PMID: 30560329 DOI: 10.1007/s10620-018-5415-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
721 Cao H, Jiang S, Yuan R, Zhang W, Liu Y, Shao C, Shao S. Inhibition of IκB Kinase 2 Attenuated the Proliferation and Induced Apoptosis of Gastric Cancer. Dig Dis Sci 2019;64:1204-16. [PMID: 30560335 DOI: 10.1007/s10620-018-5414-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
722 Zhang Y, Yu C. Prognostic values of signal transducers activators of transcription in gastric cancer. Biosci Rep 2019;39:BSR20181695. [PMID: 30944204 DOI: 10.1042/BSR20181695] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
723 Sammarco G, Varricchi G, Ferraro V, Ammendola M, De Fazio M, Altomare DF, Luposella M, Maltese L, Currò G, Marone G, Ranieri G, Memeo R. Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer. Int J Mol Sci 2019;20:E2106. [PMID: 31035644 DOI: 10.3390/ijms20092106] [Cited by in Crossref: 86] [Cited by in F6Publishing: 96] [Article Influence: 21.5] [Reference Citation Analysis]
724 Tian S, Zhan N, Li R, Dong W. Downregulation of G Protein-Coupled Estrogen Receptor (GPER) is Associated with Reduced Prognosis in Patients with Gastric Cancer. Med Sci Monit 2019;25:3115-26. [PMID: 31028714 DOI: 10.12659/MSM.913634] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
725 Liu H, Zhao YR, Chen B, Ge Z, Huang JS. High expression of SMARCE1 predicts poor prognosis and promotes cell growth and metastasis in gastric cancer. Cancer Manag Res 2019;11:3493-509. [PMID: 31118775 DOI: 10.2147/CMAR.S195137] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
726 Wangxia LV, Fang Y, Liu Y, Zhao Y, Shi Z, Zhong H. Circular RNA ARHGAP26 is over-expressed and its downregulation inhibits cell proliferation and promotes cell apoptosis in gastric cancer cells. Saudi J Gastroenterol. 2019;25:119-125. [PMID: 30719998 DOI: 10.4103/sjg.sjg_283_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
727 Wu T, Wu X, Wang HY, Chen L. Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer. Cancer Commun (Lond) 2019;39:21. [PMID: 30999966 DOI: 10.1186/s40880-019-0365-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
728 Liu L, Li Y, Pan B, Zhang T, Wei D, Zhu Y, Guo Y. Nr5a2 promotes tumor growth and metastasis of gastric cancer AGS cells by Wnt/beta-catenin signaling. Onco Targets Ther 2019;12:2891-902. [PMID: 31114234 DOI: 10.2147/OTT.S201228] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
729 Chen X, Chen W, Huang Y, Xu J, Zeng Y, Shi M, Xu L, Zhang W, Zhu G, Mao C, Shen X. A quantified risk-scoring system including the visceral fat area for peritoneal metastasis of gastric cancer. Cancer Manag Res 2019;11:2903-13. [PMID: 31114340 DOI: 10.2147/CMAR.S194356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
730 Man Z, Chen T, Zhu Z, Zhang H, Ao L, Xi L, Zhou J, Tang Z. High expression of TRIM36 is associated with radiosensitivity in gastric cancer. Oncol Lett 2019;17:4401-8. [PMID: 30944633 DOI: 10.3892/ol.2019.10122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
731 Gao C, Wu X, Zhai J, Shen J, Wang S, Shen L. Long non-coding RNA SNHG17 promotes gastric cancer progression by inhibiting P15 and P16. Transl Cancer Res 2019;8:520-31. [PMID: 35116784 DOI: 10.21037/tcr.2019.04.14] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
732 Di Bartolomeo M, Niger M, Morano F, Corallo S, Antista M, Tamberi S, Lonardi S, Di Donato S, Berardi R, Scartozzi M, Cardellino GG, Di Costanzo F, Rimassa L, Luporini AG, Longarini R, Zaniboni A, Bertolini A, Tomasello G, Pinotti G, Scagliotti G, Tortora G, Bonetti A, Spallanzani A, Frassineti GL, Tassinari D, Giuliani F, Cinieri S, Maiello E, Verusio C, Bracarda S, Catalano V, Basso M, Ciuffreda L, De Vita F, Parra HS, Fornaro L, Caporale M, de Braud F, Pietrantonio F. Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial. BMC Cancer 2019;19:283. [PMID: 30922323 DOI: 10.1186/s12885-019-5498-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
733 Pan J, Dai Q, Zhang T, Li C. Palmitate acid promotes gastric cancer metastasis via FABP5/SP1/UCA1 pathway. Cancer Cell Int 2019;19:69. [PMID: 30948929 DOI: 10.1186/s12935-019-0787-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
734 Ding N, Zou Z, Sha H, Su S, Qian H, Meng F, Chen F, Du S, Zhou S, Chen H, Zhang L, Yang J, Wei J, Liu B. iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer. Nat Commun 2019;10:1336. [PMID: 30902997 DOI: 10.1038/s41467-019-09296-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 12.3] [Reference Citation Analysis]
735 Chen D, Chen G, Jiang W, Fu M, Liu W, Sui J, Xu S, Liu Z, Zheng X, Chi L, Lin D, Li K, Chen W, Zuo N, Lu J, Chen J, Li G, Zhuo S, Yan J. Association of the Collagen Signature in the Tumor Microenvironment With Lymph Node Metastasis in Early Gastric Cancer. JAMA Surg. 2019;154:e185249. [PMID: 30698615 DOI: 10.1001/jamasurg.2018.5249] [Cited by in Crossref: 42] [Cited by in F6Publishing: 54] [Article Influence: 10.5] [Reference Citation Analysis]
736 Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer 2019;19:1-48. [PMID: 30944757 DOI: 10.5230/jgc.2019.19.e8] [Cited by in Crossref: 187] [Cited by in F6Publishing: 225] [Article Influence: 46.8] [Reference Citation Analysis]
737 Qin J, Wang S, Wang P, Wang X, Ye H, Song C, Dai L, Wang K, Jiang B, Zhang J. Autoantibody against 14-3-3 zeta: a serological marker in detection of gastric cancer. J Cancer Res Clin Oncol 2019;145:1253-62. [PMID: 30887154 DOI: 10.1007/s00432-019-02884-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
738 Wang L, Li B, Zhang L, Li Q, He Z, Zhang X, Huang X, Xu Z, Xia Y, Zhang Q, Li Q, Xu J, Sun G, Xu Z. miR-664a-3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer. Cell Prolif 2019;52:e12567. [PMID: 30883979 DOI: 10.1111/cpr.12567] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
739 Gao F, Li M, Xiang R, Zhou X, Zhu L, Zhai Y. Expression of CLDN6 in tissues of gastric cancer patients: Association with clinical pathology and prognosis. Oncol Lett 2019;17:4621-5. [PMID: 30988820 DOI: 10.3892/ol.2019.10129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
740 Hu Z, Yang D, Tang Y, Zhang X, Wei Z, Fu H, Xu J, Zhu Z, Cai Q. Five-long non-coding RNA risk score system for the effective prediction of gastric cancer patient survival. Oncol Lett 2019;17:4474-86. [PMID: 30988816 DOI: 10.3892/ol.2019.10124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
741 Chen Y, Wang D, Song Y, Zhang X, Jiao Z, Dong J, Lü L, Zou Z, Du W, Qu F. Functional polymorphisms in circadian positive feedback loop genes predict postsurgical prognosis of gastric cancer. Cancer Med 2019;8:1919-29. [PMID: 30843665 DOI: 10.1002/cam4.2050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
742 Chen C, Zhang F, Zhou N, Gu YM, Zhang YT, He YD, Wang L, Yang LX, Zhao Y, Li YM. Efficacy and safety of immune checkpoint inhibitors in advanced gastric or gastroesophageal junction cancer: a systematic review and meta-analysis. Oncoimmunology. 2019;8:e1581547. [PMID: 31069144 DOI: 10.1080/2162402x.2019.1581547] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
743 Xiong T, Li J, Chen F, Zhang F. PCAT-1: A Novel Oncogenic Long Non-Coding RNA in Human Cancers. Int J Biol Sci 2019;15:847-56. [PMID: 30906215 DOI: 10.7150/ijbs.30970] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
744 Lv Y, Zhao Y, Wang X, Chen N, Mao F, Teng Y, Wang T, Peng L, Zhang J, Cheng P, Liu Y, Kong H, Chen W, Hao C, Han B, Ma Q, Zou Q, Chen J, Zhuang Y. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway. J Immunother Cancer 2019;7:54. [PMID: 30808413 DOI: 10.1186/s40425-019-0530-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 15.3] [Reference Citation Analysis]
745 Lu SY, Chen JJ, Pan JI, Fu ZX, Wu JL, Hsieh TC. The Association Between Different Patterns of Traditional Chinese Medicine Treatment and All-Cause Mortality Among Cancer Patients. Integr Cancer Ther 2019;18:1534735418823273. [PMID: 30791738 DOI: 10.1177/1534735418823273] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
746 Yin S, Miao Z, Tan Y, Wang P, Xu X, Zhang C, Hou W, Huang J, Xu H. SPHK1-induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination. Cancer Med 2019;8:1731-43. [PMID: 30791228 DOI: 10.1002/cam4.2041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
747 Hamada T, Nowak JA, Milner DA jr. Song M, Ogino S. Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms. J Pathol. 2019;247:615-628. [PMID: 30632609 DOI: 10.1002/path.5236] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 14.5] [Reference Citation Analysis]
748 Fang H, Zhang Y, Wu Z, Wang X, Wang H, Wang Y, Chai F, Jiang Y, Jin Z, Wan Y, Zhu L, Ma S. Regional Hyperthermia Combined with Chemotherapy in Advanced Gastric Cancer. Open Med (Wars) 2019;14:85-90. [PMID: 30847395 DOI: 10.1515/med-2019-0012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
749 Shang W, Xie Z, Lu F, Fang D, Tang T, Bi R, Chen L, Jiang L. Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer. Oxid Med Cell Longev 2019;2019:9291683. [PMID: 30911354 DOI: 10.1155/2019/9291683] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
750 Liu JY, Jiang L, He T, Liu JJ, Fan JY, Xu XH, Tang B, Shi Y, Zhao YL, Qian F, Wang Y, Cui YH, Yu PW. NETO2 promotes invasion and metastasis of gastric cancer cells via activation of PI3K/Akt/NF-κB/Snail axis and predicts outcome of the patients. Cell Death Dis 2019;10:162. [PMID: 30770791 DOI: 10.1038/s41419-019-1388-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
751 Chen D, Lin X, Zhang C, An G, Li Z, Dong B, Shen L, Gao J, Zhang X. Activated Wnt signaling promotes growth and progression of AFP-producing gastric cancer in preclinical models. Cancer Manag Res 2019;11:1349-62. [PMID: 30809100 DOI: 10.2147/CMAR.S187219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
752 Luo Y, Wu J, Wu Q, Li X, Wu J, Zhang J, Rong X, Rao J, Liao Y, Bin J, Huang N, Liao W. miR-577 Regulates TGF-β Induced Cancer Progression through a SDPR-Modulated Positive-Feedback Loop with ERK-NF-κB in Gastric Cancer. Mol Ther 2019;27:1166-82. [PMID: 30879950 DOI: 10.1016/j.ymthe.2019.02.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
753 Yao Y, Yang X, Sun L, Sun S, Huang X, Zhou D, Li T, Zhang W, Abumrad NA, Zhu X, He S, Su X. Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer. EBioMedicine 2019;41:256-67. [PMID: 30738828 DOI: 10.1016/j.ebiom.2019.01.066] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 7.3] [Reference Citation Analysis]
754 Wang DD, Chen YB, Zhao JJ, Zhang XF, Zhu GC, Weng DS, Pan K, Lv L, Pan QZ, Jiang SS, Wang LL, Xia JC. TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis. Cancer Commun (Lond) 2019;39:3. [PMID: 30728082 DOI: 10.1186/s40880-019-0347-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
755 Liu G, Xu M, Gao T, Xu L, Zeng P, Bo H, Li F, Zhang W, Wang Z. Surgical Compliance and Outcomes in Gastric Cancer: a population-based cohort study. J Cancer 2019;10:779-88. [PMID: 30854083 DOI: 10.7150/jca.29073] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
756 Posselt G, Wiesauer M, Chichirau BE, Engler D, Krisch LM, Gadermaier G, Briza P, Schneider S, Boccellato F, Meyer TF, Hauser-Kronberger C, Neureiter D, Müller A, Wessler S. Helicobacter pylori-controlled c-Abl localization promotes cell migration and limits apoptosis. Cell Commun Signal 2019;17:10. [PMID: 30704478 DOI: 10.1186/s12964-019-0323-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
757 Echizen K, Horiuchi K, Aoki Y, Yamada Y, Minamoto T, Oshima H, Oshima M. NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells. Oncogene 2019;38:4250-63. [PMID: 30700829 DOI: 10.1038/s41388-019-0702-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 9.0] [Reference Citation Analysis]
758 Dai D, Zhou B, Xu W, Jin H, Wang X. CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process. J Cancer 2019;10:949-56. [PMID: 30854101 DOI: 10.7150/jca.27224] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
759 Liu H, Wu N, Zhang Z, Zhong X, Zhang H, Guo H, Nie Y, Liu Y. Long Non-coding RNA LINC00941 as a Potential Biomarker Promotes the Proliferation and Metastasis of Gastric Cancer. Front Genet 2019;10:5. [PMID: 30723491 DOI: 10.3389/fgene.2019.00005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]
760 Pang X, Zhou Z, Yu Z, Han L, Lin Z, Ao X, Liu C, He Y, Ponnusamy M, Li P, Wang J. Foxo3a-dependent miR-633 regulates chemotherapeutic sensitivity in gastric cancer by targeting Fas-associated death domain. RNA Biol 2019;16:233-48. [PMID: 30628514 DOI: 10.1080/15476286.2019.1565665] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
761 Liu C, He X, Liu X, Yu J, Zhang M, Yu F, Wang Y. RPS15A promotes gastric cancer progression via activation of the Akt/IKK-β/NF-κB signalling pathway. J Cell Mol Med 2019;23:2207-18. [PMID: 30661291 DOI: 10.1111/jcmm.14141] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
762 Suenaga Y, Kanda M, Ito S, Mochizuki Y, Teramoto H, Ishigure K, Murai T, Asada T, Ishiyama A, Matsushita H, Tanaka C, Kobayashi D, Fujiwara M, Murotani K, Kodera Y. Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer. World J Gastrointest Oncol 2019; 11(1): 17-27 [PMID: 30984347 DOI: 10.4251/wjgo.v11.i1.17] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
763 Liu H, Du F, Sun L, Wu Q, Wu J, Tong M, Wang X, Wang Q, Cao T, Gao X, Cao J, Wu N, Nie Y, Fan D, Lu Y, Zhao X. GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer. Cell Death Dis 2019;10:35. [PMID: 30674866 DOI: 10.1038/s41419-018-1270-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
764 Kauppila JH, Ohtonen P, Karttunen TJ, Kokkola A, Laine S, Rantanen T, Ristimäki A, Räsänen JV, Saarnio J, Sihvo E, Toikkanen V, Tyrväinen T. Finnish National Esophago-Gastric Cancer Cohort (FINEGO) for studying outcomes after oesophageal and gastric cancer surgery: a protocol for a retrospective, population-based, nationwide cohort study in Finland. BMJ Open 2019;9:e024094. [PMID: 30782726 DOI: 10.1136/bmjopen-2018-024094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
765 Zheng R, Liang J, Lu J, Li S, Zhang G, Wang X, Liu M, Wang W, Chu H, Tao G, Zhao Q, Wang M, Du M, Qiang F, Zhang Z. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis. Gastric Cancer 2019;22:731-41. [PMID: 30603909 DOI: 10.1007/s10120-018-00915-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [